|
|
not provided
|
1434192
|
29722
|
279
|
|
|
not specified
|
1300025
|
27559
|
114
|
|
|
Inborn genetic diseases
|
355109
|
4826
|
6
|
|
|
Hereditary cancer-predisposing syndrome
|
192537
|
242
|
59
|
|
|
Cardiovascular phenotype
|
90556
|
305
|
7
|
|
|
Ovarian serous cystadenocarcinoma
|
50773
|
14680
|
1
|
|
|
Thyroid cancer, nonmedullary, 1
|
46783
|
10567
|
7
|
|
|
Familial cancer of breast
|
42722
|
9804
|
137
|
|
|
See cases
|
26496
|
14628
|
118
|
|
|
Nonpapillary renal cell carcinoma
|
25862
|
7382
|
8
|
|
|
Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J
|
25082
|
28
|
1
|
|
|
Primary ciliary dyskinesia
|
25070
|
102
|
30
|
|
|
Hereditary breast ovarian cancer syndrome
|
24314
|
174
|
75
|
|
|
Uterine corpus endometrial carcinoma
|
23553
|
10927
|
1
|
|
|
Familial thoracic aortic aneurysm and aortic dissection
|
21909
|
79
|
29
|
|
|
Cervical cancer
|
19867
|
10124
|
5
|
|
|
Hereditary nonpolyposis colorectal neoplasms
|
19620
|
29
|
8
|
|
|
Cardiomyopathy
|
19288
|
158
|
40
|
|
|
Gastric cancer
|
18410
|
9321
|
12
|
|
|
Malignant tumor of esophagus
|
17217
|
9085
|
11
|
|
|
Acute myeloid leukemia
|
17126
|
8342
|
56
|
|
|
Fanconi anemia
|
16758
|
55
|
20
|
|
|
Lung cancer
|
16142
|
8796
|
18
|
|
|
Sarcoma
|
15795
|
8787
|
6
|
|
|
Ataxia-telangiectasia syndrome
|
14280
|
18
|
105
|
|
|
Early-infantile DEE
|
13977
|
18
|
1
|
|
|
Neurofibromatosis, type 1
|
13791
|
50
|
176
|
|
|
Long QT syndrome
|
13474
|
185
|
35
|
|
|
Hypertrophic cardiomyopathy
|
12841
|
142
|
55
|
|
|
Familial adenomatous polyposis 1
|
12356
|
13
|
82
|
|
|
Spastic paraplegia
|
12094
|
81
|
18
|
|
|
Hepatocellular carcinoma
|
11998
|
6958
|
12
|
|
|
Thymoma
|
11808
|
7378
|
1
|
|
|
Nemaline myopathy 2
|
11114
|
5
|
72
|
|
|
Melanoma
|
10977
|
6677
|
11
|
|
|
Retinal dystrophy
|
10697
|
394
|
23
|
|
|
Tuberous sclerosis 2
|
9831
|
26
|
102
|
|
|
Hereditary cancer-predisposing syndrome; Cardiovascular phenotype
|
9664
|
8
|
1
|
|
|
Breast-ovarian cancer, familial, susceptibility to, 1
|
9259
|
39
|
152
|
|
|
Malignant tumor of urinary bladder
|
8718
|
5674
|
9
|
|
|
Uterine carcinosarcoma
|
8571
|
5991
|
1
|
|
|
Duchenne muscular dystrophy
|
8552
|
23
|
89
|
|
|
Catecholaminergic polymorphic ventricular tachycardia 1
|
8092
|
20
|
52
|
|
|
Breast-ovarian cancer, familial, susceptibility to, 2
|
7773
|
32
|
141
|
|
|
RASopathy
|
7755
|
54
|
19
|
|
|
Bardet-Biedl syndrome
|
7553
|
64
|
35
|
|
|
RYR1-related disorder
|
7547
|
5
|
18
|
|
|
Charcot-Marie-Tooth disease type 2
|
7507
|
41
|
7
|
|
|
Cholangiocarcinoma
|
7092
|
5029
|
3
|
|
|
Bethlem myopathy 1A
|
6605
|
18
|
54
|
|
|
Colon adenocarcinoma
|
6500
|
4786
|
4
|
|
|
Joubert syndrome; Meckel-Gruber syndrome
|
6448
|
21
|
2
|
|
|
Alstrom syndrome
|
6322
|
5
|
90
|
|
|
Gastrointestinal stromal tumor
|
6255
|
18
|
30
|
|
|
Charcot-Marie-Tooth disease type 4
|
6088
|
36
|
7
|
|
|
Cohen syndrome
|
6056
|
13
|
96
|
|
|
Clear cell carcinoma of kidney
|
6026
|
4463
|
3
|
|
|
DICER1-related tumor predisposition
|
5847
|
4
|
24
|
|
|
Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy
|
5715
|
7
|
3
|
|
|
Dyskeratosis congenita
|
5605
|
34
|
15
|
|
|
Lynch syndrome
|
5560
|
28
|
32
|
|
|
Gorlin syndrome
|
5549
|
12
|
54
|
|
|
Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection
|
5546
|
11
|
1
|
|
|
Retinitis pigmentosa
|
5526
|
200
|
54
|
|
|
Cystic fibrosis
|
5452
|
36
|
110
|
|
|
Kabuki syndrome
|
5358
|
5
|
2
|
|
|
Papillary renal cell carcinoma type 1
|
5260
|
3390
|
22
|
|
|
Rhabdoid tumor predisposition syndrome 2
|
5241
|
4
|
26
|
|
|
Autosomal recessive polycystic kidney disease
|
5151
|
8
|
52
|
|
|
Malignant lymphoma, large B-cell, diffuse
|
5077
|
3769
|
4
|
|
|
Malignant hyperthermia, susceptibility to, 1
|
5054
|
12
|
59
|
|
|
Tuberous sclerosis syndrome
|
5010
|
6
|
22
|
|
|
Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; not provided; Hypertrophic cardiomyopathy 26
|
4965
|
2
|
1
|
|
|
Ehlers-Danlos syndrome, classic type, 1
|
4872
|
8
|
52
|
|
|
Baller-Gerold syndrome
|
4843
|
5
|
17
|
|
|
Neuroblastoma, susceptibility to, 3
|
4800
|
4
|
21
|
|
|
Colorectal cancer, susceptibility to, 10
|
4782
|
6
|
22
|
|
|
Epileptic encephalopathy
|
4743
|
77
|
21
|
|
|
Nephronophthisis
|
4736
|
42
|
9
|
|
|
Hereditary diffuse gastric adenocarcinoma
|
4690
|
7
|
52
|
|
|
Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant
|
4574
|
9
|
3
|
|
|
Charcot-Marie-Tooth disease axonal type 2O
|
4481
|
9
|
39
|
|
|
Familial cancer of breast; Fanconi anemia complementation group J
|
4432
|
5
|
6
|
|
|
LAMA2-related muscular dystrophy
|
4422
|
4
|
10
|
|
|
Tuberous sclerosis 1
|
4369
|
13
|
84
|
|
|
Familial hypercholesterolemia
|
4339
|
22
|
32
|
|
|
Polycystic kidney disease, adult type
|
4292
|
16
|
134
|
|
|
Bloom syndrome
|
4135
|
5
|
66
|
|
|
Cardiac arrhythmia
|
4026
|
42
|
19
|
|
|
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma; Arrhythmogenic right ventricular dysplasia 8
|
4022
|
3
|
3
|
|
|
CHARGE syndrome
|
3987
|
20
|
119
|
|
|
Emery-Dreifuss muscular dystrophy 5, autosomal dominant
|
3954
|
2
|
44
|
|
|
Brugada syndrome
|
3778
|
50
|
35
|
|
|
Neuronal ceroid lipofuscinosis
|
3771
|
29
|
10
|
|
|
Primary dilated cardiomyopathy
|
3736
|
175
|
67
|
|
|
Werner syndrome
|
3735
|
5
|
33
|
|
|
Jeune thoracic dystrophy
|
3660
|
35
|
6
|
|
|
Retinoblastoma
|
3624
|
17
|
54
|
|
|
Chédiak-Higashi syndrome
|
3611
|
7
|
40
|
|
|
Juvenile polyposis syndrome
|
3571
|
6
|
27
|
|
|
Hypercholesterolemia, familial, 1
|
3556
|
53
|
148
|
|
|
Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV
|
3470
|
8
|
2
|
|
|
Oligodontia-cancer predisposition syndrome
|
3453
|
4
|
31
|
|
|
Intellectual disability
|
3445
|
939
|
89
|
|
|
Colorectal cancer
|
3444
|
2345
|
45
|
|
|
Adams-Oliver syndrome 5
|
3434
|
12
|
35
|
|
|
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin
|
3427
|
3
|
10
|
|
|
Wilson disease
|
3427
|
11
|
106
|
|
|
Leigh syndrome
|
3416
|
92
|
58
|
|
|
Marfan syndrome
|
3411
|
28
|
140
|
|
|
Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2
|
3402
|
4
|
10
|
|
|
Hereditary sensory and autonomic neuropathy type 6; Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency
|
3377
|
5
|
6
|
|
|
Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3
|
3362
|
7
|
5
|
|
|
Renal cell carcinoma
|
3322
|
7
|
6
|
|
|
Norman-Roberts syndrome; Familial temporal lobe epilepsy 7
|
3316
|
5
|
8
|
|
|
Joubert syndrome; Meckel-Gruber syndrome; Nephronophthisis
|
3287
|
6
|
1
|
|
|
Ellis-van Creveld syndrome; Curry-Hall syndrome
|
3283
|
8
|
7
|
|
|
Charcot-Marie-Tooth disease
|
3245
|
119
|
24
|
|
|
Multiple endocrine neoplasia, type 2
|
3225
|
5
|
14
|
|
|
Hereditary spastic paraplegia 11
|
3214
|
11
|
73
|
|
|
Glycine encephalopathy
|
3210
|
13
|
53
|
|
|
EGFR-related lung cancer
|
3155
|
2
|
3
|
|
|
Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1
|
3150
|
3
|
10
|
|
|
Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia
|
3143
|
9
|
1
|
|
|
Lynch syndrome 5
|
3091
|
7
|
72
|
|
|
Ovarian cancer
|
3043
|
1954
|
15
|
|
|
Congenital contractural arachnodactyly
|
3027
|
3
|
56
|
|
|
Lynch syndrome 1
|
2980
|
22
|
79
|
|
|
Microcephaly, normal intelligence and immunodeficiency
|
2980
|
7
|
43
|
|
|
Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42
|
2971
|
11
|
6
|
|
|
Ehlers-Danlos syndrome, type 4
|
2954
|
7
|
74
|
|
|
Hereditary pancreatitis
|
2917
|
19
|
50
|
|
|
Progressive sclerosing poliodystrophy
|
2893
|
8
|
36
|
|
|
Glycogen storage disease, type II
|
2883
|
7
|
96
|
|
|
Catecholaminergic polymorphic ventricular tachycardia
|
2834
|
18
|
16
|
|
|
Glycogen storage disease type III
|
2822
|
3
|
61
|
|
|
Osteogenesis imperfecta type I
|
2818
|
10
|
71
|
|
|
Familial pancreatic carcinoma
|
2810
|
2163
|
5
|
|
|
Joubert syndrome
|
2782
|
45
|
22
|
|
|
Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis
|
2730
|
9
|
2
|
|
|
Severe combined immunodeficiency due to DNA-PKcs deficiency
|
2726
|
6
|
17
|
|
|
Dilated cardiomyopathy 1G
|
2717
|
25
|
91
|
|
|
Propionic acidemia
|
2714
|
8
|
66
|
|
|
Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal dominant 9
|
2683
|
4
|
6
|
|
|
Neuropathy, hereditary sensory and autonomic, type 2A; Generalized epilepsy with febrile seizures plus, type 7
|
2677
|
6
|
1
|
|
|
MHC class II deficiency
|
2630
|
16
|
27
|
|
|
Squamous cell carcinoma of the head and neck
|
2628
|
2152
|
7
|
|
|
BAP1-related tumor predisposition syndrome
|
2591
|
5
|
32
|
|
|
Mitochondrial complex II deficiency, nuclear type 1; Pheochromocytoma/paraganglioma syndrome 5
|
2580
|
1
|
3
|
|
|
Li-Fraumeni syndrome
|
2575
|
12
|
26
|
|
|
Niemann-Pick disease, type C1
|
2558
|
9
|
77
|
|
|
Hereditary pheochromocytoma and paraganglioma
|
2541
|
20
|
23
|
|
|
Usher syndrome type 2A
|
2513
|
6
|
90
|
|
|
Familial adenomatous polyposis 2
|
2484
|
8
|
65
|
|
|
Aortic aneurysm, familial thoracic 4
|
2468
|
5
|
42
|
|
|
Multiple endocrine neoplasia, type 1
|
2442
|
8
|
67
|
|
|
Squamous cell lung carcinoma
|
2428
|
1966
|
4
|
|
|
Spermatogenic failure 18; Ciliary dyskinesia, primary, 37
|
2371
|
1
|
6
|
|
|
Peroxisome biogenesis disorder
|
2350
|
21
|
17
|
|
|
Peutz-Jeghers syndrome
|
2350
|
13
|
55
|
|
|
Combined immunodeficiency due to DOCK8 deficiency
|
2330
|
12
|
40
|
|
|
Familial hypocalciuric hypercalcemia; Autosomal dominant hypocalcemia 1
|
2283
|
3
|
1
|
|
|
KBG syndrome
|
2283
|
26
|
123
|
|
|
Vici syndrome
|
2280
|
5
|
48
|
|
|
Familial sleep-related hypermotor epilepsy
|
2277
|
19
|
8
|
|
|
Perlman syndrome
|
2266
|
8
|
26
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2J
|
2250
|
21
|
45
|
|
|
Congenital myasthenic syndrome 8
|
2229
|
8
|
37
|
|
|
Alpha thalassemia-X-linked intellectual disability syndrome
|
2228
|
7
|
43
|
|
|
Early-onset myopathy with fatal cardiomyopathy
|
2203
|
20
|
30
|
|
|
Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5
|
2201
|
2
|
2
|
|
|
Zellweger spectrum disorders
|
2191
|
9
|
5
|
|
|
Kleefstra syndrome 1
|
2177
|
94
|
81
|
|
|
Birt-Hogg-Dube syndrome
|
2173
|
5
|
40
|
|
|
Tibial muscular dystrophy
|
2172
|
22
|
23
|
|
|
Myopathy, myofibrillar, 9, with early respiratory failure
|
2163
|
21
|
23
|
|
|
Combined immunodeficiency due to LRBA deficiency
|
2150
|
8
|
47
|
|
|
Uveal melanoma
|
2150
|
1843
|
4
|
|
|
Familial focal epilepsy with variable foci
|
2137
|
5
|
3
|
|
|
Hereditary spastic paraplegia
|
2128
|
114
|
26
|
|
|
Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5
|
2127
|
7
|
11
|
|
|
PTEN hamartoma tumor syndrome
|
2120
|
15
|
39
|
|
|
Aortic aneurysm, familial thoracic 7
|
2115
|
7
|
39
|
|
|
Lymphoma
|
2109
|
1781
|
2
|
|
|
Colorectal cancer, hereditary nonpolyposis, type 2
|
2100
|
3
|
54
|
|
|
Maple syrup urine disease
|
2070
|
8
|
53
|
|
|
Breast and/or ovarian cancer
|
2065
|
28
|
4
|
|
|
Very long chain acyl-CoA dehydrogenase deficiency
|
2039
|
8
|
69
|
|
|
Hypertrophic cardiomyopathy 14
|
2009
|
9
|
25
|
|
|
Maturity-onset diabetes of the young
|
2003
|
20
|
21
|
|
|
Developmental and epileptic encephalopathy 94
|
1996
|
4
|
83
|
|
|
Pitt-Hopkins-like syndrome 2
|
1994
|
9
|
25
|
|
|
Neuropathy, hereditary sensory and autonomic, type 2A; Pseudohypoaldosteronism type 2C
|
1990
|
3
|
4
|
|
|
Malignant tumor of breast
|
1986
|
73
|
18
|
|
|
Landau-Kleffner syndrome
|
1969
|
7
|
79
|
|
|
Dilated cardiomyopathy 1DD
|
1963
|
5
|
46
|
|
|
Hyperkalemic periodic paralysis
|
1949
|
6
|
21
|
|
|
Developmental and epileptic encephalopathy, 12
|
1948
|
10
|
21
|
|
|
Congenital hyperammonemia, type I
|
1940
|
2
|
46
|
|
|
Lynch syndrome 4
|
1939
|
7
|
66
|
|
|
Glioma susceptibility 1
|
1938
|
1632
|
9
|
|
|
Early Myoclonic Encephalopathy
|
1931
|
6
|
7
|
|
|
Familial melanoma
|
1931
|
17
|
9
|
|
|
Classic or attenuated familial adenomatous polyposis
|
1928
|
2
|
5
|
|
|
Neurofibromatosis, type 2
|
1923
|
6
|
49
|
|
|
Fanconi anemia complementation group A
|
1922
|
27
|
76
|
|
|
Imerslund-Grasbeck syndrome
|
1920
|
9
|
16
|
|
|
Pancreatic adenocarcinoma
|
1906
|
1106
|
2
|
|
|
Tumor predisposition syndrome 3
|
1905
|
2
|
20
|
|
|
Malignant hyperthermia, susceptibility to, 5
|
1888
|
1
|
17
|
|
|
Fabry disease
|
1879
|
7
|
76
|
|
|
Saldino-Mainzer syndrome
|
1872
|
10
|
32
|
|
|
Polycystic kidney disease 4
|
1862
|
4
|
74
|
|
|
Seizures, benign familial infantile, 3; Developmental and epileptic encephalopathy, 11
|
1845
|
6
|
10
|
|
|
Brugada syndrome 8
|
1811
|
7
|
9
|
|
|
Osteogenesis imperfecta type I; Ehlers-Danlos syndrome, classic type, 1
|
1808
|
2
|
1
|
|
|
Usher syndrome type 1
|
1806
|
12
|
56
|
|
|
Deficiency of alpha-mannosidase
|
1803
|
8
|
57
|
|
|
Leber congenital amaurosis
|
1784
|
68
|
25
|
|
|
CFTR-related disorder
|
1778
|
7
|
11
|
|
|
Ehlers-Danlos syndrome, dermatosparaxis type
|
1774
|
5
|
25
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2A
|
1757
|
7
|
76
|
|
|
Multiple acyl-CoA dehydrogenase deficiency
|
1746
|
5
|
50
|
|
|
Charlevoix-Saguenay spastic ataxia
|
1732
|
3
|
80
|
|
|
Adrenocortical carcinoma, hereditary
|
1719
|
1403
|
5
|
|
|
Neoplasm
|
1717
|
316
|
2
|
|
|
Walker-Warburg congenital muscular dystrophy
|
1707
|
9
|
5
|
|
|
Cornelia de Lange syndrome 1
|
1700
|
13
|
101
|
|
|
Fanconi anemia complementation group O
|
1687
|
6
|
14
|
|
|
Arrhythmogenic right ventricular cardiomyopathy
|
1677
|
49
|
32
|
|
|
Progressive familial heart block type IB
|
1665
|
3
|
23
|
|
|
Dilated cardiomyopathy 1O
|
1660
|
3
|
14
|
|
|
Menkes kinky-hair syndrome; Cutis laxa, X-linked; X-linked distal spinal muscular atrophy type 3
|
1655
|
5
|
7
|
|
|
Breast-ovarian cancer, familial, susceptibility to, 4
|
1654
|
6
|
36
|
|
|
Immunodeficiency 104
|
1651
|
6
|
29
|
|
|
Arrhythmogenic right ventricular dysplasia 9
|
1640
|
18
|
70
|
|
|
Nephrolithiasis/nephrocalcinosis
|
1637
|
7
|
2
|
|
|
Familial hemophagocytic lymphohistiocytosis 3
|
1634
|
3
|
38
|
|
|
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma
|
1633
|
1
|
22
|
|
|
Rubinstein-Taybi syndrome
|
1630
|
11
|
7
|
|
|
Retinitis pigmentosa 12; Leber congenital amaurosis 8
|
1624
|
3
|
3
|
|
|
Chronic lymphocytic leukemia/small lymphocytic lymphoma
|
1616
|
1338
|
1
|
|
|
Tramadol response
|
1610
|
17
|
1
|
|
|
Mucopolysaccharidosis type 1
|
1608
|
10
|
19
|
|
|
FG syndrome
|
1598
|
3
|
2
|
|
|
Autosomal dominant nonsyndromic hearing loss 1; Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome
|
1595
|
1
|
6
|
|
|
Familial cold autoinflammatory syndrome 3
|
1585
|
2
|
10
|
|
|
Cortical dysplasia-focal epilepsy syndrome
|
1584
|
8
|
31
|
|
|
Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9
|
1583
|
20
|
11
|
|
|
Phenylketonuria
|
1570
|
9
|
100
|
|
|
Developmental and epileptic encephalopathy, 23
|
1567
|
4
|
27
|
|
|
Monogenic diabetes
|
1558
|
52
|
10
|
|
|
Endometrial carcinoma
|
1553
|
39
|
25
|
|
|
Adrenoleukodystrophy
|
1551
|
11
|
84
|
|
|
Arrhythmogenic right ventricular dysplasia 10
|
1541
|
6
|
38
|
|
|
Chuvash polycythemia; Von Hippel-Lindau syndrome
|
1538
|
6
|
2
|
|
|
Hajdu-Cheney syndrome
|
1537
|
4
|
26
|
|
|
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome
|
1535
|
6
|
1
|
|
|
Noonan syndrome 9
|
1534
|
4
|
37
|
|
|
Alagille syndrome due to a JAG1 point mutation
|
1533
|
9
|
70
|
|
|
Retinitis pigmentosa 39
|
1533
|
2
|
36
|
|
|
Singleton-Merten syndrome 1; Aicardi-Goutieres syndrome 7
|
1519
|
1
|
9
|
|
|
Brachyolmia-amelogenesis imperfecta syndrome
|
1516
|
8
|
15
|
|
|
Alport syndrome
|
1510
|
9
|
25
|
|
|
Short-rib thoracic dysplasia 10 with or without polydactyly; Retinitis pigmentosa 71
|
1502
|
5
|
3
|
|
|
Intellectual disability, autosomal dominant 5
|
1495
|
7
|
96
|
|
|
Parathyroid carcinoma
|
1495
|
6
|
6
|
|
|
Glycogen storage disease, type V
|
1489
|
2
|
63
|
|
|
Focal segmental glomerulosclerosis 5; Charcot-Marie-Tooth disease dominant intermediate E
|
1488
|
4
|
4
|
|
|
Autoinflammatory syndrome
|
1482
|
43
|
4
|
|
|
Myopathy, proximal, and ophthalmoplegia
|
1479
|
8
|
40
|
|
|
Symmetrical dyschromatosis of extremities; Aicardi-Goutieres syndrome 6
|
1456
|
5
|
8
|
|
|
Nephronophthisis 15
|
1448
|
3
|
21
|
|
|
Intellectual disability, autosomal dominant 1
|
1444
|
14
|
50
|
|
|
Dilated cardiomyopathy 1JJ
|
1441
|
2
|
27
|
|
|
Hereditary sensory neuropathy-deafness-dementia syndrome
|
1433
|
6
|
17
|
|
|
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1
|
1430
|
10
|
33
|
|
|
Drash syndrome; Frasier syndrome; Wilms tumor 1; 11p partial monosomy syndrome
|
1419
|
4
|
2
|
|
|
Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form
|
1411
|
3
|
12
|
|
|
Galactosylceramide beta-galactosidase deficiency
|
1407
|
6
|
71
|
|
|
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency
|
1401
|
7
|
62
|
|
|
Hereditary hemorrhagic telangiectasia
|
1383
|
5
|
12
|
|
|
Hereditary insensitivity to pain with anhidrosis
|
1382
|
5
|
41
|
|
|
Pyruvate carboxylase deficiency
|
1376
|
4
|
34
|
|
|
Hereditary sensory and autonomic neuropathy type 7; Familial episodic pain syndrome with predominantly lower limb involvement
|
1375
|
3
|
6
|
|
|
Epidermodysplasia verruciformis
|
1374
|
11
|
2
|
|
|
Early-onset Parkinson disease 20; Developmental and epileptic encephalopathy, 53
|
1372
|
4
|
5
|
|
|
TTN-related disorder
|
1368
|
21
|
12
|
|
|
Metachromatic leukodystrophy
|
1364
|
12
|
79
|
|
|
Cone-rod dystrophy 6; Leber congenital amaurosis 1
|
1363
|
3
|
3
|
|
|
Dilated cardiomyopathy 1AA; Primary familial hypertrophic cardiomyopathy
|
1363
|
3
|
1
|
|
|
Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
|
1361
|
2
|
6
|
|
|
Mucopolysaccharidosis, MPS-II
|
1361
|
7
|
65
|
|
|
Capillary malformation-arteriovenous malformation syndrome
|
1358
|
5
|
5
|
|
|
Connective tissue disorder
|
1356
|
86
|
6
|
|
|
Wilms tumor 1
|
1354
|
7
|
28
|
|
|
Hereditary spastic paraplegia 49
|
1352
|
3
|
29
|
|
|
Arrhythmogenic right ventricular dysplasia 11
|
1351
|
3
|
43
|
|
|
Dilated cardiomyopathy 1W
|
1350
|
2
|
9
|
|
|
Li-Fraumeni syndrome 1
|
1349
|
5
|
66
|
|
|
Acrocallosal syndrome
|
1345
|
3
|
25
|
|
|
Retinitis pigmentosa 25
|
1334
|
8
|
61
|
|
|
Amyotrophic lateral sclerosis type 1; Perry syndrome; Neuronopathy, distal hereditary motor, type 7B
|
1332
|
1
|
4
|
|
|
Colorectal cancer, hereditary nonpolyposis, type 7
|
1325
|
2
|
16
|
|
|
Left ventricular noncompaction 8
|
1322
|
4
|
26
|
|
|
X-linked Alport syndrome
|
1322
|
7
|
104
|
|
|
Facioscapulohumeral muscular dystrophy 2
|
1319
|
4
|
16
|
|
|
Joubert syndrome 23; Short-rib thoracic dysplasia 14 with polydactyly
|
1317
|
2
|
8
|
|
|
Deafness-lymphedema-leukemia syndrome; Monocytopenia with susceptibility to infections
|
1314
|
4
|
3
|
|
|
Prostate cancer, hereditary, 1
|
1307
|
9
|
9
|
|
|
Idiopathic generalized epilepsy
|
1306
|
16
|
8
|
|
|
Dystonic disorder
|
1303
|
26
|
14
|
|
|
Familial intrahepatic cholestasis
|
1298
|
6
|
1
|
|
|
Familial cold autoinflammatory syndrome 2
|
1295
|
3
|
40
|
|
|
Mucolipidosis type II; Pseudo-Hurler polydystrophy
|
1294
|
1
|
7
|
|
|
Mowat-Wilson syndrome
|
1293
|
4
|
84
|
|
|
Gorlin syndrome; Medulloblastoma
|
1292
|
4
|
1
|
|
|
Developmental and epileptic encephalopathy, 9
|
1279
|
7
|
63
|
|
|
Progressive myoclonic epilepsy
|
1279
|
20
|
4
|
|
|
Tay-Sachs disease
|
1275
|
6
|
67
|
|
|
Gastrointestinal stromal tumor; Pheochromocytoma/paraganglioma syndrome 4; Pheochromocytoma
|
1263
|
6
|
2
|
|
|
Polyglandular autoimmune syndrome, type 1
|
1262
|
8
|
44
|
|
|
Hereditary spastic paraplegia 39
|
1257
|
4
|
21
|
|
|
PCNT-related disorder
|
1257
|
2
|
1
|
|
|
Aortic valve disease 2
|
1253
|
4
|
20
|
|
|
Beckwith-Wiedemann syndrome
|
1251
|
15
|
35
|
|
|
Donnai-Barrow syndrome
|
1247
|
2
|
43
|
|
|
Mucopolysaccharidosis, MPS-IV-A
|
1245
|
9
|
50
|
|
|
Genitopatellar syndrome
|
1241
|
4
|
28
|
|
|
Severe myoclonic epilepsy in infancy
|
1238
|
16
|
88
|
|
|
Congenital myasthenic syndrome 4A
|
1231
|
9
|
22
|
|
|
Renal carnitine transport defect
|
1231
|
9
|
61
|
|
|
Intellectual disability, autosomal dominant 6; Developmental and epileptic encephalopathy, 27
|
1229
|
3
|
17
|
|
|
Pityriasis rubra pilaris; Psoriasis 2
|
1228
|
5
|
7
|
|
|
T-B+ severe combined immunodeficiency due to JAK3 deficiency
|
1227
|
2
|
30
|
|
|
MHC class I deficiency
|
1223
|
7
|
17
|
|
|
Hereditary hemochromatosis
|
1220
|
6
|
4
|
|
|
Schimke immuno-osseous dysplasia
|
1219
|
3
|
36
|
|
|
Ehlers-Danlos syndrome
|
1217
|
39
|
13
|
|
|
Neuronopathy, distal hereditary motor, autosomal recessive 4; Charcot-Marie-Tooth disease recessive intermediate C
|
1215
|
2
|
8
|
|
|
Dilated cardiomyopathy 1KK
|
1213
|
3
|
28
|
|
|
Cenani-Lenz syndactyly syndrome; Sclerosteosis 2; Congenital myasthenic syndrome 17
|
1211
|
2
|
4
|
|
|
Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease
|
1210
|
4
|
1
|
|
|
Fraser syndrome 1
|
1209
|
6
|
51
|
|
|
Hereditary spastic paraplegia 4
|
1203
|
19
|
97
|
|
|
Emery-Dreifuss muscular dystrophy
|
1200
|
13
|
8
|
|
|
Long QT syndrome 5
|
1193
|
1
|
14
|
|
|
Charcot-Marie-Tooth disease dominant intermediate B
|
1192
|
10
|
24
|
|
|
Mucopolysaccharidosis, MPS-III-B; Charcot-Marie-Tooth disease axonal type 2V
|
1189
|
3
|
4
|
|
|
Multiple congenital anomalies-hypotonia-seizures syndrome 1
|
1186
|
8
|
45
|
|
|
Methylmalonic acidemia with homocystinuria, type cblX
|
1179
|
4
|
29
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2O; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3
|
1178
|
3
|
1
|
|
|
Myofibrillar myopathy 4
|
1177
|
4
|
16
|
|
|
Combined immunodeficiency with skin granulomas; Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive
|
1174
|
3
|
3
|
|
|
Neurodevelopmental disorder
|
1174
|
633
|
43
|
|
|
Charcot-Marie-Tooth disease, type I
|
1173
|
30
|
5
|
|
|
Mucopolysaccharidosis, MPS-III-A
|
1169
|
10
|
58
|
|
|
Neonatal-onset encephalopathy with rigidity and seizures
|
1166
|
2
|
22
|
|
|
Generalized epilepsy-paroxysmal dyskinesia syndrome
|
1159
|
3
|
26
|
|
|
Naxos disease; Arrhythmogenic right ventricular dysplasia 12
|
1155
|
2
|
8
|
|
|
Autosomal recessive DOPA responsive dystonia
|
1151
|
5
|
43
|
|
|
Autosomal recessive distal spinal muscular atrophy 1; Charcot-Marie-Tooth disease axonal type 2S
|
1151
|
2
|
8
|
|
|
Myofibrillar myopathy 6; Dilated cardiomyopathy 1HH
|
1143
|
1
|
5
|
|
|
Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency
|
1142
|
1
|
1
|
|
|
Familial hemophagocytic lymphohistiocytosis 5
|
1142
|
5
|
26
|
|
|
Familial hemiplegic migraine
|
1140
|
6
|
3
|
|
|
Koolen-de Vries syndrome
|
1137
|
10
|
64
|
|
|
DOCK2 deficiency
|
1136
|
6
|
15
|
|
|
Autosomal dominant polycystic kidney disease
|
1131
|
26
|
14
|
|
|
Glanzmann thrombasthenia
|
1130
|
9
|
13
|
|
|
Familial colorectal cancer
|
1127
|
26
|
12
|
|
|
Gnathodiaphyseal dysplasia; Autosomal recessive limb-girdle muscular dystrophy type 2L
|
1126
|
2
|
2
|
|
|
Joubert syndrome 21
|
1120
|
5
|
35
|
|
|
Rett syndrome
|
1119
|
11
|
114
|
|
|
Familial Mediterranean fever
|
1117
|
2
|
61
|
|
|
Intellectual disability, X-linked 1
|
1110
|
7
|
65
|
|
|
Pierson syndrome; LAMB2-related infantile-onset nephrotic syndrome
|
1100
|
3
|
5
|
|
|
Cholestanol storage disease
|
1098
|
3
|
55
|
|
|
Severe neonatal-onset encephalopathy with microcephaly
|
1097
|
14
|
20
|
|
|
Desmin-related myofibrillar myopathy
|
1093
|
6
|
45
|
|
|
Familial thoracic aortic aneurysm and aortic dissection; Hereditary cancer-predisposing syndrome
|
1093
|
1
|
1
|
|
|
Developmental and epileptic encephalopathy, 36
|
1082
|
5
|
31
|
|
|
Diamond-Blackfan anemia
|
1082
|
34
|
12
|
|
|
Severe combined immunodeficiency due to DCLRE1C deficiency
|
1082
|
7
|
22
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2B
|
1080
|
6
|
64
|
|
|
Dystonia 12
|
1080
|
3
|
25
|
|
|
Jeune thoracic dystrophy; Nephronophthisis
|
1080
|
2
|
1
|
|
|
Supravalvar aortic stenosis
|
1078
|
3
|
34
|
|
|
Ataxia-telangiectasia-like disorder
|
1075
|
2
|
3
|
|
|
Lethal multiple pterygium syndrome
|
1069
|
9
|
19
|
|
|
Creatine transporter deficiency
|
1067
|
8
|
70
|
|
|
Primary ciliary dyskinesia 3
|
1066
|
13
|
64
|
|
|
Combined oxidative phosphorylation defect type 17
|
1064
|
1
|
24
|
|
|
Carnitine palmitoyl transferase 1A deficiency
|
1055
|
2
|
31
|
|
|
Charcot-Marie-Tooth disease axonal type 2C
|
1051
|
3
|
29
|
|
|
Mucopolysaccharidosis, MPS-III-C; Retinitis pigmentosa 73
|
1051
|
6
|
5
|
|
|
Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 10
|
1048
|
5
|
1
|
|
|
Glycogen storage disease IXb
|
1048
|
4
|
29
|
|
|
Hypercholesterolemia, autosomal dominant, 3
|
1048
|
3
|
35
|
|
|
Asphyxiating thoracic dystrophy 5; Senior-Loken syndrome 8
|
1047
|
1
|
1
|
|
|
Hypertrophic cardiomyopathy 1
|
1046
|
39
|
88
|
|
|
HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED
|
1037
|
2
|
2
|
|
|
Smith-Lemli-Opitz syndrome
|
1037
|
5
|
76
|
|
|
Developmental and epileptic encephalopathy, 30
|
1034
|
7
|
19
|
|
|
Familial meningioma
|
1033
|
19
|
19
|
|
|
Ehlers-Danlos syndrome, kyphoscoliotic type 1
|
1031
|
6
|
35
|
|
|
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant
|
1027
|
5
|
53
|
|
|
Familial dysautonomia
|
1024
|
1
|
23
|
|
|
Glucose-6-phosphate transport defect
|
1023
|
3
|
32
|
|
|
Blau syndrome; Regional enteritis
|
1022
|
3
|
1
|
|
|
Methylcobalamin deficiency type cblG
|
1022
|
4
|
17
|
|
|
Autosomal dominant Parkinson disease 8
|
1017
|
2
|
33
|
|
|
Multiple congenital exostosis
|
1016
|
7
|
20
|
|
|
Developmental and epileptic encephalopathy
|
1015
|
106
|
31
|
|
|
Pyridoxine-dependent epilepsy
|
1013
|
9
|
57
|
|
|
Carnitine palmitoyltransferase II deficiency
|
1010
|
2
|
15
|
|
|
Mosaic variegated aneuploidy syndrome 1
|
1008
|
8
|
21
|
|
|
Carney complex, type 1
|
1003
|
4
|
14
|
|
|
Primary familial hypertrophic cardiomyopathy
|
1002
|
93
|
17
|
|
|
BRCA2-related cancer predisposition
|
1000
|
5
|
7
|
|
|
Cowden syndrome 1
|
998
|
8
|
78
|
|
|
Multiple gastrointestinal atresias
|
991
|
4
|
13
|
|
|
Medium-chain acyl-coenzyme A dehydrogenase deficiency
|
979
|
3
|
63
|
|
|
Telangiectasia, hereditary hemorrhagic, type 2
|
978
|
2
|
52
|
|
|
Intellectual disability, autosomal recessive 53
|
973
|
7
|
27
|
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2; Autosomal recessive limb-girdle muscular dystrophy type 2N
|
973
|
4
|
9
|
|
|
Congenital long QT syndrome
|
972
|
36
|
14
|
|
|
Epilepsy, childhood absence, susceptibility to, 6; Hyperaldosteronism, familial, type IV
|
968
|
1
|
3
|
|
|
Kabuki syndrome 1
|
968
|
13
|
139
|
|
|
Holocarboxylase synthetase deficiency
|
967
|
4
|
31
|
|
|
VPS13B-related disorder
|
967
|
3
|
1
|
|
|
Benign neonatal seizures
|
962
|
3
|
2
|
|
|
Developmental and epileptic encephalopathy, 54
|
961
|
9
|
55
|
|
|
Kufor-Rakeb syndrome; Autosomal recessive spastic paraplegia type 78
|
959
|
2
|
8
|
|
|
Glycogen storage disease, type VII
|
958
|
2
|
23
|
|
|
Bifunctional peroxisomal enzyme deficiency; Perrault syndrome
|
957
|
2
|
1
|
|
|
Loeys-Dietz syndrome 2
|
957
|
5
|
48
|
|
|
Kabuki syndrome 2
|
955
|
8
|
66
|
|
|
Congenital muscular dystrophy due to integrin alpha-7 deficiency
|
954
|
4
|
23
|
|
|
Herpes simplex encephalitis, susceptibility to, 1
|
954
|
5
|
8
|
|
|
Ellis-van Creveld syndrome
|
953
|
10
|
54
|
|
|
Immunodeficiency 14
|
953
|
5
|
38
|
|
|
Immunodeficiency 35
|
948
|
3
|
19
|
|
|
Xanthinuria type II
|
948
|
4
|
13
|
|
|
Dextro-looped transposition of the great arteries
|
946
|
3
|
7
|
|
|
Mucopolysaccharidosis type 6
|
945
|
6
|
45
|
|
|
Combined malonic and methylmalonic acidemia
|
939
|
2
|
31
|
|
|
Familial infantile myasthenia
|
938
|
3
|
31
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2K; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1; Walker-Warburg congenital muscular dystrophy
|
937
|
2
|
1
|
|
|
Shprintzen-Goldberg syndrome
|
935
|
4
|
38
|
|
|
Developmental and epileptic encephalopathy, 2; Angelman syndrome-like
|
934
|
5
|
1
|
|
|
Sotos syndrome
|
932
|
12
|
104
|
|
|
Epilepsy, familial focal, with variable foci 3
|
928
|
4
|
36
|
|
|
Hyperphosphatasia with intellectual disability syndrome 2
|
927
|
5
|
29
|
|
|
Lethal congenital glycogen storage disease of heart
|
927
|
6
|
6
|
|
|
Mucopolysaccharidosis, MPS-IV-B; GM1 gangliosidosis
|
927
|
3
|
2
|
|
|
MEGF10-related myopathy
|
926
|
1
|
15
|
|
|
Arrhythmogenic right ventricular dysplasia 13
|
925
|
5
|
17
|
|
|
2-aminoadipic 2-oxoadipic aciduria
|
923
|
3
|
22
|
|
|
Cone-rod dystrophy 13; Leber congenital amaurosis 6
|
923
|
3
|
5
|
|
|
Pitt-Hopkins syndrome
|
922
|
7
|
79
|
|
|
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome
|
921
|
5
|
26
|
|
|
Glutaric aciduria, type 1
|
919
|
7
|
73
|
|
|
Peroxisome biogenesis disorder 2B
|
914
|
6
|
9
|
|
|
Autosomal recessive nonsyndromic hearing loss 3
|
910
|
5
|
82
|
|
|
Dilated cardiomyopathy 1J
|
910
|
3
|
6
|
|
|
Aicardi-Goutieres syndrome 5
|
908
|
4
|
23
|
|
|
Developmental and epileptic encephalopathy, 34
|
906
|
3
|
19
|
|
|
Hereditary spastic paraplegia 7
|
904
|
8
|
85
|
|
|
Von Hippel-Lindau syndrome
|
903
|
9
|
60
|
|
|
Osteogenesis imperfecta
|
902
|
38
|
36
|
|
|
Autoimmune interstitial lung disease-arthritis syndrome
|
901
|
5
|
20
|
|
|
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome
|
901
|
2
|
23
|
|
|
Mucolipidosis type IV
|
901
|
6
|
37
|
|
|
Hereditary spastic paraplegia 48
|
900
|
6
|
28
|
|
|
Usher syndrome type 1F
|
896
|
4
|
24
|
|
|
Arrhythmogenic right ventricular dysplasia 5
|
893
|
1
|
16
|
|
|
Epidermolysis bullosa dystrophica
|
888
|
2
|
9
|
|
|
Familial prostate cancer
|
886
|
757
|
11
|
|
|
Finnish congenital nephrotic syndrome
|
886
|
13
|
67
|
|
|
Infantile neuroaxonal dystrophy
|
886
|
3
|
35
|
|
|
DYRK1A-related intellectual disability syndrome
|
881
|
7
|
76
|
|
|
Argininosuccinate lyase deficiency
|
880
|
5
|
57
|
|
|
Neuronal ceroid lipofuscinosis 7
|
880
|
9
|
41
|
|
|
Immunodeficiency 51
|
879
|
7
|
19
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type R18
|
878
|
2
|
24
|
|
|
Muscular dystrophy-dystroglycanopathy type B6
|
875
|
5
|
7
|
|
|
ALG1-congenital disorder of glycosylation
|
874
|
4
|
36
|
|
|
Methylcobalamin deficiency type cblE
|
874
|
3
|
18
|
|
|
Cryopyrin associated periodic syndrome
|
872
|
3
|
7
|
|
|
Usher syndrome type 1B
|
872
|
1
|
5
|
|
|
Exostoses, multiple, type 2
|
871
|
4
|
39
|
|
|
Developmental and epileptic encephalopathy, 1; Autosomal recessive spinocerebellar ataxia 12
|
869
|
9
|
1
|
|
|
Congenital factor V deficiency
|
867
|
2
|
16
|
|
|
Hereditary spherocytosis type 1
|
865
|
5
|
54
|
|
|
Multiple endocrine neoplasia type 4
|
863
|
6
|
25
|
|
|
3-methylcrotonyl-CoA carboxylase 1 deficiency
|
862
|
3
|
32
|
|
|
DiGeorge syndrome
|
862
|
20
|
23
|
|
|
PHGDH deficiency
|
857
|
3
|
16
|
|
|
Congenital muscular hypertrophy-cerebral syndrome
|
854
|
6
|
49
|
|
|
Dyskeratosis congenita, autosomal recessive 6; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4
|
852
|
1
|
5
|
|
|
Familial hypokalemia-hypomagnesemia
|
852
|
5
|
80
|
|
|
Luscan-Lumish syndrome
|
852
|
4
|
36
|
|
|
Niemann-Pick disease, type B; Niemann-Pick disease, type A
|
852
|
3
|
13
|
|
|
Osteogenesis imperfecta type 8
|
852
|
2
|
39
|
|
|
Majeed syndrome
|
850
|
4
|
24
|
|
|
Atypical hemolytic-uremic syndrome
|
849
|
33
|
11
|
|
|
Familial acute necrotizing encephalopathy
|
849
|
7
|
25
|
|
|
PKD1-related disorder
|
849
|
4
|
2
|
|
|
Breast-ovarian cancer, familial, susceptibility to, 3
|
848
|
7
|
37
|
|
|
Charcot-Marie-Tooth disease axonal type 2Z
|
846
|
1
|
33
|
|
|
Nephronophthisis 14
|
845
|
3
|
17
|
|
|
Mitochondrial trifunctional protein deficiency; Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency
|
844
|
3
|
3
|
|
|
Autosomal recessive nonsyndromic hearing loss 77
|
843
|
1
|
49
|
|
|
Hermansky-Pudlak syndrome 2
|
841
|
4
|
25
|
|
|
Charcot-Marie-Tooth disease axonal type 2P
|
840
|
2
|
38
|
|
|
Adenylosuccinate lyase deficiency
|
839
|
3
|
42
|
|
|
GNE myopathy; Sialuria
|
839
|
1
|
7
|
|
|
Candidiasis, familial, 9
|
838
|
7
|
12
|
|
|
Leber congenital amaurosis 2; Retinitis pigmentosa 20
|
838
|
2
|
4
|
|
|
Glycogen storage disease, type IV; Glycogen storage disease IV, classic hepatic
|
837
|
4
|
1
|
|
|
VPS13A-related neurodegenerative disease
|
836
|
4
|
42
|
|
|
GLUT1 deficiency syndrome 1, autosomal recessive
|
835
|
5
|
2
|
|
|
Acyl-CoA oxidase deficiency
|
833
|
3
|
23
|
|
|
COG5-congenital disorder of glycosylation
|
832
|
9
|
22
|
|
|
Leukocyte adhesion deficiency 1
|
831
|
1
|
25
|
|
|
Epilepsy, familial adult myoclonic, 5
|
829
|
3
|
17
|
|
|
Homocystinuria due to methylene tetrahydrofolate reductase deficiency
|
829
|
3
|
45
|
|
|
Tietz syndrome; Waardenburg syndrome type 2A; Melanoma, cutaneous malignant, susceptibility to, 8
|
829
|
2
|
1
|
|
|
Sandhoff disease
|
828
|
4
|
58
|
|
|
Immunodeficiency
|
827
|
12
|
9
|
|
|
Cranioectodermal dysplasia 1
|
822
|
5
|
27
|
|
|
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C
|
821
|
3
|
13
|
|
|
Colorectal cancer, susceptibility to, 12
|
819
|
4
|
30
|
|
|
KMT2D-related disorder
|
819
|
2
|
4
|
|
|
Legius syndrome
|
817
|
5
|
43
|
|
|
Lysinuric protein intolerance
|
817
|
7
|
32
|
|
|
Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency
|
816
|
4
|
1
|
|
|
Epilepsy with myoclonic atonic seizures
|
816
|
9
|
59
|
|
|
Infantile-onset ascending hereditary spastic paralysis
|
814
|
2
|
22
|
|
|
Brody myopathy
|
813
|
5
|
22
|
|
|
Citrullinemia
|
810
|
6
|
7
|
|
|
Sphingolipid activator protein 1 deficiency
|
810
|
3
|
16
|
|
|
Angelman syndrome
|
808
|
18
|
73
|
|
|
Fanconi anemia complementation group P
|
808
|
2
|
33
|
|
|
ALG6-congenital disorder of glycosylation 1C
|
805
|
3
|
26
|
|
|
Carcinoma of colon
|
804
|
64
|
15
|
|
|
Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency; Charcot-Marie-Tooth disease axonal type 2U
|
804
|
5
|
2
|
|
|
T-cell immunodeficiency, congenital alopecia, and nail dystrophy
|
802
|
1
|
12
|
|
|
Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures
|
801
|
2
|
36
|
|
|
Rare genetic deafness
|
801
|
91
|
2
|
|
|
Epilepsy
|
800
|
89
|
24
|
|
|
Immunodeficiency, common variable, 10
|
798
|
9
|
27
|
|
|
Congenital disorder of deglycosylation
|
797
|
3
|
20
|
|
|
Mitochondrial complex I deficiency, nuclear type 1
|
796
|
38
|
24
|
|
|
Tyrosinemia type I
|
796
|
4
|
40
|
|
|
Developmental and epileptic encephalopathy, 31A
|
794
|
11
|
42
|
|
|
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency
|
790
|
4
|
12
|
|
|
Hereditary factor VIII deficiency disease
|
789
|
18
|
58
|
|
|
Succinate-semialdehyde dehydrogenase deficiency
|
788
|
5
|
46
|
|
|
Atrioventricular septal defect 4
|
785
|
4
|
6
|
|
|
Periodic fever-infantile enterocolitis-autoinflammatory syndrome; Familial cold autoinflammatory syndrome 4
|
785
|
3
|
6
|
|
|
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome
|
784
|
5
|
33
|
|
|
PMM2-congenital disorder of glycosylation
|
784
|
5
|
85
|
|
|
Autosomal recessive Alport syndrome
|
783
|
6
|
65
|
|
|
Fibrous dysplasia of jaw
|
783
|
6
|
23
|
|
|
Hereditary pulmonary alveolar proteinosis
|
781
|
3
|
2
|
|
|
Joubert syndrome; Orofaciodigital syndrome I
|
781
|
5
|
1
|
|
|
Fanconi anemia complementation group E
|
777
|
2
|
21
|
|
|
Hyperekplexia 3
|
776
|
1
|
28
|
|
|
Multiple sulfatase deficiency
|
776
|
5
|
35
|
|
|
Short-rib thoracic dysplasia 6 with or without polydactyly
|
774
|
18
|
27
|
|
|
Stormorken syndrome; Combined immunodeficiency due to STIM1 deficiency; Myopathy with tubular aggregates
|
773
|
5
|
1
|
|
|
Usher syndrome type 2A; Retinitis pigmentosa 39
|
773
|
3
|
15
|
|
|
3-methylcrotonyl-CoA carboxylase 2 deficiency
|
772
|
2
|
44
|
|
|
Treacher Collins syndrome 1
|
770
|
7
|
49
|
|
|
Gamma-aminobutyric acid transaminase deficiency
|
769
|
5
|
19
|
|
|
Immunodeficiency, common variable, 7
|
769
|
5
|
20
|
|
|
Pyruvate dehydrogenase E1-alpha deficiency
|
767
|
5
|
70
|
|
|
ALG9 congenital disorder of glycosylation
|
763
|
8
|
14
|
|
|
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A
|
763
|
4
|
27
|
|
|
Schuurs-Hoeijmakers syndrome
|
758
|
2
|
49
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2D
|
757
|
3
|
49
|
|
|
Pheochromocytoma/paraganglioma syndrome 5
|
757
|
2
|
32
|
|
|
Severe combined immunodeficiency due to IKK2 deficiency
|
757
|
5
|
15
|
|
|
Anemia, nonspherocytic hemolytic, due to G6PD deficiency
|
756
|
10
|
63
|
|
|
Mucopolysaccharidosis, MPS-III-D
|
755
|
3
|
21
|
|
|
Charcot-Marie-Tooth Neuropathy X
|
754
|
4
|
1
|
|
|
Becker muscular dystrophy, Cardiomyopathy, Duchenne muscular dystrophy, Dystrophin deficiency
|
753
|
1
|
1
|
|
|
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase
|
753
|
6
|
53
|
|
|
Anauxetic dysplasia
|
750
|
4
|
1
|
|
|
Autosomal recessive nonsyndromic hearing loss 4
|
750
|
5
|
62
|
|
|
Greig cephalopolysyndactyly syndrome; Pallister-Hall syndrome
|
748
|
3
|
3
|
|
|
Giant axonal neuropathy 1
|
746
|
4
|
36
|
|
|
Prostate cancer
|
746
|
463
|
29
|
|
|
FOXG1 disorder
|
745
|
6
|
72
|
|
|
Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency
|
744
|
4
|
2
|
|
|
Isovaleryl-CoA dehydrogenase deficiency
|
744
|
1
|
42
|
|
|
Deficiency of acetyl-CoA acetyltransferase
|
743
|
4
|
41
|
|
|
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1; Paget disease of bone 2, early-onset
|
741
|
6
|
1
|
|
|
Chromosome 2q32-q33 deletion syndrome
|
740
|
6
|
73
|
|
|
Collagen 6-related myopathy
|
737
|
6
|
12
|
|
|
Cystinuria
|
735
|
6
|
75
|
|
|
Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3
|
734
|
1
|
9
|
|
|
Ornithine carbamoyltransferase deficiency
|
734
|
7
|
67
|
|
|
DNA ligase IV deficiency
|
733
|
1
|
37
|
|
|
Immunodeficiency 39
|
733
|
3
|
11
|
|
|
Polycystic kidney disease
|
731
|
16
|
16
|
|
|
Severe X-linked myotubular myopathy
|
728
|
7
|
44
|
|
|
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency
|
728
|
7
|
43
|
|
|
Dyskeratosis congenita, autosomal dominant 6
|
726
|
3
|
15
|
|
|
Ichthyosis linearis circumflexa
|
725
|
2
|
2
|
|
|
Biotinidase deficiency
|
724
|
4
|
75
|
|
|
3-methylglutaconic aciduria, type VIIB
|
723
|
6
|
22
|
|
|
Autosomal recessive ataxia, Beauce type
|
723
|
6
|
48
|
|
|
Long QT syndrome 1
|
722
|
18
|
82
|
|
|
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency
|
722
|
3
|
26
|
|
|
Haddad syndrome
|
721
|
3
|
3
|
|
|
Asphyxiating thoracic dystrophy 3
|
719
|
13
|
65
|
|
|
Combined oxidative phosphorylation defect type 27
|
719
|
3
|
21
|
|
|
Polycystic kidney disease 2
|
717
|
6
|
72
|
|
|
Beta-D-mannosidosis
|
716
|
7
|
32
|
|
|
Developmental and epileptic encephalopathy, 1; not provided; Autosomal dominant nonsyndromic hearing loss 65
|
714
|
2
|
1
|
|
|
Microcephaly 5, primary, autosomal recessive
|
713
|
4
|
70
|
|
|
Distal hereditary motor neuropathy type 2
|
712
|
3
|
6
|
|
|
Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 9
|
712
|
4
|
6
|
|
|
Congenital amegakaryocytic thrombocytopenia; Essential thrombocythemia
|
710
|
1
|
1
|
|
|
Neuronal ceroid lipofuscinosis 1
|
710
|
4
|
55
|
|
|
Autosomal recessive limb-girdle muscular dystrophy
|
708
|
23
|
10
|
|
|
Developmental and epileptic encephalopathy, 26
|
708
|
5
|
48
|
|
|
Lowe syndrome
|
708
|
4
|
46
|
|
|
Xeroderma pigmentosum, group F; Cockayne syndrome; Fanconi anemia complementation group Q
|
705
|
4
|
2
|
|
|
Hypophosphatasia
|
703
|
2
|
19
|
|
|
Congenital myasthenic syndrome
|
702
|
24
|
19
|
|
|
Transcobalamin II deficiency
|
699
|
2
|
25
|
|
|
MEGF8-related Carpenter syndrome
|
698
|
4
|
22
|
|
|
Citrin deficiency
|
697
|
2
|
2
|
|
|
Myopathy, centronuclear, 2
|
697
|
8
|
16
|
|
|
Achondrogenesis, type IA
|
695
|
2
|
17
|
|
|
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency
|
695
|
1
|
12
|
|
|
Pyogenic arthritis-pyoderma gangrenosum-acne syndrome
|
692
|
4
|
23
|
|
|
Peroxisome biogenesis disorder, complementation group 7
|
689
|
3
|
1
|
|
|
Myasthenic syndrome, congenital, 22
|
686
|
2
|
25
|
|
|
CREBBP-related disorder
|
684
|
5
|
4
|
|
|
Noonan syndrome
|
684
|
31
|
36
|
|
|
Gastrointestinal stromal tumor; Pheochromocytoma/paraganglioma syndrome 3
|
683
|
4
|
1
|
|
|
Imerslund-Grasbeck syndrome type 1; Proteinuria, chronic benign
|
682
|
3
|
5
|
|
|
Hyper-IgE recurrent infection syndrome 1, autosomal dominant; STAT3 gain of function
|
681
|
4
|
2
|
|
|
Developmental and epileptic encephalopathy, 1; Intellectual disability, X-linked, with or without seizures, ARX-related
|
679
|
4
|
1
|
|
|
Pulmonary hypertension, primary, 1
|
678
|
16
|
29
|
|
|
Hereditary nonpolyposis colon cancer
|
676
|
14
|
12
|
|
|
Developmental and epileptic encephalopathy, 25
|
675
|
4
|
31
|
|
|
Nemaline myopathy 6
|
675
|
4
|
26
|
|
|
Brugada syndrome 4
|
674
|
1
|
25
|
|
|
Granulomatous disease, chronic, X-linked
|
673
|
8
|
34
|
|
|
Leber congenital amaurosis 10; Meckel syndrome, type 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14
|
670
|
3
|
7
|
|
|
Hypogonadotropic hypogonadism 2 with or without anosmia; Pfeiffer syndrome
|
668
|
2
|
2
|
|
|
Mucopolysaccharidosis type 7
|
668
|
3
|
41
|
|
|
Brugada syndrome 1
|
667
|
13
|
57
|
|
|
Carney-Stratakis syndrome; Pheochromocytoma; Paragangliomas with sensorineural hearing loss; Cowden syndrome 3
|
667
|
4
|
1
|
|
|
Cowden syndrome
|
667
|
10
|
14
|
|
|
Microcephalic osteodysplastic primordial dwarfism type II
|
667
|
3
|
55
|
|
|
Ornithine aminotransferase deficiency
|
666
|
4
|
27
|
|
|
Intellectual disability, autosomal dominant 16
|
664
|
1
|
33
|
|
|
Aortic valve disease 1
|
663
|
14
|
31
|
|
|
Familial hemophagocytic lymphohistiocytosis 2
|
660
|
4
|
45
|
|
|
Pigmentary pallidal degeneration
|
657
|
7
|
47
|
|
|
EP300-related disorder
|
656
|
3
|
4
|
|
|
Androgen resistance syndrome; Kennedy disease
|
655
|
2
|
1
|
|
|
Familial isolated arrhythmogenic right ventricular dysplasia
|
655
|
10
|
8
|
|
|
Mitochondrial disease
|
653
|
138
|
26
|
|
|
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type
|
651
|
3
|
32
|
|
|
Danon disease
|
651
|
3
|
35
|
|
|
PLXNA1-related disorder
|
650
|
2
|
1
|
|
|
Autoimmune lymphoproliferative syndrome type 1
|
646
|
9
|
30
|
|
|
Isolated focal cortical dysplasia type II
|
646
|
5
|
16
|
|
|
Osteogenesis imperfecta type 7
|
645
|
4
|
27
|
|
|
Isolated microphthalmia 5
|
643
|
2
|
14
|
|
|
X-linked agammaglobulinemia with growth hormone deficiency
|
643
|
5
|
7
|
|
|
Fanconi anemia complementation group I
|
640
|
2
|
24
|
|
|
Hyperammonemia, type III
|
639
|
2
|
26
|
|
|
Developmental and epileptic encephalopathy, 18
|
638
|
5
|
42
|
|
|
Episodic ataxia type 1
|
638
|
5
|
32
|
|
|
Myoclonic dystonia 11
|
636
|
5
|
44
|
|
|
Emery-Dreifuss muscular dystrophy 4, autosomal dominant
|
635
|
7
|
23
|
|
|
Pendred syndrome
|
635
|
7
|
46
|
|
|
Autosomal dominant limb-girdle muscular dystrophy type 1F
|
632
|
4
|
21
|
|
|
Pyruvate dehydrogenase E3 deficiency
|
632
|
3
|
31
|
|
|
Aortic aneurysm, familial thoracic 8
|
628
|
3
|
12
|
|
|
Biotin-responsive basal ganglia disease
|
628
|
2
|
48
|
|
|
RAI1-related disorder
|
628
|
1
|
1
|
|
|
Tatton-Brown-Rahman overgrowth syndrome
|
626
|
11
|
55
|
|
|
Holoprosencephaly 9; Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome
|
623
|
1
|
9
|
|
|
Neutral lipid storage myopathy
|
622
|
4
|
23
|
|
|
Charcot-Marie-Tooth disease type 4C
|
621
|
3
|
55
|
|
|
Cutis laxa, autosomal dominant 3; Autosomal dominant spastic paraplegia type 9; de Barsy syndrome
|
620
|
2
|
1
|
|
|
Deficiency of malonyl-CoA decarboxylase
|
620
|
7
|
21
|
|
|
Senior-Loken syndrome 7; Bardet-Biedl syndrome 16
|
620
|
5
|
4
|
|
|
Autosomal recessive nonsyndromic hearing loss 12
|
616
|
6
|
36
|
|
|
CEP290-related disorder
|
615
|
3
|
12
|
|
|
Severe early-childhood-onset retinal dystrophy
|
613
|
13
|
76
|
|
|
Glycogen storage disease due to muscle and heart glycogen synthase deficiency
|
612
|
5
|
16
|
|
|
Congenital myopathy with internal nuclei and atypical cores
|
611
|
1
|
13
|
|
|
Congenital neutropenia-myelofibrosis-nephromegaly syndrome
|
611
|
3
|
14
|
|
|
Desbuquois dysplasia 1
|
610
|
8
|
16
|
|
|
PLXNA3-related disorder
|
607
|
1
|
1
|
|
|
Achondrogenesis, type IB; Atelosteogenesis type II; Multiple epiphyseal dysplasia type 4; Diastrophic dysplasia
|
606
|
1
|
7
|
|
|
Autism spectrum disorder
|
606
|
352
|
36
|
|
|
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ceroid lipofuscinosis 11
|
606
|
4
|
3
|
|
|
Loeys-Dietz syndrome 4
|
606
|
11
|
42
|
|
|
X-linked severe congenital neutropenia; Thrombocytopenia 1; Wiskott-Aldrich syndrome
|
606
|
3
|
7
|
|
|
Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 11
|
603
|
3
|
6
|
|
|
Orofaciodigital syndrome type 6; Joubert syndrome 17
|
603
|
2
|
11
|
|
|
Amelocerebrohypohidrotic syndrome
|
602
|
2
|
22
|
|
|
Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2
|
601
|
5
|
6
|
|
|
MELAS syndrome
|
600
|
40
|
22
|
|
|
Fanconi anemia complementation group D2
|
599
|
6
|
35
|
|
|
Alkaptonuria
|
598
|
3
|
38
|
|
|
Costello syndrome
|
597
|
8
|
54
|
|
|
Peroxisome biogenesis disorder 9B
|
597
|
2
|
10
|
|
|
Salla disease
|
596
|
8
|
21
|
|
|
Citalopram response
|
595
|
2
|
1
|
|
|
Escitalopram response
|
595
|
2
|
1
|
|
|
Immunodeficiency 31B; Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome; Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
|
595
|
3
|
7
|
|
|
Sertraline response
|
595
|
2
|
1
|
|
|
Voriconazole response
|
595
|
2
|
1
|
|
|
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2
|
593
|
4
|
19
|
|
|
Infantile-onset X-linked spinal muscular atrophy
|
593
|
4
|
15
|
|
|
Methylmalonic aciduria, cblA type
|
590
|
3
|
34
|
|
|
Cobalamin C disease
|
589
|
10
|
69
|
|
|
Eichsfeld type congenital muscular dystrophy
|
589
|
2
|
42
|
|
|
Mevalonic aciduria; Porokeratosis 3, disseminated superficial actinic type; Hyperimmunoglobulin D with periodic fever
|
589
|
2
|
6
|
|
|
Usher syndrome type 1D
|
588
|
6
|
44
|
|
|
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA
|
587
|
5
|
51
|
|
|
Juvenile myelomonocytic leukemia
|
587
|
11
|
13
|
|
|
Usher syndrome type 3B
|
586
|
4
|
6
|
|
|
Arginine:glycine amidinotransferase deficiency
|
584
|
6
|
14
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2P; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
|
583
|
2
|
4
|
|
|
Intellectual disability, CASK-related, X-linked
|
583
|
4
|
2
|
|
|
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency
|
583
|
3
|
23
|
|
|
Aplastic anemia
|
579
|
12
|
8
|
|
|
Atrioventricular septal defect 5
|
579
|
2
|
5
|
|
|
Hereditary leiomyomatosis and renal cell cancer
|
579
|
1
|
37
|
|
|
Neuropathy, hereditary sensory and autonomic, type 1C
|
579
|
3
|
21
|
|
|
Congenital multicore myopathy with external ophthalmoplegia
|
578
|
6
|
47
|
|
|
Episodic kinesigenic dyskinesia
|
577
|
10
|
3
|
|
|
PLXNA4-related disorder
|
577
|
1
|
1
|
|
|
Mitochondrial trifunctional protein deficiency
|
576
|
5
|
24
|
|
|
Progressive myoclonic epilepsy type 9; Lipodystrophy, partial, acquired, susceptibility to
|
576
|
6
|
1
|
|
|
Amyotrophic lateral sclerosis type 21
|
575
|
4
|
12
|
|
|
Cerebral cavernous malformation
|
575
|
10
|
44
|
|
|
Kabuki syndrome 1; Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome
|
575
|
2
|
7
|
|
|
Glycogen storage disease IXd
|
574
|
2
|
28
|
|
|
TP63-Related Spectrum Disorders
|
574
|
3
|
5
|
|
|
Ocular cystinosis; Juvenile nephropathic cystinosis; Inborn genetic diseases
|
573
|
7
|
1
|
|
|
Predisposition to invasive fungal disease due to CARD9 deficiency
|
573
|
4
|
12
|
|
|
Primary ciliary dyskinesia 7
|
572
|
6
|
57
|
|
|
Wolfram syndrome 1
|
572
|
2
|
46
|
|
|
Deficiency of aromatic-L-amino-acid decarboxylase
|
571
|
1
|
36
|
|
|
EBV-positive nodal T- and NK-cell lymphoma
|
571
|
512
|
1
|
|
|
Leber congenital amaurosis 13
|
571
|
5
|
36
|
|
|
PRPH2-related disorder
|
571
|
3
|
7
|
|
|
Autoimmune lymphoproliferative syndrome type 2A
|
570
|
2
|
14
|
|
|
Birt-Hogg-Dube syndrome 1
|
570
|
2
|
24
|
|
|
X-linked Emery-Dreifuss muscular dystrophy
|
570
|
10
|
21
|
|
|
Left ventricular noncompaction 1
|
568
|
10
|
20
|
|
|
Multiple endocrine neoplasia type 2A
|
568
|
7
|
32
|
|
|
Familial cancer of breast; Ataxia-telangiectasia syndrome
|
567
|
2
|
14
|
|
|
Axenfeld-Rieger syndrome type 3
|
565
|
9
|
31
|
|
|
Hypertrophic cardiomyopathy 4
|
565
|
10
|
89
|
|
|
Hypohidrotic X-linked ectodermal dysplasia
|
564
|
2
|
41
|
|
|
MPI-congenital disorder of glycosylation
|
564
|
2
|
25
|
|
|
Menkes kinky-hair syndrome
|
564
|
4
|
44
|
|
|
PLXNA2-related disorder
|
564
|
1
|
1
|
|
|
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6; Inclusion body myopathy with Paget disease of bone and frontotemporal dementia
|
563
|
5
|
1
|
|
|
Usher syndrome type 2C
|
563
|
8
|
55
|
|
|
Congenital dyserythropoietic anemia, type II; Cowden syndrome 7
|
562
|
4
|
3
|
|
|
Atrial septal defect 7
|
561
|
4
|
15
|
|
|
Erythrocytosis, familial, 3
|
560
|
3
|
6
|
|
|
Junctional epidermolysis bullosa gravis of Herlitz
|
560
|
7
|
25
|
|
|
Fanconi anemia complementation group C
|
559
|
4
|
45
|
|
|
Usher syndrome
|
559
|
39
|
24
|
|
|
Compton-North congenital myopathy
|
558
|
2
|
11
|
|
|
Noonan syndrome and Noonan-related syndrome
|
557
|
25
|
2
|
|
|
Epilepsy, childhood absence, susceptibility to, 1; Epilepsy, childhood absence, susceptibility to, 5
|
556
|
6
|
1
|
|
|
Brugada syndrome 5
|
555
|
2
|
8
|
|
|
Arthrogryposis multiplex congenita 6
|
554
|
3
|
16
|
|
|
Immunodeficiency 23
|
554
|
4
|
17
|
|
|
Leukocyte adhesion deficiency 3
|
553
|
4
|
17
|
|
|
Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD
|
552
|
4
|
14
|
|
|
Cranioectodermal dysplasia 2; Short-rib thoracic dysplasia 7 with or without polydactyly
|
552
|
2
|
4
|
|
|
Primary hyperoxaluria, type I
|
551
|
3
|
52
|
|
|
Trichorhinophalangeal syndrome, type III; Trichorhinophalangeal dysplasia type I
|
550
|
3
|
5
|
|
|
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2; Febrile seizures, familial, 8
|
549
|
2
|
4
|
|
|
Van Maldergem syndrome 2; Hennekam lymphangiectasia-lymphedema syndrome 2
|
549
|
1
|
8
|
|
|
Deficiency of ferroxidase
|
548
|
3
|
28
|
|
|
Peroxisome biogenesis disorder 11A (Zellweger)
|
548
|
4
|
6
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2E
|
547
|
4
|
38
|
|
|
Arginase deficiency
|
545
|
3
|
34
|
|
|
Lymphoproliferative syndrome 1
|
544
|
3
|
17
|
|
|
Coffin-Siris syndrome 1
|
543
|
25
|
111
|
|
|
Cerebral creatine deficiency syndrome
|
541
|
5
|
3
|
|
|
Charcot-Marie-Tooth disease dominant intermediate C
|
541
|
6
|
15
|
|
|
Congenital myasthenic syndrome 12
|
541
|
3
|
24
|
|
|
Methylmalonic aciduria, cblB type
|
541
|
3
|
38
|
|
|
MOGS-congenital disorder of glycosylation
|
539
|
3
|
19
|
|
|
Spastic ataxia 2
|
539
|
4
|
29
|
|
|
Hereditary spastic paraplegia 3A
|
538
|
3
|
40
|
|
|
Susceptibility to mononeuropathy of the median nerve, mild
|
536
|
3
|
7
|
|
|
Aicardi-Goutieres syndrome 1; Chilblain lupus 1; Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
|
535
|
2
|
2
|
|
|
Progressive familial intrahepatic cholestasis type 2
|
534
|
3
|
35
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2F
|
533
|
1
|
13
|
|
|
Deficiency of galactokinase
|
533
|
4
|
22
|
|
|
Hearing impairment
|
533
|
142
|
22
|
|
|
Inflammatory skin and bowel disease, neonatal, 1
|
533
|
2
|
13
|
|
|
Weaver syndrome
|
531
|
5
|
35
|
|
|
Isolated cryptophthalmia; Fraser syndrome 2
|
530
|
2
|
5
|
|
|
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome
|
529
|
1
|
15
|
|
|
SHORT syndrome; Agammaglobulinemia 7, autosomal recessive; Immunodeficiency 36 with lymphoproliferation
|
529
|
1
|
7
|
|
|
Hypertrophic cardiomyopathy 11; Dilated cardiomyopathy 1R; Atrial septal defect 5
|
528
|
3
|
4
|
|
|
Bardet-Biedl syndrome 14
|
526
|
4
|
15
|
|
|
Pheochromocytoma
|
526
|
20
|
44
|
|
|
Primary pulmonary hypertension
|
526
|
4
|
2
|
|
|
Atrial fibrillation, familial, 7
|
524
|
2
|
18
|
|
|
Combined deficiency of sialidase AND beta galactosidase
|
524
|
4
|
27
|
|
|
Congenital myasthenic syndrome 5
|
524
|
1
|
38
|
|
|
Deficiency of adenosine deaminase 2
|
524
|
4
|
36
|
|
|
Hereditary fructosuria
|
524
|
5
|
49
|
|
|
Melanoma, cutaneous malignant, susceptibility to, 5
|
524
|
3
|
6
|
|
|
RFT1-congenital disorder of glycosylation
|
524
|
3
|
27
|
|
|
Aspartylglucosaminuria
|
523
|
1
|
35
|
|
|
TNF receptor-associated periodic fever syndrome (TRAPS)
|
523
|
3
|
29
|
|
|
Charcot-Marie-Tooth disease type 2E
|
522
|
5
|
17
|
|
|
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection
|
522
|
3
|
9
|
|
|
Paroxysmal nonkinesigenic dyskinesia
|
521
|
6
|
1
|
|
|
ALG12-congenital disorder of glycosylation
|
520
|
6
|
24
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2C
|
520
|
8
|
41
|
|
|
FGFR2-related craniosynostosis
|
520
|
4
|
5
|
|
|
Bardet-Biedl syndrome 1
|
519
|
19
|
66
|
|
|
H syndrome
|
519
|
3
|
30
|
|
|
Leber congenital amaurosis 4
|
519
|
3
|
19
|
|
|
Neurofibromatosis, familial spinal; Juvenile myelomonocytic leukemia; Neurofibromatosis, type 1; Neurofibromatosis-Noonan syndrome; Café-au-lait macules with pulmonary stenosis
|
519
|
2
|
7
|
|
|
Acromesomelic dysplasia 1, Maroteaux type; Tall stature-scoliosis-macrodactyly of the great toes syndrome
|
518
|
3
|
1
|
|
|
Aicardi-Goutieres syndrome 4
|
515
|
4
|
26
|
|
|
Growth hormone insensitivity with immune dysregulation 1, autosomal recessive
|
515
|
3
|
18
|
|
|
Oculofaciocardiodental syndrome
|
515
|
4
|
45
|
|
|
Pontocerebellar hypoplasia type 1A
|
515
|
3
|
23
|
|
|
Primary ciliary dyskinesia 23
|
515
|
3
|
22
|
|
|
Retinitis pigmentosa 59
|
515
|
3
|
16
|
|
|
Polyglucosan body myopathy type 1
|
513
|
5
|
24
|
|
|
Sucrase-isomaltase deficiency
|
513
|
1
|
30
|
|
|
COG7 congenital disorder of glycosylation
|
512
|
4
|
21
|
|
|
Autosomal recessive Alport syndrome; Hematuria, benign familial, 1
|
510
|
1
|
4
|
|
|
Rienhoff syndrome
|
510
|
3
|
19
|
|
|
Combined oxidative phosphorylation defect type 14
|
509
|
7
|
23
|
|
|
Cyclical neutropenia; Neutropenia, severe congenital, 1, autosomal dominant
|
509
|
3
|
5
|
|
|
BRCA2-related disorder
|
508
|
2
|
9
|
|
|
Hypercholesterolemia, familial, 4
|
508
|
4
|
20
|
|
|
Mosaic variegated aneuploidy syndrome 2
|
508
|
3
|
12
|
|
|
3-Methylglutaconic aciduria type 2
|
507
|
7
|
30
|
|
|
Arterial tortuosity syndrome
|
507
|
1
|
32
|
|
|
Hepatic veno-occlusive disease-immunodeficiency syndrome
|
507
|
3
|
18
|
|
|
Lethal Kniest-like syndrome
|
507
|
3
|
19
|
|
|
Epilepsy, progressive myoclonic, 1B
|
506
|
6
|
23
|
|
|
Cardiac arrhythmia, ankyrin-B-related
|
505
|
3
|
38
|
|
|
Histiocytic medullary reticulosis
|
505
|
6
|
22
|
|
|
Weill-Marchesani syndrome
|
505
|
9
|
3
|
|
|
NIK deficiency
|
503
|
2
|
1
|
|
|
Bronchiectasis with or without elevated sweat chloride 1
|
502
|
6
|
15
|
|
|
Central core myopathy
|
501
|
13
|
64
|
|
|
Hyperinsulinemic hypoglycemia, familial, 1
|
501
|
8
|
54
|
|
|
Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders
|
500
|
8
|
22
|
|
|
Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome
|
499
|
1
|
29
|
|
|
Woodhouse-Sakati syndrome
|
499
|
2
|
25
|
|
|
CHARGE syndrome; Hypogonadotropic hypogonadism 5 with or without anosmia
|
498
|
2
|
14
|
|
|
Deficiency of hydroxymethylglutaryl-CoA lyase
|
498
|
4
|
32
|
|
|
Autosomal recessive nonsyndromic hearing loss 2
|
496
|
1
|
36
|
|
|
Cowden syndrome 6
|
496
|
2
|
9
|
|
|
Nemaline myopathy 8
|
496
|
1
|
27
|
|
|
Saldino-Mainzer syndrome; Retinitis pigmentosa 80
|
496
|
3
|
6
|
|
|
Combined immunodeficiency due to ZAP70 deficiency
|
495
|
1
|
10
|
|
|
Merosin deficient congenital muscular dystrophy
|
494
|
3
|
65
|
|
|
Short-rib thoracic dysplasia 11 with or without polydactyly
|
494
|
4
|
17
|
|
|
Schwartz-Jampel syndrome
|
493
|
3
|
15
|
|
|
Wolman disease
|
493
|
2
|
12
|
|
|
Arteriohepatic dysplasia
|
492
|
1
|
5
|
|
|
Neuronopathy, distal hereditary motor, type 7A; Congenital myasthenic syndrome 20
|
492
|
3
|
2
|
|
|
Growth delay due to insulin-like growth factor I resistance
|
491
|
4
|
46
|
|
|
Aicardi-Goutieres syndrome 2
|
490
|
3
|
51
|
|
|
Autosomal recessive osteopetrosis 1
|
490
|
3
|
49
|
|
|
Congenital glucose-galactose malabsorption
|
490
|
2
|
16
|
|
|
IFT172-related disorder
|
489
|
4
|
3
|
|
|
Hypokalemic periodic paralysis, type 1
|
488
|
5
|
34
|
|
|
Spongy degeneration of central nervous system
|
488
|
6
|
40
|
|
|
Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome
|
487
|
4
|
1
|
|
|
Muscle AMP deaminase deficiency
|
485
|
1
|
18
|
|
|
GNAS-related disorder
|
484
|
1
|
6
|
|
|
Sulfite oxidase deficiency
|
484
|
1
|
33
|
|
|
Neuropathy, hereditary sensory, type 1F
|
483
|
3
|
12
|
|
|
Peroxisome biogenesis disorder 3A (Zellweger)
|
483
|
3
|
14
|
|
|
Actin accumulation myopathy
|
481
|
7
|
40
|
|
|
Disorders of Intracellular Cobalamin Metabolism
|
481
|
14
|
2
|
|
|
Immunodeficiency-centromeric instability-facial anomalies syndrome 2
|
481
|
2
|
18
|
|
|
Infantile spasms
|
481
|
7
|
5
|
|
|
Familial X-linked hypophosphatemic vitamin D refractory rickets
|
480
|
7
|
54
|
|
|
Hereditary spastic paraplegia 15
|
480
|
1
|
47
|
|
|
Age related macular degeneration 1
|
479
|
4
|
10
|
|
|
Joubert syndrome 3
|
479
|
3
|
42
|
|
|
Baraitser-Winter syndrome 1
|
478
|
3
|
57
|
|
|
Brown-Vialetto-van Laere syndrome 2
|
478
|
4
|
32
|
|
|
Orofacial-digital syndrome IV; Joubert syndrome 18
|
478
|
3
|
3
|
|
|
Aniridia 1; Irido-corneo-trabecular dysgenesis
|
477
|
7
|
2
|
|
|
Holoprosencephaly 11
|
476
|
3
|
14
|
|
|
Idiopathic generalized epilepsy; Epilepsy, idiopathic generalized, susceptibility to, 13; Epilepsy, childhood absence 4
|
476
|
5
|
2
|
|
|
Neurodegeneration with brain iron accumulation 5
|
476
|
6
|
75
|
|
|
Bardet-Biedl syndrome 10
|
475
|
3
|
53
|
|
|
X-linked severe combined immunodeficiency
|
473
|
4
|
35
|
|
|
Christianson syndrome
|
472
|
5
|
38
|
|
|
Developmental and epileptic encephalopathy, 33
|
472
|
12
|
23
|
|
|
Progressive myoclonic epilepsy type 5
|
472
|
1
|
5
|
|
|
X-linked myopathy with postural muscle atrophy
|
472
|
4
|
15
|
|
|
Martsolf syndrome; Warburg micro syndrome 2
|
471
|
3
|
3
|
|
|
Nephrotic syndrome, type 3
|
471
|
3
|
34
|
|
|
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome
|
471
|
6
|
60
|
|
|
Hereditary hyperekplexia
|
470
|
3
|
2
|
|
|
Mucolipidosis type II
|
469
|
4
|
32
|
|
|
PKHD1-related disorder
|
467
|
2
|
1
|
|
|
Transitory neonatal diabetes mellitus
|
467
|
6
|
1
|
|
|
Agenesis of the corpus callosum with peripheral neuropathy
|
466
|
6
|
26
|
|
|
Charcot-Marie-Tooth disease type 2R
|
466
|
2
|
12
|
|
|
Cornelia de Lange syndrome 3
|
465
|
2
|
41
|
|
|
Syndromic multisystem autoimmune disease due to ITCH deficiency
|
465
|
2
|
12
|
|
|
Aortic aneurysm, familial thoracic 6
|
464
|
10
|
24
|
|
|
Gaucher disease
|
464
|
5
|
16
|
|
|
MUC16-related disorder
|
464
|
2
|
1
|
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11
|
464
|
2
|
26
|
|
|
Ovarian neoplasm
|
464
|
34
|
22
|
|
|
Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome
|
462
|
1
|
3
|
|
|
Autosomal recessive nonsyndromic hearing loss 9
|
461
|
7
|
54
|
|
|
Peroxisome biogenesis disorder, complementation group K
|
460
|
3
|
1
|
|
|
Ulnar-mammary syndrome
|
460
|
2
|
25
|
|
|
Autosomal dominant nonsyndromic hearing loss 20; Baraitser-winter syndrome 2
|
459
|
2
|
7
|
|
|
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4
|
459
|
2
|
30
|
|
|
GM3 synthase deficiency
|
459
|
7
|
22
|
|
|
Short-rib thoracic dysplasia 8 with or without polydactyly
|
459
|
2
|
17
|
|
|
Odonto-onycho-dermal dysplasia; Tooth agenesis, selective, 4
|
458
|
3
|
3
|
|
|
Autosomal recessive congenital ichthyosis 1
|
457
|
5
|
43
|
|
|
Bardet-Biedl syndrome; McKusick-Kaufman syndrome
|
457
|
2
|
1
|
|
|
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
457
|
5
|
20
|
|
|
Pierpont syndrome
|
457
|
3
|
19
|
|
|
Nance-Horan syndrome
|
456
|
2
|
17
|
|
|
Nephronophthisis 18
|
456
|
2
|
8
|
|
|
Peroxisome biogenesis disorder 7A (Zellweger); Peroxisome biogenesis disorder 7B
|
455
|
4
|
4
|
|
|
Acroosteolysis-keloid-like lesions-premature aging syndrome; Basal ganglia calcification, idiopathic, 4; Infantile myofibromatosis; Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome
|
454
|
1
|
1
|
|
|
Hereditary xanthinuria type 1
|
454
|
3
|
27
|
|
|
Deficiency of butyryl-CoA dehydrogenase
|
453
|
5
|
49
|
|
|
Familial adenomatous polyposis 4
|
453
|
3
|
24
|
|
|
Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language
|
453
|
7
|
47
|
|
|
Optic atrophy
|
453
|
164
|
10
|
|
|
Rafiq syndrome
|
453
|
7
|
33
|
|
|
Type 2 diabetes mellitus
|
453
|
46
|
46
|
|
|
Complex neurodevelopmental disorder
|
452
|
56
|
22
|
|
|
Progressive myoclonic epilepsy type 7
|
452
|
2
|
28
|
|
|
Hypertrophic cardiomyopathy 10
|
451
|
2
|
33
|
|
|
Nephronophthisis 4; Senior-Loken syndrome 4
|
451
|
1
|
5
|
|
|
Peroxisome biogenesis disorder 5A (Zellweger)
|
451
|
1
|
12
|
|
|
Inflammatory bowel disease 28
|
450
|
4
|
25
|
|
|
Primary ciliary dyskinesia 28
|
449
|
7
|
17
|
|
|
Dilated cardiomyopathy 1CC; Hypertrophic cardiomyopathy 20
|
448
|
2
|
6
|
|
|
Floating-Harbor syndrome; Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities
|
447
|
1
|
5
|
|
|
Tyrosinemia type II
|
447
|
3
|
17
|
|
|
Classic homocystinuria
|
446
|
2
|
56
|
|
|
Combined immunodeficiency due to MALT1 deficiency
|
446
|
3
|
18
|
|
|
Developmental and epileptic encephalopathy, 32
|
445
|
2
|
46
|
|
|
Joubert syndrome 20; Meckel syndrome, type 11
|
445
|
5
|
4
|
|
|
Alzheimer disease
|
444
|
18
|
16
|
|
|
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
444
|
3
|
24
|
|
|
Orthostatic hypotension 1
|
444
|
1
|
13
|
|
|
Seckel syndrome 1
|
444
|
4
|
18
|
|
|
Autosomal recessive inherited pseudoxanthoma elasticum
|
443
|
8
|
37
|
|
|
Autosomal recessive inherited pseudoxanthoma elasticum; Pseudoxanthoma elasticum, forme fruste; Arterial calcification, generalized, of infancy, 2
|
443
|
2
|
4
|
|
|
Joubert syndrome 14
|
443
|
6
|
21
|
|
|
Autosomal dominant limb-girdle muscular dystrophy type 1G
|
442
|
1
|
11
|
|
|
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
|
442
|
3
|
43
|
|
|
BRCA1-related cancer predisposition
|
441
|
2
|
2
|
|
|
Methylmalonic aciduria and homocystinuria type cblF
|
441
|
2
|
18
|
|
|
Oculotrichoanal syndrome; BNAR syndrome; Trigonocephaly 2
|
441
|
2
|
3
|
|
|
Rubinstein-Taybi syndrome due to CREBBP mutations
|
441
|
10
|
90
|
|
|
Nephronophthisis 16
|
440
|
2
|
18
|
|
|
Early-onset Lafora body disease
|
439
|
5
|
5
|
|
|
Telangiectasia, hereditary hemorrhagic, type 1
|
439
|
3
|
67
|
|
|
Autosomal dominant Alport syndrome; Hematuria, benign familial, 2; Alport syndrome 3b, autosomal recessive
|
438
|
2
|
4
|
|
|
Seizure
|
438
|
162
|
29
|
|
|
beta Thalassemia
|
438
|
7
|
49
|
|
|
Short-rib thoracic dysplasia 10 with or without polydactyly; Retinitis pigmentosa 71; Bardet-Biedl syndrome 20
|
437
|
4
|
4
|
|
|
Haim-Munk syndrome; Periodontitis, aggressive; Papillon-Lefèvre syndrome
|
436
|
3
|
4
|
|
|
Congenital myasthenic syndrome 2A
|
435
|
3
|
11
|
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7; Autosomal recessive limb-girdle muscular dystrophy type 2U
|
435
|
6
|
3
|
|
|
Noonan syndrome 4
|
435
|
3
|
64
|
|
|
Thrombophilia due to protein S deficiency, autosomal recessive
|
435
|
4
|
5
|
|
|
Dyskeratosis congenita, autosomal dominant 1
|
434
|
11
|
13
|
|
|
Dystonia 5; GTP cyclohydrolase I deficiency
|
434
|
5
|
2
|
|
|
Glycogen storage disease IXa1
|
433
|
2
|
45
|
|
|
Leber congenital amaurosis 3
|
433
|
3
|
24
|
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8
|
433
|
3
|
13
|
|
|
Hermansky-Pudlak syndrome
|
432
|
15
|
9
|
|
|
Cutis laxa, autosomal recessive, type 1B
|
431
|
4
|
24
|
|
|
Kostmann syndrome
|
431
|
4
|
26
|
|
|
NF1-related disorder
|
431
|
4
|
6
|
|
|
Neonatal diabetes mellitus with congenital hypothyroidism
|
431
|
1
|
14
|
|
|
Wiedemann-Steiner syndrome
|
431
|
5
|
102
|
|
|
5-Oxoprolinase deficiency
|
430
|
3
|
18
|
|
|
Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6)
|
430
|
1
|
22
|
|
|
Ethylmalonic encephalopathy
|
429
|
3
|
37
|
|
|
Leber congenital amaurosis 8
|
429
|
1
|
25
|
|
|
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency
|
428
|
2
|
25
|
|
|
DK1-congenital disorder of glycosylation
|
427
|
2
|
11
|
|
|
KIDINS220-related disorder
|
427
|
1
|
2
|
|
|
Brown-Vialetto-van Laere syndrome 1
|
425
|
3
|
19
|
|
|
Hereditary cancer
|
425
|
107
|
6
|
|
|
Hereditary hyperinsulinism
|
425
|
3
|
1
|
|
|
Combined immunodeficiency due to ORAI1 deficiency; Myopathy, tubular aggregate, 2
|
424
|
3
|
5
|
|
|
Fucosidosis
|
424
|
4
|
29
|
|
|
Occult macular dystrophy
|
424
|
3
|
28
|
|
|
Hereditary sensory and autonomic neuropathy type 1
|
423
|
2
|
3
|
|
|
Intestinal hypomagnesemia 1
|
423
|
3
|
30
|
|
|
Melanoma-pancreatic cancer syndrome
|
423
|
4
|
23
|
|
|
Nijmegen breakage syndrome-like disorder
|
423
|
3
|
35
|
|
|
Alpha-1-antitrypsin deficiency
|
421
|
1
|
53
|
|
|
Holoprosencephaly 3
|
421
|
8
|
33
|
|
|
Progressive myoclonic epilepsy type 3
|
421
|
4
|
30
|
|
|
Andersen Tawil syndrome; Short QT syndrome type 3
|
420
|
1
|
1
|
|
|
Hereditary antithrombin deficiency
|
420
|
16
|
41
|
|
|
Mitochondrial DNA depletion syndrome 13
|
420
|
2
|
40
|
|
|
Short-rib thoracic dysplasia 13 with or without polydactyly
|
419
|
2
|
9
|
|
|
Sitosterolemia
|
419
|
5
|
13
|
|
|
Myofibrillar myopathy 3
|
416
|
3
|
23
|
|
|
Herpes simplex encephalitis, susceptibility to, 3
|
414
|
6
|
6
|
|
|
Junctional epidermolysis bullosa
|
414
|
11
|
11
|
|
|
Peroxisome biogenesis disorder 12A (Zellweger)
|
412
|
2
|
11
|
|
|
Autosomal dominant epilepsy with auditory features
|
411
|
2
|
1
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2Y
|
411
|
4
|
10
|
|
|
Niemann-Pick disease, type A
|
410
|
4
|
37
|
|
|
Hyperekplexia 2
|
409
|
1
|
15
|
|
|
LZTR1-related schwannomatosis
|
408
|
4
|
36
|
|
|
Achromatopsia
|
407
|
9
|
13
|
|
|
Amyotrophic lateral sclerosis type 4
|
407
|
3
|
33
|
|
|
Hereditary spastic paraplegia 8; Ritscher-Schinzel syndrome
|
407
|
3
|
1
|
|
|
Holoprosencephaly 5
|
407
|
8
|
29
|
|
|
Mitochondrial complex IV deficiency, nuclear type 1
|
407
|
32
|
38
|
|
|
COG1 congenital disorder of glycosylation
|
406
|
6
|
17
|
|
|
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
|
406
|
4
|
55
|
|
|
Immunodeficiency 32B; Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency
|
405
|
5
|
4
|
|
|
Nemaline myopathy 10
|
405
|
2
|
21
|
|
|
Polyhydramnios, megalencephaly, and symptomatic epilepsy
|
405
|
3
|
12
|
|
|
Developmental and epileptic encephalopathy, 8
|
404
|
3
|
41
|
|
|
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency
|
404
|
3
|
20
|
|
|
Autosomal dominant Alport syndrome
|
403
|
6
|
59
|
|
|
alpha Thalassemia
|
403
|
18
|
38
|
|
|
Congenital primary aphakia; Anterior segment dysgenesis
|
402
|
2
|
1
|
|
|
Deficiency of hyaluronoglucosaminidase
|
401
|
1
|
8
|
|
|
Upshaw-Schulman syndrome
|
401
|
3
|
31
|
|
|
X-linked lymphoproliferative disease due to XIAP deficiency
|
400
|
3
|
27
|
|
|
Charcot-Marie-Tooth disease type 4A
|
399
|
5
|
23
|
|
|
Autosomal dominant cerebellar ataxia
|
398
|
16
|
4
|
|
|
Hereditary spastic paraplegia 28
|
396
|
3
|
14
|
|
|
Herpes simplex encephalitis, susceptibility to, 4
|
396
|
1
|
7
|
|
|
Parkinsonism-dystonia, infantile
|
396
|
4
|
3
|
|
|
Stuve-Wiedemann syndrome
|
396
|
4
|
16
|
|
|
ANKRD1-related dilated cardiomyopathy
|
395
|
1
|
1
|
|
|
ATM-related disorder
|
395
|
2
|
5
|
|
|
Lafora disease
|
395
|
5
|
28
|
|
|
Fanconi anemia complementation group G
|
394
|
2
|
32
|
|
|
Hirschsprung disease, susceptibility to, 1
|
394
|
40
|
26
|
|
|
Xeroderma pigmentosum
|
394
|
14
|
7
|
|
|
Joubert syndrome 15
|
393
|
1
|
13
|
|
|
Charcot-Marie-Tooth Neuropathy X; Combined oxidative phosphorylation deficiency
|
392
|
5
|
1
|
|
|
Developmental and epileptic encephalopathy, 14
|
392
|
3
|
37
|
|
|
Bardet-Biedl syndrome 2
|
390
|
3
|
41
|
|
|
Glomerulopathy with fibronectin deposits 2; Spondylometaphyseal dysplasia - Sutcliffe type
|
390
|
8
|
4
|
|
|
Congenital disorder of glycosylation, type IAA
|
389
|
3
|
8
|
|
|
Klippel-Feil syndrome 1, autosomal dominant; Isolated microphthalmia 4; Microphthalmia, isolated, with coloboma 6; Leber congenital amaurosis 17
|
389
|
2
|
1
|
|
|
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1
|
388
|
4
|
69
|
|
|
Familial hemophagocytic lymphohistiocytosis 4
|
388
|
3
|
14
|
|
|
Developmental and epileptic encephalopathy, 37
|
387
|
2
|
25
|
|
|
Insulin-dependent diabetes mellitus secretory diarrhea syndrome
|
387
|
4
|
28
|
|
|
Spondyloepiphyseal dysplasia with congenital joint dislocations
|
387
|
2
|
25
|
|
|
Megaconial type congenital muscular dystrophy
|
386
|
6
|
24
|
|
|
Primary dilated cardiomyopathy; Hypertrophic cardiomyopathy
|
386
|
9
|
5
|
|
|
Vanishing white matter disease
|
386
|
11
|
39
|
|
|
Bardet-Biedl syndrome 9
|
385
|
3
|
28
|
|
|
CDH1-related diffuse gastric and lobular breast cancer syndrome
|
385
|
2
|
9
|
|
|
Metaphyseal chondrodysplasia, McKusick type
|
385
|
2
|
17
|
|
|
Neuronal ceroid lipofuscinosis 2
|
385
|
1
|
56
|
|
|
Hermansky-Pudlak syndrome 1
|
384
|
4
|
42
|
|
|
Amyloidosis, hereditary systemic 1
|
383
|
7
|
44
|
|
|
Junctional epidermolysis bullosa with pyloric atresia; Epidermolysis bullosa, junctional 5A, intermediate
|
383
|
2
|
2
|
|
|
Melanoma, cutaneous malignant, susceptibility to, 3
|
383
|
4
|
11
|
|
|
Anophthalmia-microphthalmia syndrome
|
382
|
46
|
4
|
|
|
TSC2-related disorder
|
382
|
3
|
3
|
|
|
Congenital microvillous atrophy
|
381
|
5
|
26
|
|
|
Imerslund-Grasbeck syndrome type 1
|
381
|
5
|
19
|
|
|
Maple syrup urine disease type 1A
|
381
|
4
|
24
|
|
|
Alpha-methylacyl-CoA racemase deficiency
|
380
|
5
|
10
|
|
|
Hypertrophic cardiomyopathy 12; Dilated cardiomyopathy 1M
|
380
|
2
|
5
|
|
|
CBL-related disorder
|
379
|
6
|
50
|
|
|
Ataxia-telangiectasia-like disorder 1
|
378
|
1
|
35
|
|
|
Bardet-Biedl syndrome 12
|
378
|
2
|
34
|
|
|
Fraser syndrome 2
|
378
|
2
|
23
|
|
|
Isolated microphthalmia 2
|
378
|
2
|
7
|
|
|
Primary open angle glaucoma; Amyotrophic lateral sclerosis type 12; Glaucoma 1, open angle, E
|
377
|
5
|
1
|
|
|
Bifunctional peroxisomal enzyme deficiency
|
376
|
2
|
33
|
|
|
EAST syndrome
|
376
|
2
|
19
|
|
|
Hereditary motor and sensory neuropathy, Okinawa type; Hereditary spastic paraplegia 57
|
376
|
1
|
3
|
|
|
MYH9-related disorder
|
376
|
4
|
5
|
|
|
Neutropenia, severe congenital, 2, autosomal dominant
|
376
|
7
|
12
|
|
|
Hypercholesterolemia, autosomal dominant, type B
|
375
|
4
|
55
|
|
|
Mucopolysaccharidosis, MPS-III-C
|
375
|
2
|
39
|
|
|
Renal coloboma syndrome; Focal segmental glomerulosclerosis 7
|
375
|
3
|
5
|
|
|
Surfactant metabolism dysfunction, pulmonary, 4
|
375
|
2
|
12
|
|
|
Renal cysts and diabetes syndrome
|
374
|
8
|
46
|
|
|
Townes syndrome
|
374
|
3
|
4
|
|
|
Citrullinemia type I
|
373
|
5
|
58
|
|
|
ADCY3-related disorder
|
372
|
2
|
1
|
|
|
Hereditary factor IX deficiency disease; Thrombophilia, X-linked, due to factor 9 defect
|
372
|
3
|
1
|
|
|
Thrombophilia due to protein C deficiency, autosomal dominant
|
372
|
2
|
30
|
|
|
Aneurysm-osteoarthritis syndrome
|
371
|
3
|
44
|
|
|
Miyoshi muscular dystrophy 1
|
371
|
4
|
20
|
|
|
Aicardi-Goutieres syndrome 3
|
370
|
6
|
24
|
|
|
Generalized epilepsy with febrile seizures plus, type 9
|
370
|
5
|
27
|
|
|
PLEC-related disorder
|
370
|
4
|
2
|
|
|
Hereditary spastic paraplegia 63; Pontocerebellar hypoplasia type 9
|
369
|
5
|
7
|
|
|
Cryptosporidiosis-chronic cholangitis-liver disease syndrome
|
368
|
3
|
14
|
|
|
GNE myopathy
|
368
|
2
|
51
|
|
|
Hereditary spastic paraplegia 31
|
368
|
4
|
31
|
|
|
Lipoic acid synthetase deficiency
|
368
|
7
|
17
|
|
|
Thyroid dyshormonogenesis 6
|
368
|
2
|
48
|
|
|
Maturity-onset diabetes of the young type 2
|
367
|
4
|
55
|
|
|
Diabetes mellitus, transient neonatal, 2; Hyperinsulinemic hypoglycemia, familial, 1; Leucine-induced hypoglycemia; Type 2 diabetes mellitus; Diabetes mellitus, permanent neonatal 3
|
365
|
2
|
2
|
|
|
Familial encephalopathy with neuroserpin inclusion bodies
|
364
|
3
|
13
|
|
|
Hepatic methionine adenosyltransferase deficiency
|
364
|
4
|
21
|
|
|
Congenital prothrombin deficiency
|
363
|
2
|
13
|
|
|
Methylmalonic acidemia with homocystinuria, type cblJ
|
363
|
1
|
22
|
|
|
UDPglucose-4-epimerase deficiency
|
363
|
3
|
23
|
|
|
Weill-Marchesani 4 syndrome, recessive
|
363
|
3
|
19
|
|
|
Spinocerebellar ataxia type 19/22
|
362
|
3
|
28
|
|
|
Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome
|
360
|
3
|
7
|
|
|
Germ cell tumor of testis
|
360
|
342
|
3
|
|
|
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
|
360
|
2
|
16
|
|
|
Congenital myopathy 18
|
359
|
1
|
9
|
|
|
Pyruvate dehydrogenase E1-beta deficiency
|
359
|
4
|
15
|
|
|
Autosomal recessive early-onset Parkinson disease 6
|
358
|
5
|
30
|
|
|
Primary ciliary dyskinesia 33
|
358
|
4
|
12
|
|
|
Autosomal dominant nonsyndromic hearing loss 11
|
357
|
1
|
38
|
|
|
Dihydropteridine reductase deficiency
|
357
|
4
|
25
|
|
|
Hereditary spastic paraplegia 50
|
357
|
5
|
42
|
|
|
Joubert syndrome 7; Meckel syndrome, type 5; COACH syndrome 3
|
357
|
1
|
4
|
|
|
Primary ciliary dyskinesia 6
|
357
|
2
|
11
|
|
|
STING-associated vasculopathy with onset in infancy
|
357
|
4
|
25
|
|
|
Camptomelic dysplasia
|
356
|
4
|
37
|
|
|
Methylmalonic aciduria and homocystinuria type cblD
|
356
|
4
|
22
|
|
|
PGM1-congenital disorder of glycosylation
|
356
|
4
|
25
|
|
|
Parkinsonian-pyramidal syndrome
|
356
|
1
|
20
|
|
|
Developmental and epileptic encephalopathy, 5
|
355
|
3
|
55
|
|
|
Mucopolysaccharidosis, MPS-III-B
|
355
|
2
|
44
|
|
|
D-2-hydroxyglutaric aciduria 1
|
354
|
6
|
22
|
|
|
Alpha-N-acetylgalactosaminidase deficiency type 1
|
353
|
4
|
12
|
|
|
Hawkinsinuria; Tyrosinemia type III
|
353
|
3
|
3
|
|
|
Combined immunodeficiency due to OX40 deficiency
|
351
|
5
|
6
|
|
|
Ectodermal dysplasia and immunodeficiency 2
|
351
|
5
|
16
|
|
|
Pyridoxal phosphate-responsive seizures
|
351
|
2
|
32
|
|
|
Bronchiectasis with or without elevated sweat chloride 1; Cystic fibrosis; Hereditary pancreatitis; Congenital bilateral aplasia of vas deferens from CFTR mutation
|
350
|
7
|
8
|
|
|
Diamond-Blackfan anemia; GATA binding protein 1 related thrombocytopenia with dyserythropoiesis
|
350
|
3
|
1
|
|
|
Hereditary factor IX deficiency disease
|
350
|
2
|
34
|
|
|
Joubert syndrome 8
|
350
|
6
|
17
|
|
|
CDKL5 disorder
|
349
|
3
|
4
|
|
|
Nemaline myopathy
|
349
|
11
|
10
|
|
|
Disseminated atypical mycobacterial infection
|
348
|
3
|
1
|
|
|
Junctional epidermolysis bullosa with pyloric atresia
|
348
|
6
|
28
|
|
|
Fumarase deficiency
|
347
|
4
|
26
|
|
|
RPGRIP1L-related disorder
|
347
|
1
|
1
|
|
|
Achondrogenesis, type IB
|
346
|
2
|
16
|
|
|
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria
|
345
|
3
|
31
|
|
|
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2
|
345
|
4
|
26
|
|
|
Severe combined immunodeficiency due to CORO1A deficiency
|
345
|
7
|
12
|
|
|
Glycogen storage disease IXc
|
344
|
2
|
24
|
|
|
Immunodeficiency, common variable, 2
|
344
|
4
|
47
|
|
|
Leber congenital amaurosis 7; Cone-rod dystrophy 2
|
344
|
3
|
2
|
|
|
Renal tubular dysgenesis
|
344
|
6
|
18
|
|
|
Abetalipoproteinaemia
|
343
|
2
|
27
|
|
|
Neuropathy, hereditary motor and sensory, type 6B
|
343
|
4
|
14
|
|
|
Autosomal dominant nocturnal frontal lobe epilepsy 5
|
342
|
2
|
20
|
|
|
Bartter disease type 1
|
342
|
2
|
33
|
|
|
Frontotemporal dementia
|
342
|
25
|
30
|
|
|
Generalized juvenile polyposis/juvenile polyposis coli
|
342
|
13
|
23
|
|
|
Hypogonadotropic hypogonadism 2 with or without anosmia
|
342
|
6
|
45
|
|
|
Thyrotoxic periodic paralysis, susceptibility to, 1
|
342
|
1
|
4
|
|
|
Melnick-Fraser syndrome
|
341
|
7
|
5
|
|
|
Agammaglobulinemia 4, autosomal recessive
|
340
|
3
|
15
|
|
|
Permanent neonatal diabetes mellitus
|
340
|
8
|
12
|
|
|
APC-related disorder
|
339
|
2
|
1
|
|
|
Autoimmune lymphoproliferative syndrome type 2B
|
339
|
6
|
11
|
|
|
Fibromatosis, gingival, 1
|
339
|
3
|
7
|
|
|
Hypertrophic cardiomyopathy 19
|
339
|
2
|
7
|
|
|
Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
|
339
|
3
|
1
|
|
|
Interstitial lung disease due to ABCA3 deficiency
|
338
|
3
|
37
|
|
|
Long QT syndrome 2
|
338
|
10
|
68
|
|
|
Developmental and epileptic encephalopathy, 2
|
337
|
10
|
76
|
|
|
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2
|
337
|
1
|
6
|
|
|
Immunodeficiency due to CD25 deficiency
|
336
|
6
|
9
|
|
|
Primary ciliary dyskinesia 30
|
336
|
4
|
16
|
|
|
Encephalopathy due to GLUT1 deficiency
|
335
|
4
|
44
|
|
|
LAMA5-related disorder
|
335
|
2
|
2
|
|
|
Amyotrophic lateral sclerosis type 6; Tremor, hereditary essential, 4
|
334
|
1
|
4
|
|
|
Hereditary spastic paraplegia 47
|
334
|
6
|
36
|
|
|
Generalized epilepsy with febrile seizures plus, type 2
|
333
|
3
|
53
|
|
|
Hereditary spastic paraplegia 73
|
333
|
2
|
21
|
|
|
Hirschsprung disease, susceptibility to, 1; Multiple endocrine neoplasia type 2B; Pheochromocytoma; Familial medullary thyroid carcinoma; Multiple endocrine neoplasia type 2A
|
333
|
2
|
3
|
|
|
Medulloblastoma; Familial dysautonomia
|
333
|
1
|
2
|
|
|
Congenital disorder of glycosylation
|
332
|
21
|
12
|
|
|
Glycogen storage disease due to muscle beta-enolase deficiency
|
331
|
1
|
15
|
|
|
Inherited breast cancer and ovarian cancer
|
330
|
10
|
4
|
|
|
Kidney disorder
|
330
|
59
|
3
|
|
|
Usher syndrome type 1C
|
330
|
2
|
24
|
|
|
Autosomal recessive nonsyndromic hearing loss 1A
|
329
|
7
|
96
|
|
|
Proline dehydrogenase deficiency
|
329
|
5
|
18
|
|
|
Iodotyrosyl coupling defect
|
328
|
2
|
29
|
|
|
Charcot-Marie-Tooth disease axonal type 2F
|
327
|
1
|
24
|
|
|
Hemochromatosis type 3
|
327
|
3
|
19
|
|
|
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency
|
326
|
7
|
33
|
|
|
PHIP-related disorder
|
326
|
4
|
2
|
|
|
3-Methylglutaconic aciduria type 3; Optic atrophy 3
|
325
|
2
|
6
|
|
|
Autosomal recessive hypophosphatemic bone disease
|
325
|
2
|
43
|
|
|
Pontocerebellar hypoplasia type 6
|
325
|
2
|
45
|
|
|
Arrhythmogenic right ventricular dysplasia 2
|
324
|
4
|
14
|
|
|
Heterotaxy, visceral, 4, autosomal
|
324
|
5
|
15
|
|
|
Immunodeficiency 67
|
324
|
2
|
18
|
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14; Autosomal recessive limb-girdle muscular dystrophy type 2T
|
324
|
2
|
7
|
|
|
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome
|
323
|
2
|
45
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2W
|
323
|
3
|
11
|
|
|
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1
|
323
|
5
|
26
|
|
|
Hereditary angioedema type 1
|
323
|
2
|
30
|
|
|
Brittle cornea syndrome 1
|
322
|
4
|
36
|
|
|
Hyperprolinemia type 2
|
321
|
5
|
18
|
|
|
POLG-related disorder
|
321
|
5
|
21
|
|
|
Brain small vessel disease 1 with or without ocular anomalies
|
320
|
3
|
60
|
|
|
Ehlers-Danlos syndrome progeroid type
|
320
|
3
|
14
|
|
|
Familial hypobetalipoproteinemia 1
|
320
|
3
|
28
|
|
|
Congenital glaucoma
|
319
|
4
|
1
|
|
|
Kleefstra syndrome 2
|
319
|
7
|
74
|
|
|
Nemaline myopathy 5
|
319
|
6
|
17
|
|
|
Chondrodysplasia punctata, brachytelephalangic, autosomal
|
318
|
2
|
2
|
|
|
Colorectal cancer, susceptibility to, 12; Facial dysmorphism-immunodeficiency-livedo-short stature syndrome; Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency
|
318
|
3
|
4
|
|
|
Glycogen storage disease, type IV
|
317
|
4
|
35
|
|
|
Acyl-CoA dehydrogenase 9 deficiency
|
316
|
3
|
31
|
|
|
Dilated cardiomyopathy 1Z; Hypertrophic cardiomyopathy 13
|
316
|
1
|
5
|
|
|
PIEZO1-related disorder
|
316
|
2
|
3
|
|
|
Seizures, benign familial neonatal, 2
|
316
|
3
|
46
|
|
|
ATM-related cancer predisposition
|
315
|
4
|
7
|
|
|
Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome
|
315
|
1
|
3
|
|
|
Neu-Laxova syndrome 2
|
315
|
2
|
7
|
|
|
Nonsyndromic genetic hearing loss
|
315
|
51
|
17
|
|
|
Cone-rod dystrophy
|
314
|
78
|
17
|
|
|
Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Weill-Marchesani syndrome 2, dominant; Acromicric dysplasia; Geleophysic dysplasia 2; Progeroid and marfanoid aspect-lipodystrophy syndrome
|
314
|
4
|
6
|
|
|
Joubert syndrome 17
|
314
|
8
|
49
|
|
|
Microcephaly
|
314
|
235
|
20
|
|
|
Renal tubular acidosis with progressive nerve deafness
|
314
|
2
|
35
|
|
|
Spondyloenchondrodysplasia with immune dysregulation
|
314
|
1
|
18
|
|
|
ABCA4-related disorder
|
313
|
3
|
7
|
|
|
Duane-radial ray syndrome
|
313
|
3
|
26
|
|
|
Marinesco-Sjögren syndrome
|
313
|
3
|
26
|
|
|
OBSCN-related disorder
|
313
|
2
|
1
|
|
|
Galactosemia
|
312
|
2
|
7
|
|
|
Hereditary sensory and autonomic neuropathy with spastic paraplegia
|
312
|
1
|
13
|
|
|
Cataract 18
|
311
|
1
|
18
|
|
|
Pheochromocytoma/paraganglioma syndrome 4
|
311
|
8
|
41
|
|
|
Wiskott-Aldrich syndrome 2
|
311
|
3
|
13
|
|
|
Fanconi anemia complementation group J
|
309
|
1
|
28
|
|
|
Griscelli syndrome type 2
|
309
|
3
|
25
|
|
|
Carnitine acylcarnitine translocase deficiency
|
308
|
3
|
19
|
|
|
NCOA1-related disorder
|
308
|
1
|
1
|
|
|
Primary hyperoxaluria type 3
|
308
|
2
|
33
|
|
|
Xeroderma pigmentosum, group C
|
308
|
3
|
33
|
|
|
Alagille syndrome due to a NOTCH2 point mutation; Hajdu-Cheney syndrome
|
307
|
1
|
7
|
|
|
Nephronophthisis 9
|
307
|
6
|
5
|
|
|
Deficiency of 2-methylbutyryl-CoA dehydrogenase
|
306
|
3
|
32
|
|
|
Leukocyte adhesion deficiency type II
|
306
|
4
|
22
|
|
|
Noonan syndrome 8
|
306
|
5
|
50
|
|
|
Renal-hepatic-pancreatic dysplasia 1; Nephronophthisis 3; NPHP3-related Meckel-like syndrome
|
306
|
2
|
6
|
|
|
Vesicoureteral reflux 2
|
306
|
2
|
17
|
|
|
Amelogenesis imperfecta hypomaturation type 2A3
|
305
|
1
|
14
|
|
|
Corneal dystrophy
|
305
|
11
|
7
|
|
|
Ehlers-Danlos syndrome, spondylocheirodysplastic type
|
305
|
1
|
11
|
|
|
Autism spectrum disorder - epilepsy - arthrogryposis syndrome
|
304
|
2
|
9
|
|
|
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency
|
303
|
5
|
53
|
|
|
Ehlers-Danlos syndrome, musculocontractural type 2
|
303
|
2
|
10
|
|
|
Hereditary spastic paraplegia 30
|
303
|
2
|
37
|
|
|
Hypertrophic cardiomyopathy 2
|
303
|
17
|
25
|
|
|
Intellectual disability, autosomal recessive 42
|
303
|
2
|
24
|
|
|
Nemaline myopathy 2; Arthrogryposis multiplex congenita 6
|
303
|
2
|
7
|
|
|
Microvascular complications of diabetes, susceptibility to, 3; Hemorrhage, intracerebral, susceptibility to; Renal tubular dysgenesis of genetic origin
|
302
|
2
|
1
|
|
|
Premature ovarian failure
|
302
|
251
|
6
|
|
|
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency
|
301
|
3
|
11
|
|
|
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism
|
301
|
5
|
39
|
|
|
Progressive myoclonic epilepsy type 8
|
301
|
2
|
11
|
|
|
Achromatopsia 3
|
300
|
2
|
33
|
|
|
Combined immunodeficiency due to CTPS1 deficiency
|
300
|
3
|
8
|
|
|
Familial juvenile hyperuricemic nephropathy type 1
|
300
|
2
|
47
|
|
|
Hereditary spastic paraplegia 6
|
300
|
5
|
18
|
|
|
Hypomyelination and Congenital Cataract
|
300
|
6
|
19
|
|
|
Joubert syndrome 25
|
300
|
5
|
13
|
|
|
Recessive dystrophic epidermolysis bullosa
|
300
|
2
|
49
|
|
|
Cockayne syndrome type 2
|
299
|
5
|
42
|
|
|
Atrial standstill 1; Atrial fibrillation, familial, 11
|
298
|
2
|
1
|
|
|
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome; Brain small vessel disease 1 with or without ocular anomalies; Hemorrhage, intracerebral, susceptibility to; Retinal arterial tortuosity; Microangiopathy and leukoencephalopathy, pontine, autosomal dominant
|
298
|
3
|
3
|
|
|
Cornelia de Lange syndrome 5
|
298
|
3
|
53
|
|
|
Glutamate formiminotransferase deficiency
|
298
|
1
|
16
|
|
|
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase
|
298
|
2
|
11
|
|
|
Neurodevelopmental delay
|
298
|
203
|
20
|
|
|
Acrocallosal syndrome; Multiple epiphyseal dysplasia, Al-Gazali type; Hydrolethalus syndrome 2
|
297
|
2
|
4
|
|
|
Craniosynostosis syndrome
|
297
|
50
|
14
|
|
|
Junctional epidermolysis bullosa, non-Herlitz type
|
297
|
8
|
28
|
|
|
SLC35A2-congenital disorder of glycosylation
|
297
|
10
|
29
|
|
|
Brain small vessel disease 2A, autosomal dominant
|
296
|
3
|
43
|
|
|
Cardiac anomalies - developmental delay - facial dysmorphism syndrome
|
296
|
4
|
78
|
|
|
Familial ovarian cancer
|
296
|
22
|
7
|
|
|
Nephronophthisis-like nephropathy 1
|
296
|
3
|
12
|
|
|
Nephropathic cystinosis
|
296
|
7
|
31
|
|
|
ALG2-congenital disorder of glycosylation; Congenital myasthenic syndrome 14
|
295
|
2
|
4
|
|
|
Gray platelet syndrome
|
295
|
2
|
25
|
|
|
Long QT syndrome 11
|
295
|
5
|
26
|
|
|
Pulmonary arterial hypertension
|
295
|
31
|
10
|
|
|
Glutathione synthetase deficiency with 5-oxoprolinuria
|
294
|
2
|
4
|
|
|
Hyper-IgM syndrome type 1
|
294
|
4
|
25
|
|
|
Prostate cancer, hereditary, 9
|
294
|
1
|
17
|
|
|
Common variable immunodeficiency
|
293
|
13
|
5
|
|
|
Fructose-biphosphatase deficiency
|
293
|
2
|
32
|
|
|
Glycogen storage disease, type VI
|
293
|
1
|
32
|
|
|
Hyperphosphatasia with intellectual disability syndrome 5
|
293
|
6
|
12
|
|
|
Infantile nephronophthisis
|
293
|
5
|
32
|
|
|
Leber congenital amaurosis 5
|
293
|
3
|
19
|
|
|
Macular corneal dystrophy
|
293
|
3
|
20
|
|
|
Severe combined immunodeficiency due to LCK deficiency
|
293
|
1
|
8
|
|
|
Autosomal recessive retinitis pigmentosa
|
292
|
39
|
6
|
|
|
Cornelia de Lange syndrome 4
|
292
|
3
|
32
|
|
|
Sitosterolemia 1
|
292
|
4
|
23
|
|
|
3M syndrome 2
|
291
|
2
|
30
|
|
|
Bilateral frontoparietal polymicrogyria
|
291
|
2
|
26
|
|
|
Hypertrophic cardiomyopathy 25; Primary familial hypertrophic cardiomyopathy
|
291
|
2
|
1
|
|
|
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss; Autosomal dominant nonsyndromic hearing loss 17
|
291
|
2
|
4
|
|
|
Amyotrophic lateral sclerosis type 1
|
290
|
10
|
42
|
|
|
Aniridia 1
|
290
|
6
|
41
|
|
|
Elliptocytosis 2
|
290
|
2
|
22
|
|
|
Myoglobinuria, acute recurrent, autosomal recessive
|
290
|
4
|
22
|
|
|
NRP2-related disorder
|
290
|
2
|
2
|
|
|
Primary hyperoxaluria, type II
|
290
|
1
|
31
|
|
|
Congenital adrenal hypoplasia, X-linked; 46,XY sex reversal 2
|
289
|
2
|
3
|
|
|
Familial adenomatous polyposis 3
|
289
|
3
|
26
|
|
|
GNPTG-mucolipidosis
|
289
|
3
|
27
|
|
|
Hereditary factor XI deficiency disease
|
289
|
3
|
38
|
|
|
Deficiency of 3-hydroxyacyl-CoA dehydrogenase
|
288
|
3
|
8
|
|
|
Mitochondrial DNA depletion syndrome 9
|
288
|
3
|
24
|
|
|
Nemaline myopathy 9
|
288
|
1
|
11
|
|
|
Arrhythmogenic right ventricular dysplasia 8
|
287
|
2
|
44
|
|
|
Breast neoplasm
|
287
|
22
|
13
|
|
|
Dihydropyrimidine dehydrogenase deficiency
|
287
|
2
|
34
|
|
|
Megalencephalic leukoencephalopathy with subcortical cysts 1
|
287
|
4
|
44
|
|
|
Neurodegeneration with brain iron accumulation 6
|
287
|
2
|
13
|
|
|
Norman-Roberts syndrome
|
287
|
4
|
25
|
|
|
PKD1L1-related disorder
|
287
|
1
|
1
|
|
|
Rubinstein-Taybi syndrome due to CREBBP mutations; Menke-Hennekam syndrome 1
|
287
|
3
|
9
|
|
|
ALMS1-related disorder
|
286
|
2
|
1
|
|
|
Hereditary spherocytosis type 3
|
286
|
5
|
21
|
|
|
Noonan syndrome 1
|
286
|
21
|
101
|
|
|
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome
|
286
|
2
|
86
|
|
|
SEMA3G-related disorder
|
285
|
1
|
1
|
|
|
Tip-toe gait
|
285
|
56
|
1
|
|
|
Spermatogenic failure 28; Premature ovarian failure 15
|
284
|
2
|
4
|
|
|
Atypical glycine encephalopathy
|
283
|
1
|
16
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2I
|
283
|
2
|
33
|
|
|
Epilepsy, familial focal, with variable foci 1
|
283
|
11
|
75
|
|
|
Pseudohypoaldosteronism type 2B
|
283
|
2
|
15
|
|
|
Candidiasis, familial, 8
|
282
|
3
|
5
|
|
|
Netherton syndrome
|
282
|
1
|
42
|
|
|
Oculotrichoanal syndrome
|
282
|
2
|
8
|
|
|
3-Methylglutaconic aciduria type 3
|
281
|
4
|
21
|
|
|
Ehlers-Danlos syndrome, classic type
|
281
|
15
|
29
|
|
|
Ehlers-Danlos syndrome, spondylodysplastic type, 2; Spondyloepimetaphyseal dysplasia with joint laxity
|
281
|
4
|
3
|
|
|
Hyper-IgM syndrome type 2
|
281
|
3
|
21
|
|
|
Hereditary acrodermatitis enteropathica
|
280
|
2
|
16
|
|
|
Microcephaly 2, primary, autosomal recessive, with or without cortical malformations
|
280
|
1
|
44
|
|
|
Loeys-Dietz syndrome
|
279
|
14
|
12
|
|
|
Multiple congenital anomalies-hypotonia-seizures syndrome 2
|
279
|
3
|
28
|
|
|
Retinitis pigmentosa 26
|
279
|
4
|
31
|
|
|
Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5; Thyrotoxic periodic paralysis, susceptibility to, 1; Congenital myopathy 18
|
278
|
1
|
1
|
|
|
Neuroblastoma
|
278
|
42
|
10
|
|
|
Primary ciliary dyskinesia 32
|
278
|
3
|
12
|
|
|
Asphyxiating thoracic dystrophy 4; Nephronophthisis 12
|
277
|
1
|
5
|
|
|
Hyper-IgM syndrome type 5
|
277
|
3
|
14
|
|
|
Neuronal ceroid lipofuscinosis 3
|
277
|
1
|
37
|
|
|
POLE-related disorder
|
277
|
2
|
3
|
|
|
Age related macular degeneration 9; Atypical hemolytic-uremic syndrome with C3 anomaly; Complement component 3 deficiency
|
276
|
1
|
2
|
|
|
Hemochromatosis type 4
|
276
|
1
|
20
|
|
|
Hermansky-Pudlak syndrome 3
|
276
|
2
|
26
|
|
|
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome
|
276
|
6
|
28
|
|
|
Purine-nucleoside phosphorylase deficiency
|
276
|
2
|
22
|
|
|
Stargardt disease
|
276
|
21
|
18
|
|
|
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia
|
276
|
8
|
18
|
|
|
Bardet-Biedl syndrome 4
|
275
|
1
|
29
|
|
|
Deficiency of steroid 11-beta-monooxygenase
|
274
|
4
|
29
|
|
|
Inosine triphosphatase deficiency
|
274
|
7
|
3
|
|
|
Rotor syndrome
|
274
|
5
|
20
|
|
|
Spondyloepimetaphyseal dysplasia, PAPSS2 type
|
274
|
1
|
21
|
|
|
Absence seizure; Myoclonic epilepsy, juvenile, susceptibility to, 1
|
273
|
1
|
3
|
|
|
Stickler syndrome type 1
|
273
|
2
|
50
|
|
|
Colorectal cancer, susceptibility to, 1
|
272
|
4
|
7
|
|
|
Hereditary spastic paraplegia 75
|
272
|
2
|
15
|
|
|
SH2B1-related disorder
|
272
|
1
|
3
|
|
|
Arthrogryposis, distal, type 1A
|
271
|
7
|
16
|
|
|
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency
|
271
|
6
|
24
|
|
|
Open-angle glaucoma
|
271
|
1
|
1
|
|
|
Pyropoikilocytosis, hereditary
|
271
|
3
|
8
|
|
|
HNSHA due to aldolase A deficiency
|
270
|
4
|
11
|
|
|
Hypoalphalipoproteinemia, primary, 1
|
270
|
7
|
10
|
|
|
Peroxisome biogenesis disorder 1A (Zellweger)
|
270
|
11
|
40
|
|
|
Sjögren-Larsson syndrome
|
270
|
4
|
41
|
|
|
Deficiency of guanidinoacetate methyltransferase
|
269
|
2
|
39
|
|
|
RPGR-related retinopathy
|
269
|
2
|
5
|
|
|
Anemia, congenital dyserythropoietic, type 1a
|
268
|
4
|
22
|
|
|
Atrial fibrillation, familial, 18
|
268
|
1
|
8
|
|
|
Bone mineral density quantitative trait locus 1; Exudative vitreoretinopathy 4; Worth disease; Autosomal dominant osteopetrosis 1; Osteoporosis with pseudoglioma; Polycystic liver disease 4 with or without kidney cysts
|
268
|
1
|
2
|
|
|
Hypomyelinating leukodystrophy 6
|
268
|
2
|
39
|
|
|
Neuronopathy, distal hereditary motor, autosomal recessive 5
|
268
|
3
|
20
|
|
|
Tangier disease
|
268
|
6
|
13
|
|
|
Dilated cardiomyopathy 1II
|
267
|
2
|
5
|
|
|
MAGEL2-related disorder
|
267
|
1
|
1
|
|
|
Welander distal myopathy
|
267
|
1
|
7
|
|
|
Congenital muscular dystrophy due to partial LAMA2 deficiency
|
266
|
3
|
4
|
|
|
Niemann-Pick disease, type C2
|
266
|
3
|
27
|
|
|
Thrombocytopenia 2
|
266
|
4
|
30
|
|
|
Tyrosinase-positive oculocutaneous albinism
|
266
|
6
|
61
|
|
|
von Willebrand disease type 1
|
266
|
3
|
35
|
|
|
Meckel syndrome, type 6; Joubert syndrome 9; COACH syndrome 2; Retinitis pigmentosa 93
|
265
|
1
|
4
|
|
|
Corneal dystrophy-perceptive deafness syndrome
|
264
|
1
|
9
|
|
|
Fanconi-Bickel syndrome
|
264
|
2
|
23
|
|
|
Combined immunodeficiency due to STK4 deficiency
|
263
|
3
|
10
|
|
|
DPAGT1-congenital disorder of glycosylation; Congenital myasthenic syndrome 13
|
263
|
3
|
7
|
|
|
Dilated cardiomyopathy 1D
|
263
|
3
|
35
|
|
|
Hypogonadotropic hypogonadism 1 with or without anosmia
|
263
|
1
|
35
|
|
|
Congenital insensitivity to pain-hypohidrosis syndrome
|
262
|
4
|
12
|
|
|
KSR2-related disorder
|
262
|
1
|
1
|
|
|
Retinal disorder
|
262
|
110
|
3
|
|
|
Immunodeficiency 18
|
261
|
3
|
14
|
|
|
Long QT syndrome 3
|
261
|
2
|
40
|
|
|
Pontoneocerebellar hypoplasia
|
261
|
18
|
7
|
|
|
Wolcott-Rallison dysplasia
|
261
|
1
|
27
|
|
|
Childhood encephalopathy due to thiamine pyrophosphokinase deficiency
|
260
|
2
|
20
|
|
|
Focal segmental glomerulosclerosis
|
260
|
60
|
14
|
|
|
L-2-hydroxyglutaric aciduria
|
260
|
3
|
37
|
|
|
Potassium-aggravated myotonia; Paramyotonia congenita of Von Eulenburg; Hypokalemic periodic paralysis, type 2; Hyperkalemic periodic paralysis; Congenital myasthenic syndrome 16; Congenital myopathy 22A, classic; Congenital myopathy 22B, severe fetal
|
260
|
2
|
3
|
|
|
Developmental and epileptic encephalopathy, 69
|
259
|
1
|
37
|
|
|
Developmental and epileptic encephalopathy, 7
|
259
|
3
|
74
|
|
|
Glycine encephalopathy 1
|
259
|
4
|
29
|
|
|
Hereditary spastic paraplegia 54
|
259
|
3
|
28
|
|
|
Joubert syndrome and related disorders
|
259
|
31
|
6
|
|
|
Mesothelioma
|
259
|
246
|
2
|
|
|
Palmoplantar keratoderma-esophageal carcinoma syndrome
|
259
|
1
|
10
|
|
|
Familial renal glucosuria
|
258
|
5
|
26
|
|
|
Focal segmental glomerulosclerosis 2
|
258
|
1
|
27
|
|
|
MECP2-related disorder
|
258
|
2
|
8
|
|
|
46,XY sex reversal 9
|
257
|
2
|
6
|
|
|
Charcot-Marie-Tooth disease dominant intermediate F
|
257
|
1
|
12
|
|
|
Developmental and epileptic encephalopathy, 11
|
257
|
2
|
79
|
|
|
Familial Mediterranean fever; Familial Mediterranean fever, autosomal dominant; Acute febrile neutrophilic dermatosis
|
257
|
2
|
4
|
|
|
Hypogonadotropic hypogonadism 5 with or without anosmia
|
257
|
4
|
27
|
|
|
Schizophrenia
|
257
|
232
|
20
|
|
|
Anterior segment dysgenesis 7
|
256
|
3
|
16
|
|
|
Asphyxiating thoracic dystrophy 5; Nephronophthisis 13; Cranioectodermal dysplasia 4; Senior-Loken syndrome 8; Spermatogenic failure 72
|
256
|
1
|
3
|
|
|
BBS9-related disorder
|
256
|
1
|
1
|
|
|
Bardet-Biedl syndrome 7
|
256
|
2
|
36
|
|
|
FLNA-related disorder
|
256
|
2
|
11
|
|
|
CHD7-related disorder
|
255
|
2
|
5
|
|
|
DNAH17-related disorder
|
253
|
6
|
1
|
|
|
Developmental and epileptic encephalopathy, 4
|
253
|
10
|
93
|
|
|
Glycogen storage disease XV; Polyglucosan body myopathy type 2
|
253
|
3
|
4
|
|
|
Hyperlipoproteinemia, type I
|
253
|
3
|
29
|
|
|
Muscle eye brain disease
|
253
|
2
|
6
|
|
|
Pituitary adenoma 5, multiple types
|
253
|
5
|
8
|
|
|
Sessile serrated polyposis cancer syndrome
|
253
|
1
|
14
|
|
|
von Willebrand disease type 3
|
253
|
1
|
23
|
|
|
21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia
|
252
|
12
|
71
|
|
|
3-hydroxy-3-methylglutaryl-CoA synthase deficiency
|
252
|
2
|
29
|
|
|
Age related macular degeneration 4
|
252
|
1
|
7
|
|
|
Cerebral cavernous malformation 2
|
252
|
5
|
28
|
|
|
Dilated cardiomyopathy 1GG
|
252
|
1
|
6
|
|
|
FLNB-Related Spectrum Disorders
|
252
|
2
|
2
|
|
|
Greig cephalopolysyndactyly syndrome; Pallister-Hall syndrome; Polysyndactyly 4; Polydactyly, postaxial, type A1
|
252
|
1
|
6
|
|
|
Inflammatory bowel disease 25
|
252
|
4
|
12
|
|
|
LEPR-related disorder
|
252
|
2
|
2
|
|
|
Nephrotic syndrome, type 2
|
252
|
2
|
49
|
|
|
Polycystic liver disease 2
|
252
|
2
|
19
|
|
|
Primary ciliary dyskinesia 19
|
252
|
1
|
24
|
|
|
Autosomal recessive proximal renal tubular acidosis
|
251
|
3
|
11
|
|
|
Congenital amegakaryocytic thrombocytopenia
|
251
|
1
|
18
|
|
|
Stickler syndrome type 2
|
251
|
3
|
43
|
|
|
Autosomal dominant nonsyndromic hearing loss 4A
|
250
|
2
|
21
|
|
|
Charcot-Marie-Tooth disease X-linked dominant 1
|
250
|
5
|
68
|
|
|
Dilated cardiomyopathy 3B
|
250
|
4
|
24
|
|
|
Gingival disorder
|
250
|
1
|
1
|
|
|
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome
|
250
|
3
|
82
|
|
|
Meckel syndrome, type 1
|
250
|
4
|
20
|
|
|
Retinitis pigmentosa 28
|
250
|
2
|
25
|
|
|
Retinitis pigmentosa 3
|
250
|
4
|
36
|
|
|
Telangiectasia, hereditary hemorrhagic, type 5
|
250
|
2
|
13
|
|
|
Ehlers-Danlos syndrome, classic type, 2
|
249
|
4
|
36
|
|
|
Factor V deficiency
|
249
|
1
|
16
|
|
|
Larsen-like syndrome, B3GAT3 type
|
249
|
4
|
15
|
|
|
Thrombophilia due to thrombin defect
|
249
|
4
|
23
|
|
|
Pontocerebellar hypoplasia type 1B
|
248
|
3
|
43
|
|
|
Coffin-Lowry syndrome; Intellectual disability, X-linked 19
|
247
|
3
|
10
|
|
|
Congenital disorder of glycosylation type 1E
|
247
|
5
|
16
|
|
|
Endometrial carcinoma; Lynch syndrome 5; Mismatch repair cancer syndrome 3
|
247
|
2
|
5
|
|
|
Finnish type amyloidosis
|
247
|
1
|
18
|
|
|
Multiple congenital anomalies-hypotonia-seizures syndrome 3
|
247
|
2
|
25
|
|
|
Nail-patella syndrome
|
247
|
2
|
42
|
|
|
Agammaglobulinemia 2, autosomal recessive
|
246
|
2
|
14
|
|
|
Alzheimer disease 4
|
246
|
5
|
17
|
|
|
Breast ductal adenocarcinoma
|
246
|
254
|
2
|
|
|
Nicolaides-Baraitser syndrome
|
246
|
4
|
55
|
|
|
Xeroderma pigmentosum variant type
|
246
|
3
|
22
|
|
|
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency
|
245
|
2
|
83
|
|
|
Microcephaly 1, primary, autosomal recessive
|
245
|
8
|
38
|
|
|
Sengers syndrome; Cataract 38
|
245
|
2
|
4
|
|
|
Bailey-Bloch congenital myopathy
|
244
|
3
|
21
|
|
|
Holoprosencephaly sequence
|
244
|
13
|
6
|
|
|
Oculodentodigital dysplasia, autosomal recessive
|
244
|
3
|
3
|
|
|
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins
|
243
|
5
|
25
|
|
|
Autism
|
243
|
230
|
35
|
|
|
Fanconi anemia complementation group D1
|
243
|
2
|
21
|
|
|
Hereditary spastic paraplegia 2
|
243
|
5
|
19
|
|
|
NOTCH1-related disorder
|
243
|
3
|
5
|
|
|
Syndromic X-linked intellectual disability 14
|
243
|
3
|
22
|
|
|
BRCA1-related disorder
|
242
|
3
|
3
|
|
|
Greig cephalopolysyndactyly syndrome
|
242
|
3
|
35
|
|
|
Hemolytic uremic syndrome, atypical, susceptibility to, 1
|
242
|
8
|
22
|
|
|
Retinitis pigmentosa 12
|
242
|
1
|
25
|
|
|
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome
|
241
|
2
|
70
|
|
|
ALG8 congenital disorder of glycosylation
|
241
|
2
|
19
|
|
|
Alzheimer disease 3; Frontotemporal dementia; Pick disease; Acne inversa, familial, 3
|
241
|
1
|
2
|
|
|
Brugada syndrome 1; Long QT syndrome 3; Sick sinus syndrome 1; Progressive familial heart block, type 1A; Ventricular fibrillation, paroxysmal familial, type 1; Dilated cardiomyopathy 1E; SUDDEN INFANT DEATH SYNDROME; Atrial fibrillation, familial, 10
|
241
|
2
|
4
|
|
|
Knobloch syndrome
|
241
|
5
|
28
|
|
|
Lysosomal acid lipase deficiency
|
241
|
1
|
37
|
|
|
Maturity-onset diabetes of the young type 3
|
241
|
4
|
56
|
|
|
Muscular dystrophy, limb-girdle, autosomal dominant 4
|
241
|
4
|
24
|
|
|
Congenital myopathy with fiber type disproportion
|
240
|
15
|
23
|
|
|
Intellectual developmental disorder with autism and macrocephaly
|
240
|
5
|
78
|
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12; Limb-girdle muscular dystrophy due to POMK deficiency
|
240
|
3
|
3
|
|
|
Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities
|
240
|
6
|
22
|
|
|
Pheochromocytoma/paraganglioma syndrome 1
|
240
|
70
|
25
|
|
|
Pseudohypoaldosteronism, type IB1, autosomal recessive
|
240
|
4
|
21
|
|
|
TBX3-related disorder
|
239
|
2
|
1
|
|
|
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma; Arrhythmogenic right ventricular dysplasia 8; Lethal acantholytic epidermolysis bullosa; Woolly hair-skin fragility syndrome; Keratosis palmoplantaris striata 2; Cardiomyopathy, dilated, with wooly hair, keratoderma, and tooth agenesis
|
238
|
1
|
2
|
|
|
Genitopatellar syndrome; Blepharophimosis - intellectual disability syndrome, SBBYS type
|
238
|
1
|
17
|
|
|
Hypercalcemia, infantile, 1
|
238
|
2
|
36
|
|
|
Spondylocostal dysostosis 3, autosomal recessive
|
238
|
4
|
10
|
|
|
DNMT3A-related disorder
|
237
|
3
|
4
|
|
|
NRP1-related disorder
|
237
|
2
|
1
|
|
|
Pyruvate dehydrogenase E2 deficiency
|
237
|
3
|
21
|
|
|
Autosomal dominant nonsyndromic hearing loss 6
|
236
|
2
|
26
|
|
|
Intellectual disability, X-linked syndromic, Turner type
|
236
|
4
|
70
|
|
|
Marshall-Smith syndrome; Malan overgrowth syndrome
|
236
|
2
|
14
|
|
|
Enhanced S-cone syndrome
|
235
|
3
|
20
|
|
|
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin
|
235
|
1
|
4
|
|
|
Paramyotonia congenita of Von Eulenburg
|
235
|
2
|
20
|
|
|
Peters plus syndrome
|
235
|
3
|
28
|
|
|
Syndromic X-linked intellectual disability Raymond type
|
235
|
4
|
21
|
|
|
Type A2 brachydactyly; Acromesomelic dysplasia 3
|
235
|
1
|
1
|
|
|
Vitamin D-dependent rickets type II with alopecia
|
235
|
4
|
29
|
|
|
Global developmental delay
|
234
|
177
|
37
|
|
|
Hereditary von Willebrand disease
|
234
|
1
|
14
|
|
|
Intellectual disability, X-linked 102
|
234
|
5
|
94
|
|
|
SEMA3F-related disorder
|
234
|
1
|
1
|
|
|
Cardiomyopathy, familial restrictive, 3
|
233
|
1
|
4
|
|
|
Leber congenital amaurosis 2
|
233
|
2
|
24
|
|
|
SYNE1-related disorder
|
233
|
4
|
4
|
|
|
Vitamin B2 deficiency
|
233
|
1
|
1
|
|
|
Breast-ovarian cancer, familial, susceptibility to, 5
|
232
|
5
|
30
|
|
|
Cerebral folate transport deficiency
|
232
|
3
|
25
|
|
|
Dilated cardiomyopathy 1S
|
232
|
19
|
48
|
|
|
Familial Mediterranean fever, autosomal dominant
|
232
|
4
|
32
|
|
|
Glycogen storage disorder due to hepatic glycogen synthase deficiency
|
232
|
2
|
25
|
|
|
Hurler syndrome
|
232
|
3
|
37
|
|
|
NPHP4-related disorder
|
232
|
1
|
3
|
|
|
Neuronal ceroid lipofuscinosis 5
|
232
|
2
|
41
|
|
|
Primary ciliary dyskinesia 15
|
232
|
4
|
26
|
|
|
Cataract 6 multiple types
|
231
|
2
|
19
|
|
|
Dilated cardiomyopathy 1A
|
231
|
38
|
59
|
|
|
Hypertrophic cardiomyopathy 1; Dilated cardiomyopathy 1EE; Hypertrophic cardiomyopathy 14; Atrial septal defect 3; Sick sinus syndrome 3, susceptibility to
|
231
|
3
|
2
|
|
|
Joubert syndrome 5
|
231
|
3
|
37
|
|
|
MKS1-related disorder
|
231
|
2
|
3
|
|
|
Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency
|
231
|
1
|
1
|
|
|
Autosomal recessive nonsyndromic hearing loss 2; Usher syndrome type 1
|
230
|
1
|
3
|
|
|
Charcot-Marie-Tooth disease type 4D
|
230
|
4
|
25
|
|
|
Holt-Oram syndrome
|
230
|
2
|
42
|
|
|
Juvenile onset Parkinson disease 19A
|
230
|
1
|
10
|
|
|
Leprechaunism syndrome
|
230
|
3
|
13
|
|
|
Achromatopsia 2
|
229
|
1
|
45
|
|
|
Leber congenital amaurosis 12
|
229
|
1
|
8
|
|
|
Pulmonary hypertension, primary, 4
|
229
|
1
|
13
|
|
|
Dyskeratosis congenita, autosomal dominant 2
|
228
|
2
|
23
|
|
|
3M syndrome 1
|
227
|
3
|
47
|
|
|
Autosomal recessive congenital ichthyosis 2
|
227
|
6
|
31
|
|
|
Catecholaminergic polymorphic ventricular tachycardia 2
|
227
|
2
|
27
|
|
|
Congenital Muscular Dystrophy, alpha-dystroglycan related
|
227
|
6
|
1
|
|
|
Dyskeratosis congenita, autosomal recessive 5
|
227
|
4
|
24
|
|
|
Dystonia 9
|
227
|
4
|
12
|
|
|
Multiple epiphyseal dysplasia type 4
|
227
|
3
|
19
|
|
|
Channelopathy-associated congenital insensitivity to pain, autosomal recessive
|
226
|
2
|
28
|
|
|
DYRK1B-related disorder
|
226
|
1
|
1
|
|
|
Developmental and epileptic encephalopathy, 42
|
226
|
6
|
60
|
|
|
Immunodeficiency 28
|
226
|
5
|
7
|
|
|
Lymphoproliferative syndrome 2
|
226
|
6
|
9
|
|
|
NOTCH2-related disorder
|
226
|
1
|
2
|
|
|
Progressive encephalopathy with leukodystrophy due to DECR deficiency
|
226
|
3
|
9
|
|
|
Pure or complex autosomal recessive spastic paraplegia
|
226
|
3
|
1
|
|
|
Recessive dystrophic epidermolysis bullosa; Pretibial dystrophic epidermolysis bullosa; Dominant dystrophic epidermolysis bullosa with absence of skin; Transient bullous dermolysis of the newborn; Epidermolysis bullosa pruriginosa; Nonsyndromic congenital nail disorder 8; Generalized dominant dystrophic epidermolysis bullosa
|
226
|
1
|
3
|
|
|
X-linked intellectual disability Cabezas type
|
226
|
3
|
45
|
|
|
MSH6-related disorder
|
225
|
1
|
3
|
|
|
Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency
|
225
|
1
|
10
|
|
|
Meniere disease
|
225
|
56
|
3
|
|
|
Cerebroretinal microangiopathy with calcifications and cysts 1
|
224
|
2
|
31
|
|
|
Charcot-Marie-Tooth disease type 1C
|
224
|
3
|
18
|
|
|
Insulin-resistant diabetes mellitus AND acanthosis nigricans
|
224
|
3
|
11
|
|
|
Nephronophthisis 4
|
224
|
3
|
24
|
|
|
Vitreoretinopathy
|
224
|
6
|
4
|
|
|
von Willebrand disease type 2
|
224
|
1
|
28
|
|
|
AFF4-related disorder
|
223
|
1
|
2
|
|
|
Autosomal recessive nonsyndromic hearing loss 23
|
223
|
2
|
27
|
|
|
Dubin-Johnson syndrome
|
223
|
4
|
33
|
|
|
Hypokalemic periodic paralysis, type 2
|
223
|
2
|
23
|
|
|
Intellectual disability, autosomal dominant 14
|
223
|
6
|
60
|
|
|
Intellectual disability, autosomal dominant 52
|
223
|
2
|
56
|
|
|
Lynch syndrome 1; Muir-Torré syndrome; Mismatch repair cancer syndrome 2
|
223
|
2
|
4
|
|
|
Pigmentary retinal dystrophy
|
223
|
5
|
31
|
|
|
Diastrophic dysplasia
|
222
|
2
|
22
|
|
|
Hearing loss, autosomal recessive
|
222
|
60
|
20
|
|
|
Progressive familial intrahepatic cholestasis type 1
|
222
|
7
|
26
|
|
|
SDCCAG8-related disorder
|
222
|
2
|
1
|
|
|
Amyotrophic lateral sclerosis type 5
|
221
|
3
|
11
|
|
|
Brachydactyly type B1; Autosomal recessive Robinow syndrome
|
221
|
1
|
3
|
|
|
CFI-related disorder
|
221
|
1
|
4
|
|
|
Chronic granulomatous disease
|
221
|
7
|
3
|
|
|
Fraser syndrome 3
|
221
|
16
|
15
|
|
|
Primary erythromelalgia
|
221
|
2
|
26
|
|
|
Rabson-Mendenhall syndrome
|
221
|
2
|
11
|
|
|
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
|
220
|
2
|
26
|
|
|
Temtamy syndrome
|
220
|
6
|
28
|
|
|
Thyroid hormone resistance, generalized, autosomal dominant
|
220
|
3
|
24
|
|
|
46,XY sex reversal 6
|
219
|
3
|
22
|
|
|
Charcot-Marie-Tooth disease axonal type 2L
|
219
|
1
|
9
|
|
|
Charcot-Marie-Tooth disease axonal type 2X
|
219
|
3
|
15
|
|
|
FAT1-related disorder
|
219
|
5
|
3
|
|
|
Hennekam lymphangiectasia-lymphedema syndrome 1
|
219
|
2
|
22
|
|
|
Lower motor neuron syndrome with late-adult onset; Frontotemporal dementia and/or amyotrophic lateral sclerosis 2; Autosomal dominant mitochondrial myopathy with exercise intolerance
|
219
|
2
|
2
|
|
|
Primary ciliary dyskinesia 27
|
219
|
2
|
11
|
|
|
Senior-Loken syndrome 5
|
219
|
1
|
22
|
|
|
ARID1B-Related Disorder
|
218
|
6
|
4
|
|
|
Acromicric dysplasia
|
218
|
5
|
14
|
|
|
Cataract 14 multiple types
|
218
|
2
|
20
|
|
|
NEB-related disorder
|
218
|
3
|
3
|
|
|
Posterior column ataxia-retinitis pigmentosa syndrome
|
218
|
4
|
21
|
|
|
Steinert myotonic dystrophy syndrome
|
218
|
8
|
13
|
|
|
3-methylglutaconic aciduria type 1
|
217
|
4
|
18
|
|
|
Arterial calcification, generalized, of infancy, 1
|
217
|
3
|
16
|
|
|
Becker muscular dystrophy
|
217
|
3
|
42
|
|
|
Charcot-Marie-Tooth disease type 4H
|
217
|
1
|
22
|
|
|
DDX41-related hematologic malignancy predisposition syndrome
|
217
|
2
|
26
|
|
|
Deficiency of isobutyryl-CoA dehydrogenase
|
217
|
2
|
21
|
|
|
Hydatidiform mole, recurrent, 1
|
217
|
3
|
22
|
|
|
Hypertrophic cardiomyopathy 4; Left ventricular noncompaction 10
|
217
|
1
|
14
|
|
|
Adult hypophosphatasia
|
216
|
1
|
33
|
|
|
Basal laminar drusen; Factor H deficiency; Age related macular degeneration 4; Atypical hemolytic-uremic syndrome
|
216
|
1
|
1
|
|
|
Congenital myasthenic syndrome 16
|
216
|
2
|
8
|
|
|
Developmental and epileptic encephalopathy, 13
|
216
|
5
|
60
|
|
|
Developmental disorder
|
216
|
168
|
4
|
|
|
Fanconi anemia complementation group L
|
216
|
2
|
24
|
|
|
INPP5E-related disorder
|
216
|
1
|
2
|
|
|
Medulloblastoma
|
216
|
27
|
20
|
|
|
Pulmonary hypertension, primary, 2
|
216
|
1
|
14
|
|
|
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive
|
216
|
7
|
30
|
|
|
Alzheimer disease 3
|
215
|
1
|
38
|
|
|
Amyotrophic lateral sclerosis type 8; Adult-onset proximal spinal muscular atrophy, autosomal dominant
|
215
|
2
|
2
|
|
|
Autosomal dominant nonsyndromic hearing loss 17
|
215
|
3
|
14
|
|
|
Glucocorticoid-remediable aldosteronism
|
215
|
5
|
5
|
|
|
Merosin deficient congenital muscular dystrophy; Muscular dystrophy, limb-girdle, autosomal recessive 23
|
215
|
2
|
12
|
|
|
Epidermolysis bullosa dystrophica inversa, autosomal recessive
|
214
|
2
|
2
|
|
|
Hyperinsulinism-hyperammonemia syndrome
|
214
|
4
|
28
|
|
|
Hypoparathyroidism, deafness, renal disease syndrome
|
214
|
4
|
49
|
|
|
Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
|
214
|
3
|
22
|
|
|
Autosomal recessive distal spinal muscular atrophy 1
|
213
|
2
|
41
|
|
|
Congenital lipoid adrenal hyperplasia due to STAR deficency
|
213
|
3
|
23
|
|
|
Familial multiple polyposis syndrome
|
213
|
3
|
16
|
|
|
Glaucoma 3, primary congenital, D
|
213
|
1
|
6
|
|
|
Ichthyosis vulgaris
|
213
|
1
|
62
|
|
|
Microcephaly 3, primary, autosomal recessive
|
213
|
1
|
42
|
|
|
Primary familial dilated cardiomyopathy
|
213
|
46
|
7
|
|
|
Blau syndrome
|
212
|
2
|
33
|
|
|
Congenital brain dysgenesis due to glutamine synthetase deficiency
|
212
|
3
|
10
|
|
|
Dilated cardiomyopathy 1E
|
212
|
2
|
18
|
|
|
Focal segmental glomerulosclerosis 6
|
212
|
3
|
14
|
|
|
Migraine, familial hemiplegic, 2
|
212
|
2
|
27
|
|
|
Potassium-aggravated myotonia
|
212
|
2
|
13
|
|
|
Severe combined immunodeficiency disease
|
212
|
37
|
7
|
|
|
ANKRD11-related disorder
|
211
|
2
|
1
|
|
|
Alagille syndrome due to a JAG1 point mutation; Tetralogy of Fallot; Deafness, congenital heart defects, and posterior embryotoxon; Charcot-Marie-Tooth disease, axonal, Type 2HH
|
211
|
1
|
3
|
|
|
Autosomal dominant nonsyndromic hearing loss 11; Autosomal recessive nonsyndromic hearing loss 2; Usher syndrome type 1
|
211
|
1
|
6
|
|
|
Autosomal dominant optic atrophy classic form
|
211
|
3
|
42
|
|
|
BBS1-related disorder
|
211
|
2
|
1
|
|
|
Charcot-Marie-Tooth disease type 4B2
|
211
|
4
|
29
|
|
|
Joubert syndrome 9
|
211
|
4
|
35
|
|
|
Karyomegalic interstitial nephritis
|
211
|
2
|
20
|
|
|
Neural tube defect
|
211
|
16
|
14
|
|
|
SEMA3E-related disorder
|
211
|
1
|
1
|
|
|
SMARCA4-related disorder
|
211
|
1
|
2
|
|
|
Spherocytosis
|
211
|
8
|
4
|
|
|
Congenital stationary night blindness 1E
|
210
|
1
|
19
|
|
|
Craniometaphyseal dysplasia, autosomal dominant
|
210
|
4
|
10
|
|
|
Familial cancer of breast; Breast-ovarian cancer, familial, susceptibility to, 2
|
210
|
3
|
3
|
|
|
Frank-Ter Haar syndrome
|
210
|
1
|
19
|
|
|
PCSK1-related disorder
|
210
|
1
|
1
|
|
|
Pseudohypoaldosteronism type 2C
|
210
|
2
|
11
|
|
|
Rothmund-Thomson syndrome type 2
|
210
|
4
|
21
|
|
|
Snijders Blok-Campeau syndrome
|
210
|
4
|
64
|
|
|
Autosomal recessive nonsyndromic hearing loss 97
|
209
|
1
|
3
|
|
|
Bardet-Biedl syndrome 2; Retinitis pigmentosa 74
|
209
|
2
|
4
|
|
|
Congenital myopathy 4B, autosomal recessive; Congenital myopathy with fiber type disproportion
|
209
|
1
|
4
|
|
|
Cystic fibrosis; Congenital bilateral aplasia of vas deferens from CFTR mutation
|
209
|
5
|
9
|
|
|
Paroxysmal extreme pain disorder
|
209
|
3
|
11
|
|
|
Specific granule deficiency
|
209
|
3
|
1
|
|
|
Waardenburg syndrome type 2A
|
209
|
4
|
29
|
|
|
Autosomal recessive nonsyndromic hearing loss 12; Usher syndrome type 1D; Pituitary adenoma 5, multiple types
|
208
|
4
|
5
|
|
|
Bardet-Biedl syndrome 3; Retinitis pigmentosa 55
|
208
|
2
|
2
|
|
|
Congenital disorder of glycosylation type Ir
|
208
|
2
|
10
|
|
|
Distal arthrogryposis type 2B1
|
208
|
4
|
29
|
|
|
Ectopia lentis 1, isolated, autosomal dominant
|
208
|
6
|
13
|
|
|
FBN1-related disorder
|
208
|
3
|
7
|
|
|
Juvenile retinoschisis
|
208
|
2
|
44
|
|
|
Monogenic hearing loss
|
208
|
66
|
2
|
|
|
Pseudohypoparathyroidism type 1B
|
208
|
4
|
14
|
|
|
SETX-related disorder
|
208
|
2
|
1
|
|
|
SIM1-related disorder
|
208
|
1
|
3
|
|
|
WFS1-Related Spectrum Disorders
|
208
|
2
|
3
|
|
|
Xeroderma pigmentosum, group F
|
208
|
2
|
15
|
|
|
Autosomal dominant nonsyndromic hearing loss 22
|
207
|
2
|
30
|
|
|
Bernard Soulier syndrome
|
207
|
5
|
28
|
|
|
Focal segmental glomerulosclerosis 3, susceptibility to
|
207
|
2
|
13
|
|
|
Multiple mitochondrial dysfunctions syndrome 3; Hereditary spastic paraplegia 74
|
207
|
2
|
4
|
|
|
PTCH1-related disorder
|
207
|
3
|
6
|
|
|
Pseudohypoaldosteronism type 2D
|
207
|
1
|
13
|
|
|
Susceptibility to respiratory infections associated with CD8alpha chain mutation
|
207
|
3
|
6
|
|
|
TUB-related disorder
|
207
|
2
|
1
|
|
|
WDPCP-related disorder
|
207
|
1
|
2
|
|
|
CACNA1A-related disorder
|
206
|
6
|
8
|
|
|
Pontocerebellar hypoplasia type 2D
|
206
|
4
|
29
|
|
|
Autosomal dominant nonsyndromic hearing loss 12
|
205
|
2
|
33
|
|
|
Basal laminar drusen; Factor H deficiency; Hemolytic uremic syndrome, atypical, susceptibility to, 1; Age related macular degeneration 4
|
205
|
1
|
2
|
|
|
Breast carcinoma
|
205
|
35
|
9
|
|
|
COACH syndrome 1; Joubert syndrome 6; Meckel syndrome, type 3; RHYNS syndrome; Bardet-Biedl syndrome 14; Nephronophthisis 11
|
205
|
1
|
3
|
|
|
Cernunnos-XLF deficiency
|
205
|
2
|
11
|
|
|
Familial cancer of breast; Fanconi anemia complementation group N; Pancreatic cancer, susceptibility to, 3
|
205
|
2
|
4
|
|
|
Fanconi anemia complementation group F
|
205
|
3
|
17
|
|
|
Lymphangiomyomatosis; Tuberous sclerosis 1; Isolated focal cortical dysplasia type II
|
205
|
1
|
5
|
|
|
Nephrotic syndrome 15
|
205
|
2
|
10
|
|
|
Pigmented paravenous retinochoroidal atrophy
|
205
|
1
|
12
|
|
|
Stiff skin syndrome
|
205
|
5
|
5
|
|
|
ZTTK syndrome
|
205
|
4
|
62
|
|
|
Adult hypophosphatasia; Childhood hypophosphatasia; Infantile hypophosphatasia
|
204
|
1
|
6
|
|
|
Familial hyperinsulinism
|
204
|
7
|
5
|
|
|
Maturity-onset diabetes of the young type 1
|
204
|
3
|
36
|
|
|
Mitochondrial DNA depletion syndrome 1
|
204
|
11
|
37
|
|
|
Rhizomelic chondrodysplasia punctata type 3
|
204
|
2
|
11
|
|
|
DYNC1H1-related disorder
|
203
|
2
|
8
|
|
|
Familial cancer of breast; Breast-ovarian cancer, familial, susceptibility to, 2; Fanconi anemia complementation group D1; Medulloblastoma; Wilms tumor 1; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Familial prostate cancer
|
203
|
1
|
4
|
|
|
Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections
|
203
|
4
|
1
|
|
|
Neurofibromatosis, familial spinal
|
203
|
2
|
6
|
|
|
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome
|
202
|
3
|
78
|
|
|
Carnitine palmitoyl transferase II deficiency, severe infantile form
|
202
|
2
|
22
|
|
|
FANCA-related disorder
|
202
|
6
|
1
|
|
|
Hypertrophic cardiomyopathy 1; Myopathy, myosin storage, autosomal recessive; Myosin storage myopathy; Congenital myopathy with fiber type disproportion; Dilated cardiomyopathy 1S; MYH7-related skeletal myopathy
|
202
|
5
|
1
|
|
|
Leber congenital amaurosis 9
|
202
|
2
|
21
|
|
|
Neurofibromatosis-Noonan syndrome
|
202
|
5
|
30
|
|
|
Osteogenesis imperfecta with normal sclerae, dominant form
|
202
|
4
|
43
|
|
|
Chondrocalcinosis 2
|
201
|
5
|
5
|
|
|
Holoprosencephaly 7
|
201
|
5
|
15
|
|
|
Immunodeficiency 19
|
201
|
3
|
11
|
|
|
Low phospholipid associated cholelithiasis; Familial intrahepatic cholestasis
|
201
|
3
|
1
|
|
|
Megalencephalic leukoencephalopathy with subcortical cysts
|
201
|
4
|
6
|
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13
|
201
|
2
|
10
|
|
|
Plasma factor XI deficiency
|
201
|
1
|
1
|
|
|
Seizures, benign familial infantile, 3
|
201
|
3
|
29
|
|
|
Succinyl-CoA acetoacetate transferase deficiency
|
201
|
2
|
21
|
|
|
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities
|
200
|
3
|
46
|
|
|
Pheochromocytoma/paraganglioma syndrome 3
|
200
|
3
|
21
|
|
|
Tay-Sachs disease, variant AB
|
200
|
4
|
18
|
|
|
Becker muscular dystrophy; Duchenne muscular dystrophy; Dilated cardiomyopathy 3B
|
199
|
1
|
10
|
|
|
Bone mineral density quantitative trait locus 1; Exudative vitreoretinopathy 4; Exudative vitreoretinopathy 1; Worth disease; Autosomal dominant osteopetrosis 1; Osteoporosis with pseudoglioma; Osteoporosis; Polycystic liver disease 4 with or without kidney cysts
|
199
|
1
|
1
|
|
|
D-2-hydroxyglutaric aciduria 2
|
199
|
4
|
14
|
|
|
Mitochondrial complex I deficiency
|
199
|
33
|
30
|
|
|
Retinitis pigmentosa 40
|
199
|
29
|
30
|
|
|
EPPK1-related disorder
|
198
|
1
|
1
|
|
|
Familial hypocalciuric hypercalcemia 1; Neonatal severe primary hyperparathyroidism; Epilepsy, idiopathic generalized, susceptibility to, 8; Autosomal dominant hypocalcemia 1
|
198
|
1
|
3
|
|
|
Focal segmental glomerulosclerosis 1
|
198
|
5
|
23
|
|
|
Isolated focal non-epidermolytic palmoplantar keratoderma
|
198
|
2
|
6
|
|
|
Malignant hyperthermia of anesthesia
|
198
|
6
|
13
|
|
|
Optic atrophy 3
|
198
|
2
|
10
|
|
|
Polycystic liver disease 1
|
198
|
6
|
27
|
|
|
SEMA3D-related disorder
|
198
|
2
|
1
|
|
|
Seizures, benign familial neonatal, 1
|
198
|
5
|
37
|
|
|
Cataract 1 multiple types
|
197
|
4
|
25
|
|
|
Charcot-Marie-Tooth disease X-linked dominant 6
|
197
|
2
|
14
|
|
|
Qualitative or quantitative defects of delta-sarcoglycan
|
197
|
1
|
1
|
|
|
Sick sinus syndrome 1
|
197
|
2
|
8
|
|
|
Sterile multifocal osteomyelitis with periostitis and pustulosis
|
197
|
3
|
10
|
|
|
USH2A-related disorder
|
197
|
3
|
12
|
|
|
Ventricular fibrillation, paroxysmal familial, type 1
|
197
|
14
|
5
|
|
|
Asphyxiating thoracic dystrophy 2
|
196
|
2
|
13
|
|
|
COG4-congenital disorder of glycosylation
|
196
|
2
|
16
|
|
|
Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5; Thyrotoxic periodic paralysis, susceptibility to, 1
|
196
|
1
|
2
|
|
|
Methylmalonic acidemia
|
196
|
7
|
4
|
|
|
Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant
|
196
|
4
|
1
|
|
|
Amyotrophic lateral sclerosis type 15
|
195
|
3
|
16
|
|
|
Arrhythmogenic right ventricular dysplasia 2; Catecholaminergic polymorphic ventricular tachycardia 1; Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome
|
195
|
3
|
3
|
|
|
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome
|
195
|
4
|
46
|
|
|
BBS2-related disorder
|
195
|
1
|
3
|
|
|
Developmental and epileptic encephalopathy, 21
|
195
|
6
|
8
|
|
|
Immunodeficiency, common variable, 4
|
195
|
4
|
9
|
|
|
Meckel syndrome, type 4
|
195
|
4
|
21
|
|
|
Neutrophil immunodeficiency syndrome
|
195
|
3
|
8
|
|
|
Roberts-SC phocomelia syndrome
|
195
|
2
|
21
|
|
|
FRAS1-related disorder
|
194
|
3
|
1
|
|
|
Glucocorticoid resistance
|
194
|
3
|
12
|
|
|
Hereditary spastic paraplegia 45
|
194
|
3
|
19
|
|
|
Peripheral neuropathy
|
194
|
49
|
11
|
|
|
Reticular dysgenesis
|
194
|
2
|
14
|
|
|
Androgen resistance syndrome
|
193
|
3
|
46
|
|
|
Budd-Chiari syndrome
|
193
|
1
|
1
|
|
|
Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency
|
193
|
2
|
11
|
|
|
Kindler syndrome
|
193
|
2
|
24
|
|
|
Polydactyly
|
193
|
5
|
4
|
|
|
Warts, hypogammaglobulinemia, infections, and myelokathexis
|
193
|
4
|
5
|
|
|
Autosomal recessive nonsyndromic hearing loss 21
|
192
|
2
|
25
|
|
|
COL1A1-related disorder
|
192
|
2
|
3
|
|
|
Childhood onset GLUT1 deficiency syndrome 2
|
192
|
3
|
25
|
|
|
DNAH9-related disorder
|
192
|
4
|
1
|
|
|
Diamond-Blackfan anemia 8
|
192
|
3
|
14
|
|
|
Fibromuscular dysplasia, multifocal
|
192
|
2
|
9
|
|
|
Hermansky-Pudlak syndrome 4
|
192
|
3
|
23
|
|
|
KCNQ1-related disorder
|
192
|
2
|
7
|
|
|
NTRK2-related disorder
|
192
|
2
|
1
|
|
|
Renal hypodysplasia/aplasia 1
|
192
|
5
|
20
|
|
|
Vitamin K-dependent clotting factors, combined deficiency of, type 1
|
192
|
3
|
7
|
|
|
Acute febrile neutrophilic dermatosis
|
191
|
2
|
4
|
|
|
Aromatase deficiency
|
191
|
4
|
13
|
|
|
Autosomal recessive juvenile Parkinson disease 2
|
191
|
8
|
41
|
|
|
Autosomal recessive nonsyndromic hearing loss 37
|
191
|
1
|
12
|
|
|
Congenital stationary night blindness 1C
|
191
|
8
|
28
|
|
|
Mucopolysaccharidosis, MPS-IV-B
|
191
|
2
|
17
|
|
|
Polycystic kidney disease 3 with or without polycystic liver disease
|
191
|
3
|
30
|
|
|
Stüve-Wiedemann syndrome 1
|
191
|
1
|
17
|
|
|
Syndromic X-linked intellectual disability Hedera type
|
191
|
3
|
12
|
|
|
Autosomal recessive nonsyndromic hearing loss 30
|
190
|
1
|
31
|
|
|
Irido-corneo-trabecular dysgenesis
|
190
|
13
|
10
|
|
|
Leber congenital amaurosis 10
|
190
|
6
|
22
|
|
|
Neurodevelopmental abnormality
|
190
|
131
|
8
|
|
|
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder
|
189
|
5
|
67
|
|
|
Autosomal recessive ataxia due to ubiquinone deficiency
|
189
|
4
|
50
|
|
|
Basal cell carcinoma, susceptibility to, 1
|
189
|
6
|
7
|
|
|
Deficiency of steroid 17-alpha-monooxygenase
|
189
|
2
|
29
|
|
|
Ehlers-Danlos syndrome, kyphoscoliotic type, 2
|
189
|
2
|
24
|
|
|
Freeman-Sheldon syndrome
|
189
|
1
|
24
|
|
|
Nephronophthisis 7
|
189
|
1
|
8
|
|
|
Progressive familial heart block, type 1A
|
189
|
3
|
7
|
|
|
Diabetes insipidus, nephrogenic, autosomal
|
188
|
2
|
22
|
|
|
Familial cold autoinflammatory syndrome 3; Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation
|
188
|
1
|
6
|
|
|
Generalized pustular psoriasis
|
188
|
3
|
9
|
|
|
Leber congenital amaurosis 1
|
188
|
10
|
39
|
|
|
Myhre syndrome
|
188
|
1
|
34
|
|
|
CHEK2-related cancer predisposition
|
187
|
3
|
39
|
|
|
Congenital afibrinogenemia
|
187
|
4
|
21
|
|
|
Intellectual disability, X-linked 93
|
187
|
1
|
46
|
|
|
Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart
|
187
|
1
|
47
|
|
|
Thrombocytopenia
|
187
|
35
|
8
|
|
|
ALG3-congenital disorder of glycosylation
|
186
|
4
|
25
|
|
|
Deficiency of iodide peroxidase
|
186
|
3
|
30
|
|
|
Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome; Dilated cardiomyopathy 1A; Charcot-Marie-Tooth disease type 2B1; Emery-Dreifuss muscular dystrophy 2, autosomal dominant; Heart-hand syndrome, Slovenian type; Hutchinson-Gilford syndrome; Familial partial lipodystrophy, Dunnigan type; Mandibuloacral dysplasia with type A lipodystrophy; Congenital muscular dystrophy due to LMNA mutation; Emery-Dreifuss muscular dystrophy 3, autosomal recessive; Restrictive dermopathy 2
|
186
|
3
|
4
|
|
|
Ehlers-Danlos syndrome, musculocontractural type
|
186
|
3
|
10
|
|
|
Familial infantile myoclonic epilepsy
|
186
|
3
|
7
|
|
|
IFT74-related disorder
|
186
|
1
|
2
|
|
|
Immunodeficiency, common variable, 1
|
186
|
6
|
12
|
|
|
Maple syrup urine disease type 1B
|
186
|
1
|
16
|
|
|
Meckel syndrome, type 6
|
186
|
3
|
20
|
|
|
Obesity
|
186
|
53
|
28
|
|
|
Retinal cone dystrophy 4
|
186
|
1
|
13
|
|
|
Heimler syndrome 1
|
185
|
4
|
13
|
|
|
Hyaline fibromatosis syndrome
|
185
|
3
|
30
|
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3
|
185
|
2
|
19
|
|
|
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome
|
185
|
3
|
58
|
|
|
RPE65-related recessive retinopathy
|
185
|
1
|
3
|
|
|
Atelosteogenesis type II
|
184
|
2
|
11
|
|
|
Carpenter syndrome
|
184
|
2
|
4
|
|
|
Cerebrooculofacioskeletal syndrome 1
|
184
|
5
|
11
|
|
|
Chitotriosidase deficiency
|
184
|
1
|
5
|
|
|
Cranioectodermal dysplasia 2
|
184
|
3
|
13
|
|
|
Hyper-IgE recurrent infection syndrome 3, autosomal recessive
|
184
|
8
|
11
|
|
|
Intellectual disability-severe speech delay-mild dysmorphism syndrome
|
184
|
3
|
83
|
|
|
Joubert syndrome with renal defect; Nephronophthisis 1; Senior-Loken syndrome 1
|
184
|
2
|
5
|
|
|
Microphthalmia with brain and digit anomalies; Orofacial cleft 11
|
184
|
2
|
2
|
|
|
Nephrotic syndrome
|
184
|
61
|
15
|
|
|
SEMA3C-related disorder
|
184
|
1
|
1
|
|
|
3-hydroxyisobutyryl-CoA hydrolase deficiency
|
183
|
3
|
29
|
|
|
ADGRV1-related disorder
|
183
|
2
|
2
|
|
|
COL18A1-related disorder
|
183
|
3
|
2
|
|
|
COL2A1-related disorder
|
183
|
1
|
8
|
|
|
Congenital myasthenic syndrome 18
|
183
|
2
|
10
|
|
|
Dent disease type 1
|
183
|
3
|
33
|
|
|
Encephalopathy, acute, infection-induced, susceptibility to, 4
|
183
|
2
|
6
|
|
|
Hereditary diffuse leukoencephalopathy with spheroids
|
183
|
5
|
22
|
|
|
Myosin storage myopathy
|
183
|
6
|
20
|
|
|
Primary ciliary dyskinesia 14
|
183
|
2
|
29
|
|
|
SEMA3A-related disorder
|
183
|
1
|
1
|
|
|
SEMA3B-related disorder
|
183
|
3
|
1
|
|
|
Syndromic X-linked intellectual disability Claes-Jensen type
|
183
|
4
|
78
|
|
|
Bietti crystalline corneoretinal dystrophy
|
182
|
5
|
33
|
|
|
Childhood apraxia of speech
|
182
|
7
|
35
|
|
|
Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency
|
182
|
3
|
17
|
|
|
Hypophosphatemic rickets, autosomal recessive, 2
|
182
|
1
|
10
|
|
|
Intellectual disability, autosomal dominant 6
|
182
|
1
|
65
|
|
|
Periventricular heterotopia with microcephaly, autosomal recessive
|
182
|
3
|
26
|
|
|
Amyotrophic lateral sclerosis
|
181
|
63
|
20
|
|
|
Anophthalmia/microphthalmia-esophageal atresia syndrome
|
181
|
11
|
37
|
|
|
Choroideremia
|
181
|
7
|
44
|
|
|
Cone-rod dystrophy 15
|
181
|
3
|
29
|
|
|
Dilated cardiomyopathy 1X
|
181
|
1
|
7
|
|
|
Ectopia lentis 2, isolated, autosomal recessive
|
181
|
4
|
17
|
|
|
Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome
|
181
|
2
|
16
|
|
|
Fibrochondrogenesis 1
|
181
|
2
|
11
|
|
|
Hermansky-Pudlak syndrome 9
|
181
|
1
|
15
|
|
|
Hypoplastic left heart syndrome
|
181
|
10
|
10
|
|
|
Hypotonia, infantile, with psychomotor retardation and characteristic facies 2
|
181
|
4
|
38
|
|
|
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome
|
181
|
2
|
37
|
|
|
Temtamy preaxial brachydactyly syndrome
|
181
|
2
|
9
|
|
|
Autosomal dominant polycystic liver disease
|
180
|
26
|
4
|
|
|
Congenital generalized lipodystrophy type 1
|
180
|
1
|
25
|
|
|
RET-related disorder
|
180
|
3
|
4
|
|
|
Spondylocostal dysostosis 2, autosomal recessive
|
180
|
6
|
13
|
|
|
Alexander disease
|
179
|
2
|
58
|
|
|
Autosomal recessive nonsyndromic hearing loss 8
|
179
|
2
|
56
|
|
|
Café-au-lait macules with pulmonary stenosis
|
179
|
2
|
6
|
|
|
Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19
|
179
|
3
|
6
|
|
|
Familial cold autoinflammatory syndrome 1
|
179
|
1
|
13
|
|
|
Hypersulfaturia; Nephrolithiasis susceptibility caused by SLC26A1
|
179
|
1
|
2
|
|
|
Hypertrophic cardiomyopathy 26
|
179
|
4
|
47
|
|
|
Mulibrey nanism syndrome
|
179
|
6
|
25
|
|
|
Parkinson disease 17
|
179
|
2
|
9
|
|
|
Phelan-McDermid syndrome
|
179
|
30
|
71
|
|
|
Proteosome-associated autoinflammatory syndrome
|
179
|
2
|
1
|
|
|
Sacral defect with anterior meningocele
|
179
|
2
|
3
|
|
|
ABCC2-related disorder
|
178
|
4
|
1
|
|
|
Acrodysostosis 2 with or without hormone resistance
|
178
|
3
|
24
|
|
|
Basal laminar drusen
|
178
|
1
|
9
|
|
|
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome
|
178
|
2
|
36
|
|
|
Cutis laxa with osteodystrophy
|
178
|
3
|
17
|
|
|
Leber congenital amaurosis 6
|
178
|
1
|
30
|
|
|
Lethal acantholytic epidermolysis bullosa
|
178
|
1
|
5
|
|
|
Long QT syndrome 10
|
178
|
4
|
8
|
|
|
PALB2-related disorder
|
178
|
2
|
8
|
|
|
Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal
|
178
|
2
|
9
|
|
|
Pseudo-Hurler polydystrophy
|
178
|
3
|
25
|
|
|
Woolly hair-skin fragility syndrome
|
178
|
2
|
6
|
|
|
Autosomal recessive distal spinal muscular atrophy 2; Amyotrophic lateral sclerosis type 16
|
177
|
4
|
4
|
|
|
CC2D2A-related disorder
|
177
|
1
|
7
|
|
|
Cerebellar dysfunction with variable cognitive and behavioral abnormalities
|
177
|
11
|
55
|
|
|
Dilated cardiomyopathy 2B
|
177
|
2
|
9
|
|
|
Familial colorectal cancer type X
|
177
|
9
|
2
|
|
|
JAG1-related disorder
|
177
|
1
|
3
|
|
|
BBS10-related disorder
|
176
|
1
|
1
|
|
|
Focal segmental glomerulosclerosis 5
|
176
|
2
|
22
|
|
|
Holoprosencephaly 9
|
176
|
1
|
19
|
|
|
Lissencephaly 9 with complex brainstem malformation
|
176
|
3
|
38
|
|
|
Alternating hemiplegia of childhood 1
|
175
|
3
|
13
|
|
|
Congenital myotonia, autosomal recessive form
|
175
|
4
|
51
|
|
|
Deafness-lymphedema-leukemia syndrome; GATA2 deficiency with susceptibility to MDS/AML
|
175
|
7
|
1
|
|
|
Fleck corneal dystrophy
|
175
|
2
|
10
|
|
|
Intellectual disability, autosomal dominant 43
|
175
|
4
|
50
|
|
|
Left ventricular noncompaction 10
|
175
|
2
|
33
|
|
|
Pyknodysostosis
|
175
|
1
|
31
|
|
|
Thrombophilia due to protein S deficiency, autosomal dominant
|
175
|
1
|
32
|
|
|
Bartter disease type 3; Bartter disease type 4B
|
174
|
2
|
4
|
|
|
Desmoid disease, hereditary; Familial adenomatous polyposis 1; Hepatocellular carcinoma; Gastric cancer; Colorectal cancer; Gastric adenocarcinoma and proximal polyposis of the stomach
|
174
|
1
|
4
|
|
|
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant; Autosomal recessive hypohidrotic ectodermal dysplasia syndrome
|
174
|
4
|
1
|
|
|
Accelerated tumor formation, susceptibility to
|
173
|
3
|
3
|
|
|
Autosomal dominant centronuclear myopathy
|
173
|
6
|
32
|
|
|
Cardiomyopathy, familial hypertrophic 27
|
173
|
2
|
30
|
|
|
Complement component 3 deficiency
|
173
|
1
|
10
|
|
|
Deficiency of steroid 11-beta-monooxygenase; Glucocorticoid-remediable aldosteronism
|
173
|
3
|
1
|
|
|
Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26
|
173
|
1
|
7
|
|
|
Osteogenesis imperfecta, perinatal lethal
|
173
|
3
|
49
|
|
|
Parietal foramina 2
|
173
|
1
|
8
|
|
|
Partial hypoxanthine-guanine phosphoribosyltransferase deficiency; Lesch-Nyhan syndrome
|
173
|
3
|
6
|
|
|
Wolff-Parkinson-White pattern
|
173
|
51
|
11
|
|
|
Alopecia universalis congenita
|
172
|
2
|
9
|
|
|
Atrichia with papular lesions
|
172
|
2
|
6
|
|
|
BBS4-related disorder
|
172
|
1
|
1
|
|
|
Developmental delay with variable intellectual impairment and behavioral abnormalities
|
172
|
2
|
52
|
|
|
Episodic ataxia type 2
|
172
|
10
|
51
|
|
|
NPC1-related disorder
|
172
|
2
|
2
|
|
|
Ullrich congenital muscular dystrophy 1A
|
172
|
5
|
45
|
|
|
3 beta-Hydroxysteroid dehydrogenase deficiency
|
171
|
2
|
19
|
|
|
APC-Associated Polyposis Disorders
|
171
|
1
|
4
|
|
|
Abnormality of the musculature
|
171
|
55
|
1
|
|
|
Athabaskan severe combined immunodeficiency
|
171
|
1
|
3
|
|
|
Cenani-Lenz syndactyly syndrome
|
171
|
3
|
12
|
|
|
Charcot-Marie-Tooth disease type 4F
|
171
|
4
|
26
|
|
|
Embryonal rhabdomyosarcoma
|
171
|
39
|
3
|
|
|
Intellectual disability, autosomal dominant 13
|
171
|
5
|
57
|
|
|
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome
|
171
|
5
|
58
|
|
|
Muir-Torré syndrome
|
171
|
3
|
14
|
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4
|
171
|
3
|
20
|
|
|
Otospondylomegaepiphyseal dysplasia, autosomal recessive
|
171
|
2
|
17
|
|
|
Senior-Loken syndrome 4
|
171
|
2
|
9
|
|
|
Smith-Magenis syndrome
|
171
|
8
|
67
|
|
|
Torsion dystonia 6
|
171
|
2
|
25
|
|
|
Agammaglobulinemia 6, autosomal recessive
|
170
|
1
|
5
|
|
|
Autosomal recessive nonsyndromic hearing loss 4; Pendred syndrome
|
170
|
3
|
11
|
|
|
Autosomal recessive nonsyndromic hearing loss 66; Isolated neonatal sclerosing cholangitis
|
170
|
2
|
1
|
|
|
Charcot-Marie-Tooth disease type 2B
|
170
|
3
|
7
|
|
|
Corticosterone methyl oxidase type II deficiency
|
170
|
1
|
1
|
|
|
Hypokalemic periodic paralysis, type 1; Potassium-aggravated myotonia; Paramyotonia congenita of Von Eulenburg; Hypokalemic periodic paralysis, type 2; Hyperkalemic periodic paralysis; Congenital myasthenic syndrome 16
|
170
|
2
|
1
|
|
|
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities
|
170
|
4
|
62
|
|
|
MYH7-related skeletal myopathy
|
170
|
6
|
20
|
|
|
Short-rib thoracic dysplasia 7 with or without polydactyly
|
170
|
2
|
7
|
|
|
X-linked agammaglobulinemia
|
170
|
2
|
38
|
|
|
Amyotrophic lateral sclerosis type 6
|
169
|
2
|
18
|
|
|
COL4A1-related disorder
|
169
|
2
|
9
|
|
|
GLI2-related disorder
|
169
|
1
|
5
|
|
|
MYO5B-related disorder
|
169
|
4
|
1
|
|
|
SRD5A3-congenital disorder of glycosylation
|
169
|
2
|
21
|
|
|
Somatotroph adenoma
|
169
|
6
|
13
|
|
|
COL7A1-related disorder
|
168
|
2
|
5
|
|
|
Factor H deficiency
|
168
|
1
|
14
|
|
|
Familial isolated deficiency of vitamin E
|
168
|
2
|
30
|
|
|
Fetal anomalies with a likely genetic cause
|
168
|
135
|
2
|
|
|
Hereditary spastic paraplegia 64
|
168
|
2
|
15
|
|
|
Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome
|
168
|
4
|
13
|
|
|
Joubert syndrome 7
|
168
|
4
|
21
|
|
|
Kartagener syndrome
|
168
|
24
|
34
|
|
|
Matthew-Wood syndrome
|
168
|
3
|
20
|
|
|
Neurodegeneration with brain iron accumulation 4
|
168
|
2
|
31
|
|
|
Neurodevelopmental disorder with or without early-onset generalized epilepsy
|
168
|
2
|
37
|
|
|
Polyposis syndrome, hereditary mixed, 2
|
168
|
1
|
8
|
|
|
Autosomal recessive nonsyndromic hearing loss 7
|
167
|
3
|
38
|
|
|
Bohring-Opitz syndrome
|
167
|
2
|
43
|
|
|
Chondrodysplasia with joint dislocations, gPAPP type
|
167
|
2
|
7
|
|
|
Cleidocranial dysostosis
|
167
|
4
|
40
|
|
|
Combined immunodeficiency due to CD3gamma deficiency
|
167
|
5
|
11
|
|
|
Glaucoma 3A
|
167
|
6
|
34
|
|
|
Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism
|
167
|
4
|
39
|
|
|
Immunodeficiency 25
|
167
|
3
|
11
|
|
|
Intellectual disability, autosomal dominant 45
|
167
|
4
|
50
|
|
|
Late-infantile neuronal ceroid lipofuscinosis
|
167
|
1
|
2
|
|
|
POLD1-related disorder
|
167
|
1
|
2
|
|
|
Familial cancer of breast; Breast-ovarian cancer, familial, susceptibility to, 2; Fanconi anemia complementation group D1; Medulloblastoma; Wilms tumor 1; Prostate cancer; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3
|
166
|
1
|
2
|
|
|
Hereditary spherocytosis type 4
|
166
|
2
|
21
|
|
|
Joubert syndrome 1
|
166
|
16
|
20
|
|
|
Miyoshi muscular dystrophy 1; Autosomal recessive limb-girdle muscular dystrophy type 2B; Distal myopathy with anterior tibial onset
|
166
|
1
|
10
|
|
|
Osteopetrosis
|
166
|
10
|
5
|
|
|
TRIM32-related disorder
|
166
|
1
|
1
|
|
|
Abnormal esophagus morphology
|
165
|
130
|
1
|
|
|
Hypogonadotropic hypogonadism 7 with or without anosmia
|
165
|
11
|
31
|
|
|
Atrial fibrillation, familial, 6
|
164
|
4
|
5
|
|
|
BBS12-related disorder
|
164
|
1
|
1
|
|
|
Candidiasis, familial, 6
|
164
|
1
|
7
|
|
|
Chronic infantile neurological, cutaneous and articular syndrome; Keratitis fugax hereditaria; Familial amyloid nephropathy with urticaria AND deafness; Familial cold autoinflammatory syndrome 1; Hearing loss, autosomal dominant 34, with or without inflammation
|
164
|
1
|
3
|
|
|
Congenital ichthyosis of skin
|
164
|
3
|
2
|
|
|
Cystinosis
|
164
|
2
|
15
|
|
|
Epilepsy, idiopathic generalized, susceptibility to, 11; Familial hyperaldosteronism type II; Leukoencephalopathy with mild cerebellar ataxia and white matter edema
|
164
|
2
|
2
|
|
|
FBN3-related disorder
|
164
|
1
|
1
|
|
|
Glutaric acidemia type 2C
|
164
|
1
|
1
|
|
|
Hyperglycinuria
|
164
|
4
|
9
|
|
|
LRP2-related disorder
|
164
|
1
|
1
|
|
|
Male infertility
|
164
|
87
|
11
|
|
|
Oxoglutaricaciduria
|
164
|
2
|
11
|
|
|
Pancreatic cancer, susceptibility to, 1
|
164
|
2
|
8
|
|
|
Agammaglobulinemia 3, autosomal recessive
|
163
|
2
|
8
|
|
|
Autosomal recessive Robinow syndrome
|
163
|
2
|
22
|
|
|
FAT4-related disorder
|
163
|
1
|
3
|
|
|
Geleophysic dysplasia 1
|
163
|
2
|
25
|
|
|
Lymphatic malformation 6
|
163
|
3
|
31
|
|
|
MSH2-related disorder
|
163
|
1
|
4
|
|
|
Methylmalonic acidemia due to transcobalamin receptor defect
|
163
|
1
|
7
|
|
|
Oroticaciduria
|
163
|
1
|
8
|
|
|
Primary hypomagnesemia
|
163
|
1
|
32
|
|
|
Bardet-Biedl syndrome 13; Meckel syndrome, type 1; Joubert syndrome 28
|
162
|
2
|
5
|
|
|
C3 glomerulonephritis
|
162
|
7
|
12
|
|
|
Cone-rod dystrophy 5
|
162
|
4
|
13
|
|
|
Dilated cardiomyopathy 1L
|
162
|
1
|
8
|
|
|
Ehlers-Danlos syndrome, arthrochalasia type
|
162
|
5
|
16
|
|
|
Heart defect - tongue hamartoma - polysyndactyly syndrome; Bardet-Biedl syndrome 15
|
162
|
1
|
5
|
|
|
Hermansky-Pudlak syndrome 5
|
162
|
3
|
20
|
|
|
Hypohidrotic ectodermal dysplasia
|
162
|
3
|
3
|
|
|
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome
|
162
|
1
|
31
|
|
|
MYO7A-related disorder
|
162
|
1
|
10
|
|
|
PLA2G6-associated neurodegeneration
|
162
|
4
|
8
|
|
|
Pelizaeus-Merzbacher disease
|
162
|
8
|
38
|
|
|
Short QT syndrome type 1; Long QT syndrome 2
|
162
|
1
|
7
|
|
|
Short stature
|
162
|
88
|
16
|
|
|
Atrial fibrillation, familial, 14
|
161
|
2
|
12
|
|
|
COL11A1-related disorder
|
161
|
2
|
6
|
|
|
Dalmatian hypouricemia
|
161
|
1
|
17
|
|
|
Epilepsy, idiopathic generalized, susceptibility to, 12
|
161
|
3
|
13
|
|
|
Farber lipogranulomatosis
|
161
|
2
|
20
|
|
|
Non-acquired combined pituitary hormone deficiency with spine abnormalities
|
161
|
1
|
16
|
|
|
Ocular cystinosis
|
161
|
5
|
6
|
|
|
Platelet-type bleeding disorder 9
|
161
|
2
|
2
|
|
|
Pyogenic bacterial infections due to MyD88 deficiency
|
161
|
2
|
7
|
|
|
Cone-rod dystrophy 2
|
160
|
6
|
21
|
|
|
Joubert syndrome 16
|
160
|
1
|
18
|
|
|
Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness
|
160
|
2
|
16
|
|
|
Mismatch repair cancer syndrome 1; Muir-Torré syndrome; Colorectal cancer, hereditary nonpolyposis, type 2
|
160
|
2
|
5
|
|
|
RECQL4-related disorder
|
160
|
2
|
3
|
|
|
Aicardi Goutieres syndrome
|
159
|
9
|
5
|
|
|
Bartter disease type 2
|
159
|
1
|
33
|
|
|
CUBN-related disorder
|
159
|
3
|
3
|
|
|
Congenital anomaly of kidney and urinary tract
|
159
|
58
|
11
|
|
|
Congenital sensory neuropathy with selective loss of small myelinated fibers
|
159
|
2
|
12
|
|
|
Endometrial carcinoma; Colorectal cancer, hereditary nonpolyposis, type 7; Colorectal cancer
|
159
|
2
|
2
|
|
|
Glycogen storage disease type X
|
159
|
5
|
18
|
|
|
Neuronal ceroid lipofuscinosis 8
|
159
|
1
|
27
|
|
|
Amyotrophic lateral sclerosis type 8
|
158
|
2
|
5
|
|
|
Autism spectrum disorder due to AUTS2 deficiency
|
158
|
12
|
62
|
|
|
Brachydactyly
|
158
|
5
|
3
|
|
|
Branchiootorenal syndrome 2
|
158
|
4
|
16
|
|
|
Breast-ovarian cancer, familial, susceptibility to, 3; Fanconi anemia complementation group O
|
158
|
3
|
7
|
|
|
Carnitine palmitoyl transferase II deficiency, severe infantile form; Carnitine palmitoyl transferase II deficiency, myopathic form; Carnitine palmitoyl transferase II deficiency, neonatal form; Encephalopathy, acute, infection-induced, susceptibility to, 4
|
158
|
2
|
2
|
|
|
Ceroid lipofuscinosis, neuronal, 4 (Kufs type)
|
158
|
2
|
11
|
|
|
Deficiency of phosphoserine phosphatase
|
158
|
3
|
11
|
|
|
Distal spinal muscular atrophy
|
158
|
25
|
10
|
|
|
Erythrocytosis, familial, 4
|
158
|
4
|
13
|
|
|
Lynch syndrome 4; Mismatch repair cancer syndrome 4
|
158
|
1
|
7
|
|
|
Nephronophthisis 12
|
158
|
2
|
21
|
|
|
Nephrotic syndrome, type 6
|
158
|
2
|
8
|
|
|
Neutral 1 amino acid transport defect
|
158
|
1
|
21
|
|
|
Osteogenesis imperfecta type III
|
158
|
13
|
34
|
|
|
Sulfate transporter-related osteochondrodysplasia
|
158
|
2
|
2
|
|
|
Adult-onset proximal spinal muscular atrophy, autosomal dominant
|
157
|
3
|
4
|
|
|
Amyotrophic lateral sclerosis type 10; FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED
|
157
|
2
|
1
|
|
|
Autosomal dominant pseudohypoaldosteronism type 1
|
157
|
4
|
21
|
|
|
COG8-congenital disorder of glycosylation
|
157
|
5
|
16
|
|
|
Combined oxidative phosphorylation defect type 8
|
157
|
1
|
17
|
|
|
Congenital secretory diarrhea, chloride type
|
157
|
2
|
35
|
|
|
Duane-radial ray syndrome; Oculootoradial syndrome
|
157
|
1
|
3
|
|
|
Hereditary spastic paraplegia 53
|
157
|
2
|
7
|
|
|
Holoprosencephaly 2
|
157
|
5
|
13
|
|
|
Hyperimmunoglobulin D with periodic fever
|
157
|
3
|
27
|
|
|
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly
|
157
|
4
|
23
|
|
|
MACF1-related disorder
|
157
|
3
|
1
|
|
|
MKKS-related disorder
|
157
|
1
|
2
|
|
|
Usher syndrome type 2C; Febrile seizures, familial, 4
|
157
|
1
|
3
|
|
|
Exudative vitreoretinopathy 1
|
156
|
10
|
27
|
|
|
Infantile hypophosphatasia
|
156
|
2
|
31
|
|
|
Neuronal ceroid lipofuscinosis 13
|
156
|
1
|
16
|
|
|
Andersen Tawil syndrome
|
155
|
3
|
33
|
|
|
Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8
|
155
|
4
|
6
|
|
|
Familial cancer of breast; Breast-ovarian cancer, familial, susceptibility to, 1; Fanconi anemia, complementation group S
|
155
|
2
|
1
|
|
|
Hypophosphatemic nephrolithiasis/osteoporosis 1; Fanconi renotubular syndrome 2; Hypercalcemia, infantile, 2
|
155
|
1
|
3
|
|
|
Peroxisome biogenesis disorder 7A (Zellweger)
|
155
|
3
|
14
|
|
|
Tumoral calcinosis, hyperphosphatemic, familial, 1
|
155
|
4
|
20
|
|
|
Aortic aneurysm, familial thoracic 7; Megacystis-microcolon-intestinal hypoperistalsis syndrome 1
|
154
|
4
|
5
|
|
|
BLOOD GROUP--SWANN SYSTEM; BLOOD GROUP--WALDNER TYPE; BLOOD GROUP--FROESE; BLOOD GROUP--WRIGHT ANTIGEN; Southeast Asian ovalocytosis; Hereditary spherocytosis type 4; BLOOD GROUP--DIEGO SYSTEM; Cryohydrocytosis; Autosomal dominant distal renal tubular acidosis; Renal tubular acidosis, distal, 4, with hemolytic anemia; Malaria, susceptibility to
|
154
|
1
|
2
|
|
|
Diamond-Blackfan anemia 10
|
154
|
3
|
20
|
|
|
Myopathy, centronuclear, 5
|
154
|
4
|
21
|
|
|
Neural tube defects, folate-sensitive
|
154
|
2
|
3
|
|
|
Schaaf-Yang syndrome
|
154
|
1
|
57
|
|
|
ZNF469-related disorder
|
154
|
2
|
1
|
|
|
COL6A3-related disorder
|
153
|
2
|
5
|
|
|
Congenital dyserythropoietic anemia, type I
|
153
|
3
|
7
|
|
|
Fibrochondrogenesis 2
|
153
|
1
|
9
|
|
|
Hereditary cryohydrocytosis with reduced stomatin
|
153
|
3
|
7
|
|
|
Kufor-Rakeb syndrome
|
153
|
2
|
23
|
|
|
Maturity-onset diabetes of the young type 8
|
153
|
1
|
26
|
|
|
Microcephaly 9, primary, autosomal recessive
|
153
|
1
|
16
|
|
|
O'Donnell-Luria-Rodan syndrome
|
153
|
5
|
45
|
|
|
Orofacial cleft 6, susceptibility to; Popliteal pterygium syndrome; Van der Woude syndrome
|
153
|
1
|
1
|
|
|
Pituitary hormone deficiency, combined, 2
|
153
|
2
|
26
|
|
|
Schöpf-Schulz-Passarge syndrome
|
153
|
3
|
5
|
|
|
Adams-Oliver syndrome 4
|
152
|
1
|
9
|
|
|
Age related macular degeneration 5
|
152
|
5
|
2
|
|
|
Cleft lip/palate-ectodermal dysplasia syndrome
|
152
|
1
|
10
|
|
|
Corticosterone 18-monooxygenase deficiency; Corticosterone methyloxidase type 2 deficiency
|
152
|
2
|
2
|
|
|
Familial hypocalciuric hypercalcemia 1
|
152
|
1
|
32
|
|
|
Hereditary hyperferritinemia with congenital cataracts; Neuroferritinopathy
|
152
|
4
|
1
|
|
|
Hereditary spherocytosis type 2
|
152
|
5
|
44
|
|
|
Left-right axis malformations
|
152
|
1
|
3
|
|
|
Type 2 diabetes mellitus; Hypoinsulinemic hypoglycemia and body hemihypertrophy
|
152
|
2
|
3
|
|
|
ABCB11-related disorder
|
151
|
2
|
1
|
|
|
ABCB4-related disorder
|
151
|
2
|
4
|
|
|
Brunner syndrome
|
151
|
2
|
20
|
|
|
Epidermolysis bullosa, junctional 6, with pyloric atresia
|
151
|
2
|
5
|
|
|
FLNC-related disorder
|
151
|
2
|
5
|
|
|
Infantile cortical hyperostosis
|
151
|
3
|
12
|
|
|
Laryngo-onycho-cutaneous syndrome
|
151
|
2
|
8
|
|
|
Leber congenital amaurosis 7
|
151
|
2
|
12
|
|
|
Pulmonary hypertension, primary, 1; Pulmonary venoocclusive disease 1
|
151
|
2
|
3
|
|
|
Sarcotubular myopathy; Bardet-Biedl syndrome 11
|
151
|
1
|
7
|
|
|
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II
|
150
|
2
|
1
|
|
|
COG6-congenital disorder of glycosylation; Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome
|
150
|
1
|
2
|
|
|
Cerebral cavernous malformation 3
|
150
|
4
|
21
|
|
|
Gaze palsy, familial horizontal, with progressive scoliosis 1
|
150
|
3
|
18
|
|
|
Lissencephaly due to LIS1 mutation
|
150
|
3
|
43
|
|
|
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency
|
150
|
3
|
10
|
|
|
Piebaldism
|
150
|
4
|
21
|
|
|
TERT-related disorder
|
150
|
2
|
3
|
|
|
TRIO-related disorder
|
150
|
3
|
6
|
|
|
TTC8-related disorder
|
150
|
1
|
1
|
|
|
UCP3-related disorder
|
150
|
2
|
2
|
|
|
X-linked lymphoproliferative disease due to SH2D1A deficiency
|
150
|
2
|
23
|
|
|
Congenital defect of folate absorption
|
149
|
4
|
17
|
|
|
GRACILE syndrome
|
149
|
2
|
16
|
|
|
Hyperparathyroidism 1
|
149
|
3
|
9
|
|
|
Intellectual developmental disorder with seizures and language delay
|
149
|
2
|
51
|
|
|
MYH7-related disorder
|
149
|
5
|
10
|
|
|
Mitochondrial neurogastrointestinal encephalomyopathy
|
149
|
6
|
3
|
|
|
Pierson syndrome
|
149
|
2
|
18
|
|
|
Borjeson-Forssman-Lehmann syndrome
|
148
|
1
|
37
|
|
|
Ehlers-Danlos syndrome, arthrochalasia type, 2
|
148
|
2
|
21
|
|
|
Epidermolysis bullosa simplex due to plakophilin deficiency
|
148
|
1
|
7
|
|
|
Hereditary spherocytosis type 5
|
148
|
1
|
13
|
|
|
Imerslund-Grasbeck syndrome type 2
|
148
|
4
|
13
|
|
|
MYH6-related disorder
|
148
|
3
|
2
|
|
|
Senior-Loken syndrome 6
|
148
|
4
|
7
|
|
|
Symmetrical dyschromatosis of extremities
|
148
|
4
|
15
|
|
|
Benign recurrent intrahepatic cholestasis type 2
|
147
|
2
|
10
|
|
|
CEP164-related disorder
|
147
|
1
|
1
|
|
|
Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1
|
147
|
4
|
20
|
|
|
Hemochromatosis type 2A
|
147
|
2
|
23
|
|
|
Idiopathic basal ganglia calcification 1
|
147
|
7
|
42
|
|
|
Mandibulofacial dysostosis-microcephaly syndrome
|
147
|
1
|
72
|
|
|
Microcephaly 6, primary, autosomal recessive
|
147
|
2
|
21
|
|
|
Tumoral calcinosis, hyperphosphatemic, familial, 3
|
147
|
2
|
7
|
|
|
Xeroderma pigmentosum group A
|
147
|
3
|
25
|
|
|
CDH23-related disorder
|
146
|
3
|
5
|
|
|
Diabetes mellitus type 1; Type 1 diabetes mellitus 20; Maturity-onset diabetes of the young type 3; Type 2 diabetes mellitus; Hepatic adenomas, familial; Nonpapillary renal cell carcinoma
|
146
|
2
|
1
|
|
|
Diffuse midline glioma, H3 K27M-mutant
|
146
|
34
|
2
|
|
|
Dilated cardiomyopathy 1AA
|
146
|
1
|
28
|
|
|
Frontotemporal dementia and/or amyotrophic lateral sclerosis 7
|
146
|
5
|
14
|
|
|
Hereditary spastic paraplegia 43
|
146
|
2
|
9
|
|
|
Oligosynaptic infertility; 46,XY disorder of sex development
|
146
|
1
|
1
|
|
|
Proline dehydrogenase deficiency; Schizophrenia 4
|
146
|
2
|
4
|
|
|
Townes-Brocks syndrome 1
|
146
|
1
|
53
|
|
|
Type 2 collagenopathy
|
146
|
1
|
6
|
|
|
X-linked intellectual disability, Cantagrel type
|
146
|
2
|
57
|
|
|
Amelogenesis imperfecta type 1G
|
145
|
2
|
21
|
|
|
Atypical hemolytic-uremic syndrome with C3 anomaly
|
145
|
1
|
16
|
|
|
Carnitine palmitoyl transferase II deficiency, myopathic form
|
145
|
2
|
21
|
|
|
Congenital disorder of glycosylation, type IIq
|
145
|
3
|
9
|
|
|
Developmental and epileptic encephalopathy, 28
|
145
|
9
|
38
|
|
|
FOCAD-related disorder
|
145
|
1
|
1
|
|
|
History of neurodevelopmental disorder
|
145
|
67
|
2
|
|
|
Lung adenocarcinoma
|
145
|
50
|
9
|
|
|
Macrocephaly-developmental delay syndrome
|
145
|
5
|
26
|
|
|
Progressive familial intrahepatic cholestasis type 3
|
145
|
4
|
29
|
|
|
Pyruvate dehydrogenase complex deficiency
|
145
|
5
|
6
|
|
|
TMEM165-congenital disorder of glycosylation
|
145
|
4
|
9
|
|
|
Autosomal dominant distal renal tubular acidosis
|
144
|
1
|
21
|
|
|
Carnitine palmitoyl transferase II deficiency, neonatal form
|
144
|
2
|
13
|
|
|
Cone-rod dystrophy 7
|
144
|
3
|
12
|
|
|
DNAH11-related disorder
|
144
|
3
|
2
|
|
|
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3
|
144
|
2
|
18
|
|
|
LAMB2-related infantile-onset nephrotic syndrome
|
144
|
3
|
11
|
|
|
Lissencephaly due to TUBA1A mutation
|
144
|
3
|
67
|
|
|
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss
|
144
|
4
|
33
|
|
|
Meckel syndrome, type 5
|
144
|
2
|
9
|
|
|
Metaphyseal chondrodysplasia, Schmid type
|
144
|
2
|
29
|
|
|
Osteoglophonic dysplasia
|
144
|
4
|
6
|
|
|
Renal hypomagnesemia 4
|
144
|
3
|
6
|
|
|
Vitelliform macular dystrophy 2
|
144
|
5
|
39
|
|
|
FBN2-related disorder
|
143
|
2
|
2
|
|
|
Inflammatory bowel disease 1
|
143
|
8
|
15
|
|
|
Retinitis pigmentosa 1
|
143
|
3
|
40
|
|
|
Schneckenbecken dysplasia
|
143
|
1
|
8
|
|
|
WFS1-related disorder
|
143
|
2
|
3
|
|
|
Waardenburg syndrome type 1
|
143
|
8
|
41
|
|
|
Wilson-Turner syndrome
|
143
|
2
|
13
|
|
|
ZFHX3-related disorder
|
143
|
1
|
3
|
|
|
Basal cell nevus syndrome 1
|
142
|
6
|
27
|
|
|
Charcot-Marie-Tooth disease type 4B3
|
142
|
2
|
24
|
|
|
GM1 gangliosidosis type 2; GM1 gangliosidosis type 3; Mucopolysaccharidosis, MPS-IV-B; Infantile GM1 gangliosidosis
|
142
|
2
|
8
|
|
|
Inherited ovarian cancer (without breast cancer)
|
142
|
12
|
4
|
|
|
Neuronopathy, distal hereditary motor, autosomal recessive 4
|
142
|
3
|
10
|
|
|
Autosomal recessive nonsyndromic hearing loss 28
|
141
|
5
|
46
|
|
|
CEDNIK syndrome
|
141
|
3
|
18
|
|
|
FMN2-related disorder
|
141
|
2
|
1
|
|
|
FSIP2-related disorder
|
141
|
2
|
1
|
|
|
Myoclonic dystonia 26
|
141
|
3
|
11
|
|
|
Patterned macular dystrophy 2
|
141
|
1
|
11
|
|
|
Pyruvate kinase deficiency of red cells
|
141
|
3
|
42
|
|
|
Aortic aneurysm, familial thoracic 4; Visceral myopathy 2; Megacystis-microcolon-intestinal hypoperistalsis syndrome 2
|
140
|
2
|
4
|
|
|
CACNA1H-related disorder
|
140
|
1
|
3
|
|
|
Capillary malformation-arteriovenous malformation 1
|
140
|
5
|
43
|
|
|
DICER1-related disorder
|
140
|
1
|
2
|
|
|
Hypogonadotropic hypogonadism 2 with or without anosmia; Jackson-Weiss syndrome; Pfeiffer syndrome; Hartsfield-Bixler-Demyer syndrome; Osteoglophonic dysplasia; Trigonocephaly 1; Encephalocraniocutaneous lipomatosis
|
140
|
1
|
4
|
|
|
Lynch-like syndrome
|
140
|
4
|
1
|
|
|
Oculocutaneous albinism type 1A
|
140
|
3
|
44
|
|
|
Retinitis pigmentosa 45
|
140
|
2
|
29
|
|
|
Vitamin D-dependent rickets, type 1A
|
140
|
1
|
25
|
|
|
3-methylglutaconic aciduria type 5
|
139
|
2
|
9
|
|
|
Acute intermittent porphyria
|
139
|
5
|
43
|
|
|
Amyotrophic lateral sclerosis type 2, juvenile
|
139
|
2
|
20
|
|
|
Autosomal dominant nocturnal frontal lobe epilepsy 4
|
139
|
1
|
22
|
|
|
Autosomal recessive nonsyndromic hearing loss 31
|
139
|
1
|
9
|
|
|
BRIP1-related disorder
|
139
|
1
|
6
|
|
|
Cayman type cerebellar ataxia
|
139
|
1
|
9
|
|
|
Dystonia 16
|
139
|
3
|
18
|
|
|
Familial cylindromatosis
|
139
|
2
|
6
|
|
|
LZTR1-related disorder
|
139
|
2
|
4
|
|
|
Lissencephaly 4
|
139
|
3
|
9
|
|
|
Migraine, familial hemiplegic, 3
|
139
|
2
|
9
|
|
|
Platelet-type bleeding disorder 10
|
139
|
1
|
24
|
|
|
Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1
|
139
|
5
|
22
|
|
|
TWIST1-related craniosynostosis; Saethre-Chotzen syndrome
|
139
|
2
|
3
|
|
|
Trigonocephaly 1
|
139
|
4
|
3
|
|
|
Warburg micro syndrome 2
|
139
|
1
|
17
|
|
|
Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency
|
138
|
3
|
12
|
|
|
Ciliary dyskinesia, primary, 40
|
138
|
8
|
29
|
|
|
Congenital myopathy 4B, autosomal recessive
|
138
|
2
|
16
|
|
|
Congenital nephrotic syndrome
|
138
|
2
|
2
|
|
|
Fanconi anemia complementation group B
|
138
|
1
|
20
|
|
|
Heimler syndrome 2
|
138
|
1
|
10
|
|
|
Hereditary spastic paraplegia 10
|
138
|
1
|
37
|
|
|
Hereditary spastic paraplegia 35
|
138
|
5
|
46
|
|
|
Immunodeficiency-centromeric instability-facial anomalies syndrome 1
|
138
|
3
|
16
|
|
|
Microcephaly 4, primary, autosomal recessive
|
138
|
1
|
21
|
|
|
Peroxisome biogenesis disorder 6A (Zellweger)
|
138
|
2
|
11
|
|
|
Pseudohypoaldosteronism, type IB1, autosomal recessive; Bronchiectasis with or without elevated sweat chloride 2; Liddle syndrome 3
|
138
|
2
|
3
|
|
|
Age related macular degeneration 9
|
137
|
1
|
3
|
|
|
Atypical hemolytic-uremic syndrome with I factor anomaly; Age related macular degeneration 13; Factor I deficiency
|
137
|
1
|
2
|
|
|
Autosomal recessive congenital ichthyosis 3
|
137
|
4
|
21
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2N
|
137
|
3
|
12
|
|
|
Autosomal recessive nonsyndromic hearing loss 23; Usher syndrome type 1D; Usher syndrome type 1F
|
137
|
2
|
5
|
|
|
Brachydactyly type B1
|
137
|
1
|
13
|
|
|
DMD-related disorder
|
137
|
1
|
5
|
|
|
Interstitial lung disease 2
|
137
|
23
|
23
|
|
|
Jervell and Lange-Nielsen syndrome 1
|
137
|
4
|
19
|
|
|
Joubert syndrome 6
|
137
|
2
|
27
|
|
|
Metachondromatosis
|
137
|
2
|
15
|
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1
|
137
|
5
|
26
|
|
|
Pyruvate dehydrogenase E3-binding protein deficiency
|
137
|
4
|
27
|
|
|
Sneddon syndrome; Deficiency of adenosine deaminase 2
|
137
|
1
|
3
|
|
|
Abnormal bleeding; Thrombocytopenia
|
136
|
72
|
2
|
|
|
Amyotrophic neuralgia
|
136
|
2
|
15
|
|
|
Cerebrooculofacioskeletal syndrome 2
|
136
|
1
|
9
|
|
|
Combined oxidative phosphorylation deficiency 44
|
136
|
3
|
19
|
|
|
Cone-rod dystrophy 12
|
136
|
3
|
19
|
|
|
DNHD1-related disorder
|
136
|
1
|
1
|
|
|
Episodic pain syndrome, familial, 2
|
136
|
2
|
22
|
|
|
FADD-related immunodeficiency
|
136
|
3
|
5
|
|
|
Hereditary intrinsic factor deficiency
|
136
|
1
|
12
|
|
|
Hypothyroidism due to TSH receptor mutations
|
136
|
4
|
23
|
|
|
Idiopathic hypereosinophilic syndrome
|
136
|
1
|
3
|
|
|
KMT2C-related disorder
|
136
|
2
|
3
|
|
|
Meckel syndrome, type 8; Joubert syndrome 24
|
136
|
1
|
5
|
|
|
ANO5-Related Muscle Diseases
|
135
|
3
|
2
|
|
|
Cholestasis, intrahepatic, of pregnancy, 3
|
135
|
4
|
13
|
|
|
Clark-Baraitser syndrome
|
135
|
2
|
49
|
|
|
Febrile seizures, familial, 11
|
135
|
2
|
6
|
|
|
Inflammatory bowel disease
|
135
|
10
|
6
|
|
|
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies
|
135
|
11
|
49
|
|
|
Normal pregnancy
|
135
|
138
|
1
|
|
|
Primary ciliary dyskinesia 9
|
135
|
1
|
21
|
|
|
Saethre-Chotzen syndrome
|
135
|
6
|
19
|
|
|
TP53-related disorder
|
135
|
1
|
5
|
|
|
Wagner disease
|
135
|
2
|
22
|
|
|
Abnormality of the nervous system
|
134
|
100
|
3
|
|
|
Autosomal dominant nonsyndromic hearing loss 1
|
134
|
1
|
20
|
|
|
COL11A2-related disorder
|
134
|
1
|
5
|
|
|
Coffin-Siris syndrome
|
134
|
13
|
18
|
|
|
Cranium bifidum occultum
|
134
|
1
|
1
|
|
|
Crouzon syndrome
|
134
|
1
|
30
|
|
|
Ehlers-Danlos syndrome due to tenascin-X deficiency
|
134
|
3
|
43
|
|
|
Primary ciliary dyskinesia 13
|
134
|
3
|
23
|
|
|
TTC21B-related disorder
|
134
|
1
|
1
|
|
|
Xeroderma pigmentosum, group G
|
134
|
2
|
16
|
|
|
Agammaglobulinemia
|
133
|
3
|
2
|
|
|
Alternating hemiplegia of childhood 2
|
133
|
2
|
32
|
|
|
Autosomal recessive nonsyndromic hearing loss 18B
|
133
|
2
|
47
|
|
|
Cone-rod dystrophy 13
|
133
|
1
|
17
|
|
|
Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder
|
133
|
3
|
65
|
|
|
Developmental delay with or without dysmorphic facies and autism
|
133
|
2
|
45
|
|
|
Diabetes mellitus, transient neonatal, 2
|
133
|
3
|
10
|
|
|
Drash syndrome
|
133
|
2
|
13
|
|
|
Familial hypoparathyroidism
|
133
|
6
|
5
|
|
|
Hemolytic anemia
|
133
|
8
|
6
|
|
|
Nemaline myopathy 7
|
133
|
2
|
9
|
|
|
Nephrotic syndrome, type 4
|
133
|
2
|
21
|
|
|
Oculocutaneous albinism
|
133
|
4
|
8
|
|
|
Pallister-Hall syndrome
|
133
|
1
|
14
|
|
|
RTEL1-related disorder
|
133
|
2
|
3
|
|
|
Usher syndrome type 2D
|
133
|
1
|
8
|
|
|
3MC syndrome 1
|
132
|
4
|
22
|
|
|
Asphyxiating thoracic dystrophy 4
|
132
|
2
|
7
|
|
|
Cone dystrophy with supernormal rod response
|
132
|
1
|
26
|
|
|
Congenital myasthenic syndrome 15
|
132
|
2
|
4
|
|
|
Heterotaxy, visceral, 5, autosomal
|
132
|
3
|
18
|
|
|
Homozygous familial hypercholesterolemia
|
132
|
4
|
2
|
|
|
Lamellar ichthyosis
|
132
|
12
|
4
|
|
|
Microcephaly, normal intelligence and immunodeficiency; Aplastic anemia; Acute lymphoid leukemia
|
132
|
2
|
5
|
|
|
Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures
|
132
|
2
|
46
|
|
|
Peroxisome biogenesis disorder 4A (Zellweger)
|
132
|
5
|
25
|
|
|
TSC1-related disorder
|
132
|
1
|
2
|
|
|
Triglyceride storage disease with ichthyosis
|
132
|
3
|
17
|
|
|
Autosomal recessive omodysplasia
|
131
|
2
|
7
|
|
|
Bartsocas-Papas syndrome 1
|
131
|
1
|
10
|
|
|
Blepharophimosis, ptosis, and epicanthus inversus syndrome
|
131
|
2
|
31
|
|
|
Cockayne syndrome type 1
|
131
|
3
|
31
|
|
|
Congenital adrenal hyperplasia
|
131
|
11
|
2
|
|
|
DCTN1-related disorder
|
131
|
1
|
3
|
|
|
Exostoses, multiple, type 1
|
131
|
3
|
45
|
|
|
Fanconi anemia, complementation group S
|
131
|
4
|
11
|
|
|
Glucocorticoid deficiency 1
|
131
|
2
|
17
|
|
|
LEOPARD syndrome 1
|
131
|
2
|
31
|
|
|
Lathosterolosis
|
131
|
2
|
11
|
|
|
Loeys-Dietz syndrome 1
|
131
|
4
|
35
|
|
|
MC4R-related disorder
|
131
|
1
|
1
|
|
|
Medulloblastoma WNT activated
|
131
|
26
|
1
|
|
|
Multiple endocrine neoplasia
|
131
|
4
|
4
|
|
|
Neurodevelopmental disorder with hypotonia, seizures, and absent language
|
131
|
4
|
40
|
|
|
Orofaciodigital syndrome I; Retinitis pigmentosa 23; Simpson-Golabi-Behmel syndrome type 2; Joubert syndrome 10
|
131
|
2
|
3
|
|
|
Pulmonary fibrosis
|
131
|
14
|
3
|
|
|
Rhizomelic chondrodysplasia punctata type 1
|
131
|
1
|
19
|
|
|
ABCA4-related retinopathy
|
130
|
3
|
7
|
|
|
Autosomal recessive Alport syndrome; Benign familial hematuria
|
130
|
1
|
3
|
|
|
Autosomal recessive nonsyndromic hearing loss 18A
|
130
|
2
|
17
|
|
|
Brugada syndrome 7
|
130
|
1
|
7
|
|
|
Cataract 36
|
130
|
3
|
14
|
|
|
Episodic ataxia type 5
|
130
|
2
|
5
|
|
|
Galloway-Mowat syndrome 1
|
130
|
3
|
28
|
|
|
Growth delay due to insulin-like growth factor type 1 deficiency
|
130
|
3
|
10
|
|
|
Intellectual disability-hypotonia-spasticity-sleep disorder syndrome
|
130
|
3
|
35
|
|
|
Plasminogen deficiency, type I; Angioedema, hereditary, 4
|
130
|
2
|
2
|
|
|
Primary ciliary dyskinesia 5
|
130
|
3
|
39
|
|
|
Rhizomelic chondrodysplasia punctata
|
130
|
5
|
3
|
|
|
Sphingomyelin/cholesterol lipidosis
|
130
|
5
|
7
|
|
|
TNXB-related disorder
|
130
|
2
|
2
|
|
|
Xeroderma pigmentosum, group D
|
130
|
3
|
24
|
|
|
Auriculocondylar syndrome 2
|
129
|
1
|
24
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2A; Muscular dystrophy, limb-girdle, autosomal dominant 4
|
129
|
3
|
9
|
|
|
BBS7-related disorder
|
129
|
2
|
1
|
|
|
Branchiootic syndrome 3; Autosomal dominant nonsyndromic hearing loss 23
|
129
|
4
|
5
|
|
|
COL4A4-related disorder
|
129
|
1
|
3
|
|
|
Congenital stationary night blindness autosomal dominant 2
|
129
|
2
|
7
|
|
|
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies
|
129
|
4
|
25
|
|
|
DNAH1-related disorder
|
129
|
1
|
2
|
|
|
FREM2-related disorder
|
129
|
1
|
2
|
|
|
Familial cancer of breast; Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to, 4; Fanconi anemia, complementation group S
|
129
|
2
|
1
|
|
|
Hypothyroidism, congenital, nongoitrous, 2
|
129
|
4
|
21
|
|
|
LRP1B-related disorder
|
129
|
1
|
1
|
|
|
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome
|
129
|
3
|
27
|
|
|
Microcephaly 7, primary, autosomal recessive
|
129
|
1
|
25
|
|
|
Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability
|
129
|
1
|
55
|
|
|
PMS2-related disorder
|
129
|
1
|
3
|
|
|
Renal tubular dysgenesis of genetic origin
|
129
|
3
|
18
|
|
|
ARID1A-related disorder
|
128
|
3
|
1
|
|
|
Amelogenesis imperfecta
|
128
|
15
|
8
|
|
|
Brooke-Spiegler syndrome
|
128
|
2
|
11
|
|
|
Intellectual developmental disorder 61
|
128
|
5
|
52
|
|
|
Intellectual developmental disorder, autosomal dominant 64
|
128
|
3
|
46
|
|
|
UNC13A-related disorder
|
128
|
1
|
2
|
|
|
ALG11-congenital disorder of glycosylation
|
127
|
9
|
18
|
|
|
COL6A2-related disorder
|
127
|
2
|
5
|
|
|
DNAH5-related disorder
|
127
|
3
|
1
|
|
|
Factor XIII, A subunit, deficiency of
|
127
|
1
|
21
|
|
|
Intellectual disability, autosomal dominant 50
|
127
|
3
|
58
|
|
|
Keratosis follicularis
|
127
|
4
|
17
|
|
|
Laron-type isolated somatotropin defect
|
127
|
2
|
23
|
|
|
Metatropic dysplasia
|
127
|
2
|
15
|
|
|
Multiple cutaneous and mucosal venous malformations
|
127
|
1
|
14
|
|
|
Noonan syndrome 1; Juvenile myelomonocytic leukemia; Metachondromatosis; LEOPARD syndrome 1
|
127
|
1
|
5
|
|
|
Pseudohypoaldosteronism type 2E
|
127
|
2
|
8
|
|
|
Thrombomodulin-related bleeding disorder
|
127
|
1
|
8
|
|
|
Action myoclonus-renal failure syndrome
|
126
|
3
|
22
|
|
|
Amyotrophic lateral sclerosis type 5; Hereditary spastic paraplegia 11; Charcot-Marie-Tooth disease axonal type 2X
|
126
|
2
|
11
|
|
|
Arrhythmogenic right ventricular dysplasia 12
|
126
|
2
|
15
|
|
|
Autosomal dominant nonsyndromic hearing loss 10
|
126
|
3
|
19
|
|
|
Bardet-Biedl syndrome 13
|
126
|
2
|
12
|
|
|
Bardet-Biedl syndrome 6
|
126
|
2
|
20
|
|
|
Branchiootic syndrome 1
|
126
|
3
|
19
|
|
|
Congenital fibrosis of extraocular muscles type 1
|
126
|
2
|
18
|
|
|
Craniolenticulosutural dysplasia
|
126
|
2
|
10
|
|
|
Diaphanospondylodysostosis
|
126
|
1
|
12
|
|
|
Endometrial carcinoma; Familial adenomatous polyposis 4
|
126
|
3
|
2
|
|
|
LRP5-related disorder
|
126
|
1
|
2
|
|
|
Martsolf syndrome
|
126
|
2
|
7
|
|
|
Meckel syndrome, type 3
|
126
|
2
|
22
|
|
|
Mitochondrial complex II deficiency, nuclear type 1
|
126
|
6
|
22
|
|
|
Renal hypomagnesemia 5 with ocular involvement
|
126
|
2
|
17
|
|
|
SYNE2-related disorder
|
126
|
1
|
1
|
|
|
Adenine phosphoribosyltransferase deficiency
|
125
|
4
|
14
|
|
|
Autosomal recessive spinocerebellar ataxia 10
|
125
|
2
|
32
|
|
|
COL5A1-related disorder
|
125
|
2
|
1
|
|
|
Carnitine deficiency
|
125
|
1
|
2
|
|
|
Catecholaminergic polymorphic ventricular tachycardia 4; Long QT syndrome 14
|
125
|
4
|
2
|
|
|
Coffin-Siris syndrome 6
|
125
|
6
|
42
|
|
|
Diamond-Blackfan anemia 5
|
125
|
4
|
11
|
|
|
Dyslipidemia
|
125
|
2
|
1
|
|
|
Dystonia 5
|
125
|
5
|
33
|
|
|
Early onset severe obesity
|
125
|
25
|
1
|
|
|
IFT140-related disorder
|
125
|
3
|
1
|
|
|
Mitochondrial DNA depletion syndrome, myopathic form
|
125
|
2
|
26
|
|
|
Naxos disease
|
125
|
2
|
9
|
|
|
Nephronophthisis 8
|
125
|
2
|
1
|
|
|
Renal dysplasia, cystic, susceptibility to
|
125
|
2
|
12
|
|
|
Steroid-resistant nephrotic syndrome
|
125
|
9
|
6
|
|
|
Syndromic X-linked intellectual disability Najm type
|
125
|
3
|
54
|
|
|
ATP8B1-related disorder
|
124
|
2
|
2
|
|
|
Autosomal recessive congenital ichthyosis 5
|
124
|
2
|
19
|
|
|
Diamond-Blackfan anemia 6
|
124
|
3
|
26
|
|
|
Fanconi anemia complementation group N; Pancreatic cancer, susceptibility to, 3; Breast-ovarian cancer, familial, susceptibility to, 5
|
124
|
2
|
5
|
|
|
GLI3-related disorder
|
124
|
1
|
4
|
|
|
KMT2A-related disorder
|
124
|
2
|
1
|
|
|
Nephronophthisis 3
|
124
|
2
|
21
|
|
|
Polydactyly of a triphalangeal thumb
|
124
|
5
|
4
|
|
|
Retinitis pigmentosa 4
|
124
|
1
|
23
|
|
|
Usher syndrome type 1C; Autosomal recessive nonsyndromic hearing loss 18A
|
124
|
1
|
3
|
|
|
APOB-related disorder
|
123
|
2
|
3
|
|
|
ARHGEF28-related disorder
|
123
|
2
|
1
|
|
|
Autosomal dominant Alport syndrome; Autosomal recessive Alport syndrome; Benign familial hematuria
|
123
|
3
|
3
|
|
|
Corticosterone 18-monooxygenase deficiency
|
123
|
1
|
10
|
|
|
Dilated cardiomyopathy 1U
|
123
|
2
|
4
|
|
|
Global developmental delay with or without impaired intellectual development
|
123
|
6
|
31
|
|
|
Hemolytic anemia due to glucophosphate isomerase deficiency
|
123
|
1
|
16
|
|
|
Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism
|
123
|
1
|
35
|
|
|
Isolated Nonsyndromic Congenital Heart Disease
|
123
|
1
|
1
|
|
|
Maturity-onset diabetes of the young type 11
|
123
|
4
|
19
|
|
|
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2
|
123
|
7
|
21
|
|
|
Multiple mitochondrial dysfunctions syndrome 1
|
123
|
2
|
13
|
|
|
SPEN-related disorder
|
123
|
1
|
1
|
|
|
Transcobalamin I deficiency
|
123
|
1
|
1
|
|
|
Weiss-Kruszka syndrome
|
123
|
3
|
45
|
|
|
Cataract 5 multiple types
|
122
|
4
|
14
|
|
|
Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency
|
122
|
2
|
19
|
|
|
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome
|
122
|
4
|
31
|
|
|
Hypogonadotropic hypogonadism 3 with or without anosmia
|
122
|
1
|
39
|
|
|
Intellectual developmental disorder 62
|
122
|
3
|
42
|
|
|
MYBPC3-related disorder
|
122
|
1
|
7
|
|
|
Perrault syndrome 1
|
122
|
9
|
20
|
|
|
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome
|
122
|
2
|
16
|
|
|
Seckel syndrome 4
|
122
|
2
|
9
|
|
|
Sitosterolemia 2
|
122
|
3
|
24
|
|
|
Spinocerebellar ataxia type 14
|
122
|
1
|
38
|
|
|
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B1
|
122
|
6
|
26
|
|
|
CACNA1C-related disorder
|
121
|
1
|
8
|
|
|
Charcot-Marie-Tooth disease type 4B1
|
121
|
1
|
36
|
|
|
Developmental delay, impaired speech, and behavioral abnormalities
|
121
|
3
|
37
|
|
|
Hypophosphatemic rickets, autosomal recessive, 1
|
121
|
1
|
13
|
|
|
NIPBL-related disorder
|
121
|
1
|
1
|
|
|
NOTCH3-related disorder
|
121
|
2
|
2
|
|
|
Neuronopathy, distal hereditary motor, type 5A
|
121
|
3
|
14
|
|
|
Ocular cystinosis; Juvenile nephropathic cystinosis; Nephropathic cystinosis
|
121
|
2
|
7
|
|
|
Rhizomelic chondrodysplasia punctata type 2
|
121
|
2
|
17
|
|
|
TRRAP-related disorder
|
121
|
2
|
2
|
|
|
TWIST1-related craniosynostosis
|
121
|
5
|
13
|
|
|
Warburg micro syndrome 1
|
121
|
2
|
29
|
|
|
Wiskott-Aldrich syndrome
|
121
|
3
|
29
|
|
|
COL4A3-related disorder
|
120
|
2
|
3
|
|
|
Congenital bile acid synthesis defect 2
|
120
|
1
|
17
|
|
|
Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3
|
120
|
3
|
23
|
|
|
Familial visceral amyloidosis, Ostertag type
|
120
|
4
|
22
|
|
|
Geleophysic dysplasia
|
120
|
7
|
3
|
|
|
Hecht syndrome
|
120
|
3
|
12
|
|
|
Heterotaxy, visceral, 1, X-linked
|
120
|
3
|
14
|
|
|
Hyperparathyroidism 2 with jaw tumors
|
120
|
2
|
13
|
|
|
Inherited MMR deficiency (Lynch syndrome)
|
120
|
4
|
4
|
|
|
Intellectual disability, autosomal dominant 39
|
120
|
2
|
57
|
|
|
Intellectual disability, autosomal recessive 13
|
120
|
2
|
43
|
|
|
Maturity-onset diabetes of the young type 7
|
120
|
2
|
14
|
|
|
NEK1-related disorder
|
120
|
1
|
1
|
|
|
Noonan syndrome 5
|
120
|
3
|
37
|
|
|
OTOG-related disorder
|
120
|
1
|
1
|
|
|
PEX6-related disorder
|
120
|
1
|
2
|
|
|
RELN-related disorder
|
120
|
4
|
2
|
|
|
Radio-Tartaglia syndrome
|
120
|
1
|
48
|
|
|
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome
|
120
|
3
|
51
|
|
|
Aortic valve disease 1; Adams-Oliver syndrome 5
|
119
|
3
|
12
|
|
|
Bartter syndrome
|
119
|
5
|
3
|
|
|
Bronchiectasis with or without elevated sweat chloride 1; Liddle syndrome 1; Pseudohypoaldosteronism, type IB2, autosomal recessive
|
119
|
1
|
2
|
|
|
Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies
|
119
|
2
|
37
|
|
|
DST-related disorder
|
119
|
3
|
4
|
|
|
Diaphyseal medullary stenosis-bone malignancy syndrome
|
119
|
2
|
8
|
|
|
Dilated cardiomyopathy 1W; Hypertrophic cardiomyopathy 15
|
119
|
3
|
9
|
|
|
FLCN-related disorder
|
119
|
1
|
1
|
|
|
Heterotopia, periventricular, X-linked dominant
|
119
|
3
|
46
|
|
|
Intellectual disability, autosomal dominant 9
|
119
|
3
|
50
|
|
|
MLH1-related disorder
|
119
|
3
|
1
|
|
|
Mitochondrial DNA depletion syndrome 8a
|
119
|
3
|
17
|
|
|
POMC-related disorder
|
119
|
2
|
1
|
|
|
Pterin-4 alpha-carbinolamine dehydratase 1 deficiency
|
119
|
2
|
12
|
|
|
ALS2-related disorder
|
118
|
2
|
4
|
|
|
Cutis laxa
|
118
|
9
|
4
|
|
|
Deficiency of butyrylcholinesterase
|
118
|
3
|
25
|
|
|
Hyper-IgE recurrent infection syndrome 1, autosomal dominant
|
118
|
6
|
30
|
|
|
Lamb-Shaffer syndrome
|
118
|
8
|
57
|
|
|
SCN1A-related disorder
|
118
|
2
|
6
|
|
|
Thyroid dyshormonogenesis 1
|
118
|
1
|
15
|
|
|
Warburg micro syndrome 3
|
118
|
3
|
9
|
|
|
Arrhythmogenic right ventricular dysplasia 10; Dilated cardiomyopathy 1BB
|
117
|
3
|
8
|
|
|
Centronuclear myopathy
|
117
|
21
|
9
|
|
|
Combined oxidative phosphorylation defect type 11
|
117
|
1
|
28
|
|
|
Cone-rod synaptic disorder, congenital nonprogressive
|
117
|
5
|
16
|
|
|
Congenital muscular dystrophy with intellectual disability and severe epilepsy
|
117
|
4
|
9
|
|
|
Congenital stationary night blindness 1D
|
117
|
1
|
13
|
|
|
DYNC2H1-related disorder
|
117
|
1
|
3
|
|
|
Deafness-encephaloneuropathy-obesity-valvulopathy syndrome
|
117
|
2
|
16
|
|
|
Dystonia 28, childhood-onset
|
117
|
3
|
45
|
|
|
Gaucher disease type I
|
117
|
4
|
41
|
|
|
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency
|
117
|
1
|
28
|
|
|
HSPG2-related disorder
|
117
|
3
|
2
|
|
|
Hypotrichosis 6
|
117
|
1
|
12
|
|
|
McKusick-Kaufman syndrome; Bardet-Biedl syndrome 6
|
117
|
1
|
6
|
|
|
Melanoma and neural system tumor syndrome
|
117
|
3
|
5
|
|
|
Multiple endocrine neoplasia type 2B
|
117
|
2
|
20
|
|
|
NPHP3-related disorder
|
117
|
3
|
4
|
|
|
Neuroblastoma, susceptibility to, 2
|
117
|
2
|
6
|
|
|
Niemann-Pick disease, type C
|
117
|
2
|
2
|
|
|
Retinal macular dystrophy type 2
|
117
|
1
|
8
|
|
|
Spinocerebellar ataxia type 35
|
117
|
1
|
29
|
|
|
Stargardt disease 4
|
117
|
1
|
7
|
|
|
Trimethylaminuria
|
117
|
3
|
20
|
|
|
Van der Woude syndrome 1
|
117
|
4
|
24
|
|
|
Axenfeld-Rieger syndrome type 3; Anterior segment dysgenesis 3
|
116
|
3
|
5
|
|
|
Cardiofaciocutaneous syndrome 4
|
116
|
2
|
27
|
|
|
DNAH2-related disorder
|
116
|
1
|
1
|
|
|
Dicarboxylic aminoaciduria
|
116
|
2
|
6
|
|
|
Foveal hypoplasia 1
|
116
|
3
|
6
|
|
|
Hypotonia, infantile, with psychomotor retardation and characteristic facies 3
|
116
|
1
|
46
|
|
|
Intellectual disability, autosomal dominant 56
|
116
|
5
|
54
|
|
|
Isolated microphthalmia 3
|
116
|
3
|
8
|
|
|
MDN1-related disorder
|
116
|
2
|
1
|
|
|
Sifrim-Hitz-Weiss syndrome
|
116
|
2
|
52
|
|
|
Trichohepatoenteric syndrome 2
|
116
|
3
|
24
|
|
|
Tubulinopathy
|
116
|
3
|
5
|
|
|
COL4A2-related disorder
|
115
|
1
|
4
|
|
|
Chuvash polycythemia
|
115
|
3
|
13
|
|
|
Dilated cardiomyopathy 1KK; MYPN-related myopathy
|
115
|
2
|
5
|
|
|
Dilated cardiomyopathy 1L; Autosomal recessive limb-girdle muscular dystrophy type 2F
|
115
|
1
|
4
|
|
|
Dilated cardiomyopathy 1P
|
115
|
2
|
14
|
|
|
Ectopia lentis et pupillae
|
115
|
2
|
10
|
|
|
Factor VII deficiency
|
115
|
1
|
11
|
|
|
KIF1A-related disorder
|
115
|
2
|
5
|
|
|
MORM syndrome; Joubert syndrome 1
|
115
|
1
|
3
|
|
|
Mitochondrial complex II deficiency, nuclear type 1; Dilated cardiomyopathy 1GG; Pheochromocytoma/paraganglioma syndrome 5; Neurodegeneration with ataxia and late-onset optic atrophy
|
115
|
1
|
3
|
|
|
PEX1-related disorder
|
115
|
3
|
3
|
|
|
Parkinson disease, late-onset
|
115
|
27
|
30
|
|
|
Pulmonary hypertension, neonatal, susceptibility to
|
115
|
1
|
1
|
|
|
SCN5A-related disorder
|
115
|
2
|
10
|
|
|
Arthrogryposis, distal, with impaired proprioception and touch
|
114
|
4
|
36
|
|
|
Atrioventricular septal defect, susceptibility to, 2
|
114
|
4
|
9
|
|
|
Beck-Fahrner syndrome
|
114
|
1
|
38
|
|
|
CELSR1-related disorder
|
114
|
4
|
1
|
|
|
Charcot-Marie-Tooth disease axonal type 2N
|
114
|
2
|
31
|
|
|
Congenital contractures of the limbs and face, hypotonia, and developmental delay
|
114
|
2
|
39
|
|
|
Familial multiple trichoepitheliomata
|
114
|
2
|
3
|
|
|
Hermansky-Pudlak syndrome 6
|
114
|
3
|
25
|
|
|
Hypobetalipoproteinemia
|
114
|
3
|
4
|
|
|
Intellectual disability, autosomal recessive 1
|
114
|
1
|
17
|
|
|
Lethal polymalformative syndrome, Boissel type
|
114
|
1
|
11
|
|
|
Long QT syndrome 12
|
114
|
6
|
17
|
|
|
Methylcrotonyl-CoA carboxylase deficiency
|
114
|
2
|
4
|
|
|
Osteogenesis imperfecta type 13
|
114
|
3
|
16
|
|
|
Spondylometaphyseal dysplasia, Kozlowski type
|
114
|
2
|
12
|
|
|
TMEM67-related disorder
|
114
|
1
|
5
|
|
|
TRPC5-related disorder
|
114
|
1
|
1
|
|
|
ANK2-related disorder
|
113
|
3
|
2
|
|
|
Abnormality of neuronal migration
|
113
|
77
|
2
|
|
|
Acromesomelic dysplasia 1, Maroteaux type
|
113
|
3
|
27
|
|
|
Autosomal dominant keratitis
|
113
|
3
|
2
|
|
|
Axenfeld-Rieger syndrome type 1
|
113
|
5
|
14
|
|
|
Cone dystrophy 4
|
113
|
1
|
25
|
|
|
DCHS2-related disorder
|
113
|
1
|
1
|
|
|
FANCM-related disorder
|
113
|
2
|
2
|
|
|
FLNB-related disorder
|
113
|
1
|
4
|
|
|
Factor 5 and Factor VIII, combined deficiency of, 2
|
113
|
2
|
4
|
|
|
Hereditary spastic paraplegia 8
|
113
|
8
|
22
|
|
|
Long QT syndrome 6
|
113
|
4
|
13
|
|
|
MGAT2-congenital disorder of glycosylation
|
113
|
2
|
12
|
|
|
Neuronopathy, distal hereditary motor, autosomal dominant 8
|
113
|
2
|
7
|
|
|
PTEN-related disorder
|
113
|
5
|
9
|
|
|
Perry syndrome
|
113
|
1
|
14
|
|
|
Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency
|
113
|
2
|
15
|
|
|
SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES
|
113
|
4
|
6
|
|
|
Sorsby fundus dystrophy
|
113
|
1
|
8
|
|
|
Spondylocostal dysostosis 1, autosomal recessive
|
113
|
5
|
17
|
|
|
ALG8 congenital disorder of glycosylation; Polycystic liver disease 3 with or without kidney cysts
|
112
|
2
|
2
|
|
|
Atypical hemolytic-uremic syndrome; Complement component 3 deficiency; C3 glomerulonephritis
|
112
|
1
|
1
|
|
|
Autosomal dominant nonsyndromic hearing loss 3A
|
112
|
1
|
31
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2K
|
112
|
1
|
11
|
|
|
BARD1-related cancer predisposition
|
112
|
1
|
3
|
|
|
CIC-related disorder
|
112
|
1
|
1
|
|
|
Corticosterone methyloxidase type 2 deficiency
|
112
|
1
|
8
|
|
|
Elliptocytosis 1
|
112
|
1
|
14
|
|
|
Epiphyseal dysplasia, multiple, 2
|
112
|
3
|
15
|
|
|
Hereditary motor and sensory neuropathy with optic atrophy
|
112
|
4
|
8
|
|
|
Hereditary spastic paraplegia 72
|
112
|
2
|
7
|
|
|
Immunodeficiency 37
|
112
|
2
|
3
|
|
|
Isolated microphthalmia 6
|
112
|
2
|
12
|
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6
|
112
|
4
|
8
|
|
|
Self-limited epilepsy with centrotemporal spikes
|
112
|
39
|
2
|
|
|
Usher syndrome type 2
|
112
|
7
|
9
|
|
|
VWF-related disorder
|
112
|
1
|
4
|
|
|
Waardenburg syndrome type 4C
|
112
|
2
|
24
|
|
|
Arterial calcification, generalized, of infancy, 1; Type 2 diabetes mellitus; Hypophosphatemic rickets, autosomal recessive, 2; Hypopigmentation-punctate palmoplantar keratoderma syndrome; Inherited obesity
|
111
|
1
|
2
|
|
|
Autosomal dominant hypocalcemia 1
|
111
|
1
|
24
|
|
|
Cerebral palsy, spastic quadriplegic, 2
|
111
|
3
|
12
|
|
|
Charcot-Marie-Tooth disease type 2A2
|
111
|
3
|
55
|
|
|
Congenital heart disease
|
111
|
58
|
14
|
|
|
Familial pulmonary capillary hemangiomatosis
|
111
|
3
|
16
|
|
|
Intellectual disability, autosomal recessive 5
|
111
|
2
|
24
|
|
|
Joubert syndrome with renal defect
|
111
|
4
|
11
|
|
|
Maple syrup urine disease, mild variant
|
111
|
2
|
4
|
|
|
NSD1-related disorder
|
111
|
1
|
1
|
|
|
Periventricular nodular heterotopia 7
|
111
|
3
|
31
|
|
|
Peroxisome biogenesis disorder 2A (Zellweger)
|
111
|
1
|
8
|
|
|
SAMD9-related disorder
|
111
|
1
|
3
|
|
|
Sideroblastic anemia 2
|
111
|
2
|
15
|
|
|
carboxymethyl-dextran-A2-gadolinium-DOTA
|
111
|
3
|
1
|
|
|
ABCG8-related disorder
|
110
|
2
|
1
|
|
|
Autosomal recessive congenital ichthyosis 10
|
110
|
2
|
24
|
|
|
Branched-chain keto acid dehydrogenase kinase deficiency
|
110
|
2
|
13
|
|
|
Congenital myasthenic syndrome 4C
|
110
|
12
|
25
|
|
|
Erythrocyte AMP deaminase deficiency
|
110
|
1
|
5
|
|
|
Factor V and factor VIII, combined deficiency of, type 1
|
110
|
5
|
9
|
|
|
Hereditary spastic paraplegia 62
|
110
|
2
|
8
|
|
|
MSH3-related disorder
|
110
|
2
|
1
|
|
|
MYOM2-related disorder
|
110
|
2
|
1
|
|
|
Microcephaly, seizures, and developmental delay
|
110
|
2
|
27
|
|
|
Multiple epiphyseal dysplasia type 1
|
110
|
2
|
30
|
|
|
Seckel syndrome 5
|
110
|
2
|
8
|
|
|
Severe intellectual disability-progressive spastic diplegia syndrome
|
110
|
3
|
63
|
|
|
X-linked mixed hearing loss with perilymphatic gusher
|
110
|
1
|
34
|
|
|
Allan-Herndon-Dudley syndrome
|
109
|
4
|
46
|
|
|
Beta-thalassemia HBB/LCRB
|
109
|
9
|
35
|
|
|
Bruck syndrome 2
|
109
|
2
|
22
|
|
|
Charcot-Marie-Tooth disease type 1B
|
109
|
3
|
29
|
|
|
Familial steroid-resistant nephrotic syndrome with sensorineural deafness
|
109
|
2
|
22
|
|
|
GM1 gangliosidosis
|
109
|
2
|
7
|
|
|
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions
|
109
|
3
|
25
|
|
|
Intellectual developmental disorder with autistic features and language delay, with or without seizures
|
109
|
3
|
32
|
|
|
Multicentric osteolysis nodulosis arthropathy spectrum
|
109
|
2
|
11
|
|
|
Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities
|
109
|
5
|
41
|
|
|
SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN
|
109
|
1
|
5
|
|
|
Scapuloperoneal spinal muscular atrophy
|
109
|
2
|
5
|
|
|
Tyrosinase-positive oculocutaneous albinism; SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES
|
109
|
2
|
4
|
|
|
AXIN2-related disorder
|
108
|
1
|
4
|
|
|
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly
|
108
|
2
|
28
|
|
|
Autosomal recessive distal renal tubular acidosis
|
108
|
4
|
11
|
|
|
CDH1-related disorder
|
108
|
2
|
1
|
|
|
DYSF-related disorder
|
108
|
2
|
6
|
|
|
Desmosterolosis
|
108
|
1
|
15
|
|
|
FGFR3-related disorder
|
108
|
1
|
6
|
|
|
Familial spontaneous pneumothorax
|
108
|
1
|
10
|
|
|
Hyperekplexia 1
|
108
|
3
|
39
|
|
|
MYH3-related disorder
|
108
|
2
|
7
|
|
|
Nephronophthisis 9; Renal-hepatic-pancreatic dysplasia 2; Polycystic kidney disease 8
|
108
|
3
|
2
|
|
|
Patterned macular dystrophy 1
|
108
|
1
|
19
|
|
|
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3
|
108
|
1
|
17
|
|
|
RYR1-related myopathy
|
108
|
2
|
11
|
|
|
RYR2-related disorder
|
108
|
3
|
5
|
|
|
STT3B-congenital disorder of glycosylation
|
108
|
4
|
5
|
|
|
Usher syndrome type 3
|
108
|
1
|
17
|
|
|
Atrial fibrillation, familial, 3
|
107
|
2
|
7
|
|
|
Autosomal dominant nonsyndromic hearing loss 2A
|
107
|
3
|
29
|
|
|
Brachyrachia (short spine dysplasia)
|
107
|
2
|
3
|
|
|
Combined oxidative phosphorylation defect type 7; Spastic paraplegia
|
107
|
1
|
1
|
|
|
Congenital dyserythropoietic anemia, type II
|
107
|
2
|
25
|
|
|
Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype
|
107
|
46
|
2
|
|
|
Dilated cardiomyopathy 1G; Hypertrophic cardiomyopathy 9
|
107
|
9
|
8
|
|
|
Epidermolysis bullosa simplex
|
107
|
5
|
5
|
|
|
Familial adenomatous polyposis 2; Gastric cancer
|
107
|
2
|
4
|
|
|
Histidinemia
|
107
|
1
|
5
|
|
|
Hypertrophic cardiomyopathy 6
|
107
|
2
|
21
|
|
|
Lethal congenital contractural syndrome Finnish type
|
107
|
2
|
1
|
|
|
Noonan syndrome 10
|
107
|
2
|
46
|
|
|
Prolidase deficiency
|
107
|
1
|
27
|
|
|
Renal cysts and diabetes syndrome; Type 2 diabetes mellitus; Nonpapillary renal cell carcinoma
|
107
|
2
|
3
|
|
|
Tietz syndrome
|
107
|
2
|
7
|
|
|
ABCC8-related disorder
|
106
|
2
|
4
|
|
|
Bardet-Biedl syndrome 5
|
106
|
2
|
23
|
|
|
Beckwith-Wiedemann syndrome; IMAGe syndrome
|
106
|
1
|
6
|
|
|
Branchiootic syndrome 1; Branchiootorenal syndrome 1; Otofaciocervical syndrome 1
|
106
|
1
|
5
|
|
|
CHEK2-related disorder
|
106
|
1
|
2
|
|
|
Citrullinemia, type II, adult-onset
|
106
|
3
|
6
|
|
|
Currarino triad
|
106
|
4
|
16
|
|
|
DCHS1-related disorder
|
106
|
2
|
2
|
|
|
Dermatofibrosis lenticularis disseminata
|
106
|
3
|
18
|
|
|
Epilepsy, idiopathic generalized, susceptibility to, 13
|
106
|
1
|
6
|
|
|
Hereditary retinoblastoma
|
106
|
1
|
3
|
|
|
Huntington disease-like 1
|
106
|
2
|
3
|
|
|
Intellectual developmental disorder with dysmorphic facies and ptosis
|
106
|
2
|
44
|
|
|
Low phospholipid associated cholelithiasis
|
106
|
2
|
15
|
|
|
Mast syndrome
|
106
|
1
|
19
|
|
|
NEFH-related disorder
|
106
|
1
|
1
|
|
|
SON-related disorder
|
106
|
2
|
1
|
|
|
Urofacial syndrome type 1
|
106
|
1
|
12
|
|
|
Aicardi-Goutieres syndrome 6
|
105
|
3
|
28
|
|
|
Alacrima, achalasia, and intellectual disability syndrome
|
105
|
2
|
10
|
|
|
CSMD1-related disorder
|
105
|
4
|
1
|
|
|
Fanconi anemia complementation group J; Ovarian cancer
|
105
|
1
|
1
|
|
|
Hypotonia, ataxia, and delayed development syndrome
|
105
|
1
|
51
|
|
|
Jalili syndrome
|
105
|
1
|
18
|
|
|
MAP1B-related disorder
|
105
|
2
|
1
|
|
|
Oculocutaneous albinism type 1A; Oculocutaneous albinism type 1B; SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN
|
105
|
1
|
2
|
|
|
Oculocutaneous albinism type 4
|
105
|
2
|
29
|
|
|
Otofaciocervical syndrome 1
|
105
|
1
|
7
|
|
|
RAB23-related Carpenter syndrome
|
105
|
2
|
14
|
|
|
Retinitis pigmentosa 51; Bardet-Biedl syndrome 8
|
105
|
1
|
4
|
|
|
Roberts-SC phocomelia syndrome; Juberg-Hayward syndrome
|
105
|
1
|
4
|
|
|
Sick sinus syndrome 2, autosomal dominant
|
105
|
3
|
13
|
|
|
Steel syndrome
|
105
|
2
|
26
|
|
|
Usher syndrome type 1G
|
105
|
3
|
20
|
|
|
X-linked intellectual disability-cerebellar hypoplasia syndrome
|
105
|
2
|
50
|
|
|
ANKRD26-related disorder
|
104
|
2
|
1
|
|
|
Acrodysostosis 1 with or without hormone resistance
|
104
|
2
|
11
|
|
|
Amyotrophic lateral sclerosis type 10
|
104
|
9
|
26
|
|
|
Arthrogryposis, renal dysfunction, and cholestasis 1; Keratoderma-ichthyosis-deafness syndrome, autosomal recessive; Cholestasis, progressive familial intrahepatic, 12
|
104
|
1
|
2
|
|
|
Autosomal recessive congenital ichthyosis 6
|
104
|
3
|
20
|
|
|
Chuvash polycythemia; Pheochromocytoma; Von Hippel-Lindau syndrome; Nonpapillary renal cell carcinoma
|
104
|
2
|
3
|
|
|
Conotruncal heart malformations
|
104
|
9
|
9
|
|
|
Cutis laxa, autosomal dominant 1
|
104
|
1
|
13
|
|
|
Ehlers-Danlos syndrome, type 4; Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome
|
104
|
2
|
6
|
|
|
Hypouricemia, renal, 2
|
104
|
3
|
20
|
|
|
ITGB4-related disorder
|
104
|
2
|
1
|
|
|
Jervell and Lange-Nielsen syndrome 2
|
104
|
1
|
11
|
|
|
MAPT-Related Spectrum Disorders
|
104
|
1
|
2
|
|
|
Myopathy, lactic acidosis, and sideroblastic anemia 1
|
104
|
3
|
18
|
|
|
Neurodevelopmental disorder with or without variable brain abnormalities; NEDBA
|
104
|
2
|
34
|
|
|
PPARG-related disorder
|
104
|
2
|
2
|
|
|
Short QT syndrome type 2
|
104
|
2
|
5
|
|
|
Short QT syndrome type 3
|
104
|
2
|
3
|
|
|
Autosomal recessive nonsyndromic hearing loss 63
|
103
|
7
|
20
|
|
|
COG6-congenital disorder of glycosylation
|
103
|
1
|
23
|
|
|
Developmental delay with autism spectrum disorder and gait instability
|
103
|
3
|
29
|
|
|
Episodic ataxia type 6
|
103
|
1
|
14
|
|
|
Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency
|
103
|
2
|
8
|
|
|
Hypertrichotic osteochondrodysplasia Cantu type
|
103
|
3
|
28
|
|
|
Melanoma, cutaneous malignant, susceptibility to, 1
|
103
|
5
|
6
|
|
|
NPHP1-related disorder
|
103
|
2
|
3
|
|
|
Osteogenesis imperfecta type 11
|
103
|
1
|
24
|
|
|
Primary ciliary dyskinesia 16
|
103
|
3
|
7
|
|
|
Sanfilippo syndrome
|
103
|
6
|
3
|
|
|
Vitamin D hydroxylation-deficient rickets, type 1B
|
103
|
2
|
17
|
|
|
Adams-Oliver syndrome 2
|
102
|
1
|
32
|
|
|
Arthrogryposis, renal dysfunction, and cholestasis 1
|
102
|
4
|
28
|
|
|
Autosomal recessive nonsyndromic hearing loss 24
|
102
|
1
|
21
|
|
|
Autosomal recessive osteopetrosis 7
|
102
|
3
|
11
|
|
|
Charcot-Marie-Tooth disease type 2D
|
102
|
1
|
17
|
|
|
Chondrosarcoma
|
102
|
1
|
5
|
|
|
Cranioectodermal dysplasia 4
|
102
|
1
|
8
|
|
|
DSP-related disorder
|
102
|
1
|
4
|
|
|
Developmental and epileptic encephalopathy, 1
|
102
|
36
|
35
|
|
|
Diabetes insipidus, nephrogenic, X-linked
|
102
|
2
|
26
|
|
|
EEM syndrome
|
102
|
1
|
8
|
|
|
Hydrocephalus, nonsyndromic, autosomal recessive 2
|
102
|
4
|
37
|
|
|
Infantile GM1 gangliosidosis
|
102
|
2
|
27
|
|
|
Intellectual disability, X-linked 49
|
102
|
1
|
37
|
|
|
Microcytic anemia
|
102
|
1
|
7
|
|
|
NPHP3-related Meckel-like syndrome
|
102
|
2
|
9
|
|
|
Oculocutaneous albinism type 3
|
102
|
2
|
19
|
|
|
Pigmented paravenous retinochoroidal atrophy; Retinitis pigmentosa 12; Leber congenital amaurosis 8
|
102
|
1
|
2
|
|
|
Sialic acid storage disease, severe infantile type
|
102
|
3
|
21
|
|
|
Spinocerebellar ataxia type 11
|
102
|
1
|
22
|
|
|
TJP2-related disorder
|
102
|
1
|
2
|
|
|
XIRP2-related disorder
|
102
|
1
|
1
|
|
|
Autosomal recessive osteopetrosis 5
|
101
|
2
|
9
|
|
|
CPE-related disorder
|
101
|
2
|
1
|
|
|
CTCF-related neurodevelopmental disorder
|
101
|
4
|
46
|
|
|
Charcot-Marie-Tooth disease type 4J
|
101
|
1
|
20
|
|
|
Chronic infantile neurological, cutaneous and articular syndrome
|
101
|
1
|
13
|
|
|
DOCK6-related disorder
|
101
|
1
|
1
|
|
|
Diabetic retinopathy
|
101
|
2
|
1
|
|
|
Familial amyloid nephropathy with urticaria AND deafness
|
101
|
1
|
11
|
|
|
Familial colorectal cancer type X; Polymerase proofreading-related adenomatous polyposis
|
101
|
3
|
1
|
|
|
Familial hyperthyroidism due to mutations in TSH receptor
|
101
|
2
|
11
|
|
|
Familial spontaneous pneumothorax; Nonpapillary renal cell carcinoma; Colorectal cancer; Birt-Hogg-Dube syndrome 1
|
101
|
1
|
3
|
|
|
Hypercholanemia, familial 1
|
101
|
4
|
7
|
|
|
Limb-girdle muscular dystrophy
|
101
|
39
|
12
|
|
|
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
|
101
|
4
|
7
|
|
|
Microcephaly and chorioretinopathy 1
|
101
|
2
|
35
|
|
|
Mitochondrial complex III deficiency nuclear type 2
|
101
|
5
|
22
|
|
|
Moyamoya disease 2
|
101
|
5
|
28
|
|
|
Nephrogenic diabetes insipidus
|
101
|
3
|
7
|
|
|
Polymerase proofreading-related adenomatous polyposis
|
101
|
3
|
5
|
|
|
Progressive sclerosing poliodystrophy; Mitochondrial DNA depletion syndrome 1; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1; Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis; Mitochondrial DNA depletion syndrome 4b
|
101
|
4
|
2
|
|
|
Renal-hepatic-pancreatic dysplasia 1
|
101
|
2
|
9
|
|
|
Retinitis pigmentosa 38
|
101
|
5
|
35
|
|
|
SCN2A-related disorder
|
101
|
1
|
9
|
|
|
SETBP1-related disorder
|
101
|
1
|
5
|
|
|
Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis
|
101
|
4
|
21
|
|
|
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans
|
101
|
2
|
30
|
|
|
Stromme syndrome
|
101
|
2
|
26
|
|
|
Troyer syndrome
|
101
|
3
|
19
|
|
|
Atrial fibrillation, familial, 9
|
100
|
2
|
3
|
|
|
Charcot-Marie-Tooth disease recessive intermediate A
|
100
|
2
|
13
|
|
|
Dilated cardiomyopathy 1HH
|
100
|
2
|
22
|
|
|
Hypertrophic cardiomyopathy 11
|
100
|
1
|
17
|
|
|
Intellectual disability, autosomal dominant 29
|
100
|
2
|
48
|
|
|
LAMA2-related disorder
|
100
|
3
|
5
|
|
|
MET-related disorder
|
100
|
1
|
1
|
|
|
Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency
|
100
|
2
|
11
|
|
|
Pleuropulmonary blastoma
|
100
|
4
|
14
|
|
|
SEPN1-related disorder
|
100
|
1
|
1
|
|
|
Batten-Turner congenital myopathy
|
99
|
3
|
4
|
|
|
Brain-lung-thyroid syndrome
|
99
|
3
|
21
|
|
|
Complement component 5 deficiency; Eculizumab, poor response to
|
99
|
2
|
2
|
|
|
Fibromatosis, gingival, 1; Noonan syndrome 4
|
99
|
2
|
4
|
|
|
Global developmental delay with speech and behavioral abnormalities
|
99
|
1
|
34
|
|
|
Greenberg dysplasia
|
99
|
1
|
8
|
|
|
Isolated thoracic aortic aneurysm
|
99
|
16
|
1
|
|
|
MLH3-related disorder
|
99
|
1
|
2
|
|
|
Microcephaly, epilepsy, and diabetes syndrome
|
99
|
4
|
3
|
|
|
NCOR2-related disorder
|
99
|
2
|
1
|
|
|
Neuronal ceroid lipofuscinosis 10
|
99
|
3
|
19
|
|
|
Pulmonary arterial hypertension; Idiopathic and/or familial pulmonary arterial hypertension
|
99
|
2
|
1
|
|
|
Asphyxiating thoracic dystrophy 5
|
98
|
1
|
5
|
|
|
Autosomal dominant striatal neurodegeneration type 1
|
98
|
1
|
8
|
|
|
Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to, 4; Fanconi anemia, complementation group S
|
98
|
2
|
3
|
|
|
COL4A5-related disorder
|
98
|
1
|
1
|
|
|
Cataract 33
|
98
|
2
|
4
|
|
|
Ceroid lipofuscinosis, neuronal, 6A
|
98
|
2
|
35
|
|
|
Cone-rod dystrophy 3
|
98
|
3
|
27
|
|
|
Congenital lactase deficiency
|
98
|
2
|
13
|
|
|
Leber congenital amaurosis 14
|
98
|
2
|
13
|
|
|
MYO18B-related disorder
|
98
|
1
|
1
|
|
|
Non-obstructive azoospermia
|
98
|
36
|
11
|
|
|
Noonan syndrome 2; LZTR1-related schwannomatosis; Noonan syndrome 10
|
98
|
3
|
7
|
|
|
Occipital pachygyria and polymicrogyria
|
98
|
2
|
23
|
|
|
PRR12-related disorder
|
98
|
2
|
1
|
|
|
Progressive sclerosing poliodystrophy; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1; Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis; Mitochondrial DNA depletion syndrome 4b
|
98
|
2
|
7
|
|
|
SETD1B-related disorder
|
98
|
1
|
1
|
|
|
SIN3A-related intellectual disability syndrome due to a point mutation
|
98
|
3
|
45
|
|
|
Spastic ataxia
|
98
|
65
|
6
|
|
|
Timothy syndrome; Brugada syndrome 3; Long QT syndrome 8
|
98
|
1
|
4
|
|
|
8q24.3 microdeletion syndrome
|
97
|
3
|
51
|
|
|
Autosomal recessive axonal neuropathy with neuromyotonia
|
97
|
1
|
21
|
|
|
Beare-Stevenson cutis gyrata syndrome
|
97
|
1
|
9
|
|
|
Congenital adrenal hypoplasia, X-linked
|
97
|
5
|
29
|
|
|
Diamond-Blackfan anemia 1
|
97
|
5
|
26
|
|
|
Glucocorticoid deficiency with achalasia
|
97
|
3
|
36
|
|
|
Heterotaxy, visceral, 8, autosomal
|
97
|
1
|
24
|
|
|
Intellectual developmental disorder with speech delay, autism, and dysmorphic facies
|
97
|
5
|
36
|
|
|
LYST-related disorder
|
97
|
2
|
1
|
|
|
Lethal tight skin contracture syndrome
|
97
|
5
|
11
|
|
|
MTOR-related disorder
|
97
|
1
|
2
|
|
|
MYO15A-related disorder
|
97
|
1
|
1
|
|
|
Methylmalonate semialdehyde dehydrogenase deficiency
|
97
|
2
|
13
|
|
|
Neuronopathy, distal hereditary motor, type 7B
|
97
|
1
|
10
|
|
|
Peroxisome biogenesis disorder 1A (Zellweger); Heimler syndrome 1; Peroxisome biogenesis disorder 1B
|
97
|
3
|
11
|
|
|
Retinitis pigmentosa 19
|
97
|
3
|
24
|
|
|
SMPD1-related disorder
|
97
|
3
|
1
|
|
|
Spinocerebellar ataxia type 5
|
97
|
1
|
40
|
|
|
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1
|
97
|
2
|
11
|
|
|
Alkuraya-Kucinskas syndrome
|
96
|
1
|
31
|
|
|
Dilated cardiomyopathy 1R
|
96
|
2
|
20
|
|
|
FAT2-related disorder
|
96
|
3
|
1
|
|
|
Geroderma osteodysplastica
|
96
|
1
|
24
|
|
|
Hoyeraal-Hreidarsson syndrome; Autosomal recessive dyskeratosis congenita
|
96
|
2
|
1
|
|
|
Intellectual disability, autosomal dominant 57
|
96
|
6
|
44
|
|
|
Joubert syndrome 2
|
96
|
1
|
13
|
|
|
PKD2-related disorder
|
96
|
2
|
1
|
|
|
Sialuria
|
96
|
2
|
14
|
|
|
Tourette syndrome
|
96
|
4
|
9
|
|
|
Trichorhinophalangeal dysplasia type I
|
96
|
6
|
44
|
|
|
Waardenburg syndrome
|
96
|
13
|
9
|
|
|
Abnormal brain morphology
|
95
|
77
|
5
|
|
|
Atypical hemolytic-uremic syndrome with thrombomodulin anomaly; Thrombomodulin-related bleeding disorder
|
95
|
1
|
2
|
|
|
COL12A1-related disorder
|
95
|
2
|
3
|
|
|
COL1A2-related disorder
|
95
|
1
|
6
|
|
|
Coxopodopatellar syndrome
|
95
|
2
|
22
|
|
|
Developmental and epileptic encephalopathy, 46
|
95
|
4
|
34
|
|
|
Familial visceral amyloidosis, Ostertag type; Congenital afibrinogenemia; Familial dysfibrinogenemia
|
95
|
1
|
1
|
|
|
Fanconi anemia complementation group N
|
95
|
1
|
16
|
|
|
Hyperinsulinemic hypoglycemia, familial, 2
|
95
|
1
|
20
|
|
|
Hypodontia
|
95
|
7
|
6
|
|
|
Late-onset retinal degeneration
|
95
|
2
|
12
|
|
|
Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome
|
95
|
2
|
42
|
|
|
Miller syndrome
|
95
|
2
|
18
|
|
|
Mitochondrial complex I deficiency, nuclear type 16
|
95
|
3
|
27
|
|
|
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5
|
95
|
2
|
10
|
|
|
Myoepithelial tumor
|
95
|
95
|
1
|
|
|
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures
|
95
|
6
|
43
|
|
|
Phytanic acid storage disease
|
95
|
3
|
27
|
|
|
Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked
|
95
|
4
|
15
|
|
|
SCAPER-related disorder
|
95
|
2
|
1
|
|
|
SDHA-related disorder
|
95
|
1
|
4
|
|
|
Stargardt disease 3
|
95
|
2
|
7
|
|
|
AHDC1-related disorder
|
94
|
1
|
1
|
|
|
Aarskog syndrome
|
94
|
2
|
39
|
|
|
Autosomal recessive nonsyndromic hearing loss 1A; Autosomal recessive nonsyndromic hearing loss 1B; Autosomal dominant nonsyndromic hearing loss 3B; Hidrotic ectodermal dysplasia syndrome
|
94
|
4
|
3
|
|
|
Decreased circulating carnitine concentration
|
94
|
1
|
2
|
|
|
FREM1-related disorder
|
94
|
2
|
5
|
|
|
Factor VII-activating protease marburg I
|
94
|
3
|
1
|
|
|
HUWE1-related disorder
|
94
|
3
|
2
|
|
|
Hereditary coproporphyria
|
94
|
5
|
15
|
|
|
Infantile onset spinocerebellar ataxia
|
94
|
2
|
17
|
|
|
Mitochondrial complex IV deficiency, nuclear type 3
|
94
|
3
|
8
|
|
|
Muscular dystrophy, limb-girdle, autosomal recessive 23
|
94
|
5
|
36
|
|
|
Osteogenesis imperfecta type 6
|
94
|
3
|
30
|
|
|
PDGFRA-related disorder
|
94
|
2
|
1
|
|
|
Retinitis pigmentosa 11
|
94
|
4
|
28
|
|
|
TCOF1-related disorder
|
94
|
1
|
1
|
|
|
Timothy syndrome
|
94
|
1
|
30
|
|
|
UBR4-related disorder
|
94
|
6
|
2
|
|
|
ALDH18A1-related de Barsy syndrome
|
93
|
2
|
24
|
|
|
Apparent mineralocorticoid excess
|
93
|
1
|
18
|
|
|
Autosomal dominant aplasia and myelodysplasia
|
93
|
2
|
13
|
|
|
Autosomal dominant nonsyndromic hearing loss 20
|
93
|
2
|
25
|
|
|
Autosomal dominant nonsyndromic hearing loss 5
|
93
|
3
|
21
|
|
|
Behavior disorder
|
93
|
2
|
1
|
|
|
Bosch-Boonstra-Schaaf optic atrophy syndrome
|
93
|
2
|
45
|
|
|
Bronchiectasis with or without elevated sweat chloride 3; Liddle syndrome 2; Pseudohypoaldosteronism, type IB3, autosomal recessive
|
93
|
1
|
1
|
|
|
Chudley-McCullough syndrome
|
93
|
4
|
27
|
|
|
Cognitive impairment with or without cerebellar ataxia
|
93
|
2
|
33
|
|
|
Colorectal cancer, susceptibility to, 10; Mandibular hypoplasia-deafness-progeroid syndrome; Immunodeficiency 120
|
93
|
1
|
2
|
|
|
Combined PSAP deficiency
|
93
|
2
|
12
|
|
|
Congenital generalized lipodystrophy type 2; Hereditary spastic paraplegia 17; Severe neurodegenerative syndrome with lipodystrophy; Neuronopathy, distal hereditary motor, type 5C
|
93
|
2
|
2
|
|
|
Deafness-lymphedema-leukemia syndrome
|
93
|
2
|
14
|
|
|
Developmental and epileptic encephalopathy 98
|
93
|
2
|
16
|
|
|
FG syndrome 1
|
93
|
4
|
21
|
|
|
Isolated Coronal Synostosis
|
93
|
1
|
1
|
|
|
KIF1B-related disorder
|
93
|
3
|
1
|
|
|
MYH11-related disorder
|
93
|
2
|
1
|
|
|
Noonan syndrome 6
|
93
|
2
|
22
|
|
|
Orofacial cleft 8
|
93
|
2
|
2
|
|
|
PDZD2-related disorder
|
93
|
2
|
2
|
|
|
Primary ciliary dyskinesia 10
|
93
|
3
|
14
|
|
|
Pseudohyperaldosteronism type 2; Autosomal dominant pseudohypoaldosteronism type 1
|
93
|
1
|
2
|
|
|
Schnyder crystalline corneal dystrophy
|
93
|
3
|
6
|
|
|
Surfactant metabolism dysfunction, pulmonary, 1
|
93
|
3
|
17
|
|
|
UGT1A1-related disorder
|
93
|
1
|
4
|
|
|
VCAN-related disorder
|
93
|
1
|
1
|
|
|
Atypical hemolytic-uremic syndrome with I factor anomaly
|
92
|
3
|
13
|
|
|
Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome
|
92
|
1
|
33
|
|
|
Autosomal recessive multiple pterygium syndrome
|
92
|
3
|
26
|
|
|
Autosomal recessive nonsyndromic hearing loss 35
|
92
|
1
|
18
|
|
|
CUL4B-related disorder
|
92
|
2
|
2
|
|
|
Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; King Denborough syndrome
|
92
|
3
|
7
|
|
|
Coenzyme Q10 deficiency, primary, 1; Multiple system atrophy 1, susceptibility to
|
92
|
2
|
1
|
|
|
Congenital heart defects, multiple types, 4
|
92
|
4
|
19
|
|
|
Dent disease type 1; Hypophosphatemic rickets, X-linked recessive; X-linked recessive nephrolithiasis with renal failure; Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
92
|
3
|
4
|
|
|
Emery-Dreifuss muscular dystrophy 2, autosomal dominant
|
92
|
5
|
33
|
|
|
FAT3-related disorder
|
92
|
1
|
1
|
|
|
Left ventricular noncompaction cardiomyopathy
|
92
|
41
|
7
|
|
|
Maturity-onset diabetes of the young type 1; Type 2 diabetes mellitus; Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young
|
92
|
1
|
5
|
|
|
NLRP2-related disorder
|
92
|
1
|
1
|
|
|
Neonatal severe primary hyperparathyroidism
|
92
|
1
|
15
|
|
|
Paroxysmal nonkinesigenic dyskinesia 1
|
92
|
4
|
27
|
|
|
RECQL5-related disorder
|
92
|
2
|
1
|
|
|
Spinocerebellar ataxia type 28
|
92
|
2
|
25
|
|
|
Van der Woude syndrome 2
|
92
|
4
|
17
|
|
|
X-linked myopathy with excessive autophagy
|
92
|
2
|
11
|
|
|
ABCC6-related disorder
|
91
|
2
|
3
|
|
|
ALK-related disorder
|
91
|
1
|
1
|
|
|
Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia
|
91
|
3
|
31
|
|
|
Bronchiectasis with or without elevated sweat chloride 2
|
91
|
3
|
9
|
|
|
CRB2-related disorder
|
91
|
1
|
2
|
|
|
Congenital factor VII deficiency
|
91
|
1
|
27
|
|
|
Congenital isolated adrenocorticotropic hormone deficiency
|
91
|
2
|
18
|
|
|
Congenital muscular dystrophy due to LMNA mutation
|
91
|
3
|
20
|
|
|
Congenital myasthenic syndrome 9
|
91
|
1
|
11
|
|
|
DeSanto-Shinawi syndrome due to WAC point mutation
|
91
|
3
|
43
|
|
|
Developmental cataract
|
91
|
47
|
9
|
|
|
Glanzmann thrombasthenia 1
|
91
|
5
|
16
|
|
|
Hemolytic anemia due to glutathione reductase deficiency
|
91
|
3
|
9
|
|
|
Holoprosencephaly 4
|
91
|
4
|
14
|
|
|
Intellectual disability, X-linked, syndromic 33
|
91
|
1
|
35
|
|
|
Intellectual disability, autosomal dominant 30
|
91
|
4
|
41
|
|
|
Intellectual disability, autosomal recessive 65
|
91
|
2
|
41
|
|
|
MED12-Related Disorders
|
91
|
2
|
6
|
|
|
Oculodentodigital dysplasia
|
91
|
1
|
18
|
|
|
PCLO-related disorder
|
91
|
1
|
1
|
|
|
PTPRS-related disorder
|
91
|
1
|
1
|
|
|
Paget disease of bone 2, early-onset
|
91
|
3
|
5
|
|
|
Primary failure of tooth eruption; Chondrodysplasia Blomstrand type; Eiken syndrome; Metaphyseal chondrodysplasia, Jansen type
|
91
|
2
|
2
|
|
|
RNF213-related disorder
|
91
|
2
|
1
|
|
|
SAMD9L-related disorder
|
91
|
1
|
3
|
|
|
Sialic acid storage disease, severe infantile type; Salla disease
|
91
|
3
|
6
|
|
|
Tooth agenesis, selective, 3
|
91
|
3
|
17
|
|
|
Adult polyglucosan body disease
|
90
|
1
|
16
|
|
|
Autosomal recessive nonsyndromic hearing loss 16
|
90
|
7
|
38
|
|
|
Bethlem myopathy 2
|
90
|
5
|
30
|
|
|
Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive
|
90
|
2
|
6
|
|
|
Ectopic tissue
|
90
|
1
|
1
|
|
|
Euthyroid goiter; Rhabdomyosarcoma, embryonal, 2; Pleuropulmonary blastoma; Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome
|
90
|
1
|
4
|
|
|
Hyperparathyroidism 1; Parathyroid carcinoma; Hyperparathyroidism 2 with jaw tumors
|
90
|
2
|
5
|
|
|
Intellectual disability, autosomal recessive 7
|
90
|
1
|
22
|
|
|
NBAS-related disorder
|
90
|
2
|
1
|
|
|
Osteopetrosis with renal tubular acidosis
|
90
|
2
|
17
|
|
|
Paget disease of bone 3
|
90
|
4
|
6
|
|
|
Autosomal dominant nonsyndromic hearing loss 56
|
89
|
3
|
17
|
|
|
Autosomal recessive early-onset Parkinson disease 7
|
89
|
1
|
16
|
|
|
Autosomal recessive limb-girdle muscular dystrophy type 2L
|
89
|
1
|
37
|
|
|
BDNF-related disorder
|
89
|
1
|
1
|
|
|
CACNA1S-related disorder
|
89
|
1
|
1
|
|
|
Catecholaminergic polymorphic ventricular tachycardia 5
|
89
|
1
|
17
|
|
|
Choroidal dystrophy, central areolar 2
|
89
|
1
|
11
|
|
|
Congenital myotonia, autosomal dominant form
|
89
|
4
|
43
|
|
|
Dilated cardiomyopathy 1AA; Myopathy, congenital, with structured cores and z-line abnormalities; Myopathy, distal, 6, adult-onset, autosomal dominant
|
89
|
1
|
2
|
|
|
Dominant beta-thalassemia; Heinz body anemia; Hb SS disease; Malaria, susceptibility to; METHEMOGLOBINEMIA, BETA TYPE; Erythrocytosis, familial, 6; Hereditary persistence of fetal hemoglobin; Beta-thalassemia HBB/LCRB
|
89
|
3
|
3
|
|
|
Dyskinesia with orofacial involvement, autosomal dominant
|
89
|
1
|
31
|
|
|
Hypogonadotropic hypogonadism
|
89
|
25
|
8
|
|
|
Intellectual disability, autosomal dominant 22
|
89
|
7
|
46
|
|
|
Joubert syndrome 24
|
89
|
2
|
12
|
|
|
KDM6B-related disorder
|
89
|
2
|
2
|
|
|
KIT-related disorder
|
89
|
1
|
3
|
|
|
LDLR-related disorder
|
89
|
2
|
1
|
|
|
MED13L-related disorder
|
89
|
1
|
4
|
|
|
Meacham syndrome
|
89
|
2
|
3
|
|
|
Microcephalic primordial dwarfism due to RTTN deficiency
|
89
|
1
|
24
|
|
|
Microcytic anemia with liver iron overload
|
89
|
1
|
8
|
|
|
Noonan syndrome-like disorder with loose anagen hair 1
|
89
|
2
|
39
|
|
|
Otospondylomegaepiphyseal dysplasia, autosomal dominant
|
89
|
2
|
16
|
|
|
Pilarowski-Bjornsson syndrome
|
89
|
3
|
31
|
|
|
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5
|
89
|
3
|
7
|
|
|
Radial aplasia-thrombocytopenia syndrome
|
89
|
10
|
39
|
|
|
SPTAN1-related disorder
|
89
|
1
|
5
|
|
|
ALPK3-related disorder
|
88
|
2
|
2
|
|
|
Arthrogryposis, renal dysfunction, and cholestasis 2
|
88
|
2
|
14
|
|
|
Autosomal dominant nonsyndromic hearing loss 25
|
88
|
1
|
13
|
|
|
Autosomal recessive nonsyndromic hearing loss 84B
|
88
|
1
|
40
|
|
|
BARD1-related disorder
|
88
|
1
|
1
|
|
|
Branchiootorenal syndrome 1
|
88
|
3
|
37
|
|
|
Chopra-Amiel-Gordon syndrome
|
88
|
2
|
32
|
|
|
Coffin-Lowry syndrome
|
88
|
1
|
44
|
|
|
Combined immunodeficiency due to partial RAG1 deficiency
|
88
|
1
|
4
|
|
|
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema
|
88
|
4
|
29
|
|
|
EHHADH-related disorder
|
88
|
1
|
1
|
|
|
LRRK1-related disorder
|
88
|
2
|
1
|
|
|
MYO7B-related disorder
|
88
|
3
|
1
|
|
|
Meier-Gorlin syndrome 1
|
88
|
5
|
22
|
|
|
Multiple synostoses syndrome 3
|
88
|
1
|
6
|
|
|
Poirier-Bienvenu neurodevelopmental syndrome
|
88
|
4
|
45
|
|
|
Porphobilinogen synthase deficiency
|
88
|
2
|
12
|
|
|
Primary ciliary dyskinesia 11
|
88
|
4
|
22
|
|
|
SQSTM1-related disorder
|
88
|
2
|
3
|
|
|
Sengers syndrome
|
88
|
2
|
19
|
|
|
Au-Kline syndrome
|
87
|
3
|
45
|
|
|
Autosomal recessive nonsyndromic hearing loss 67
|
87
|
2
|
17
|
|
|
Baraitser-winter syndrome 2
|
87
|
2
|
27
|
|
|
|